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Resume 
L'objectif de cette etude est d'etudier la possibility de produire des fibres polymeriques 
modifiees en surfaces, pouvant moduler le comportement de cellules endothelials dans 
certaines directions et induire une angiogenese directionnelle dans un systeme tridimensional 
de culture des cellules. Ceci est dans le but de developper in vitro un echafaudage 
prevascularise et tridimensionnel sous la forme d'un reseau de fibres. Cette etude a ete realisee 
selon les trois etapes suivantes : 1) Modification et caracterisation des surfaces des materiaux, 
et plus specifiquement, des surfaces des fibres polymeriques, avec une modification de surface 
utilisant une strategie de multicouche par depot plasmatique de polymere en greffant du 
dextrane et des composes bioactifs afin de produire une reponse biologique previsible. 
2) Evaluation in vitro des fibres de polymere modifiees en surface sur le comportement des 
cellules endotheliales dans un systeme de culture de cellules en monocouche (2D). 
3) Evaluation in vitro des fibres de polymere modifiees en surface sur le comportement des 
cellules endotheliales (angiogeneese) dans des systemes de cultures tridimensionnels (3D) de 
cellules. 
Dans une premiere etape, la surface des fibres poly (terephtalate d'ethylene) (PET) de 
diametre de 100 (im ou des fibres du polytetrafluoroethylene (PTFE) (monofilaments) etaient 
enduites en utilisant une strategie de modification de surface par multicouche en 3 etapes. Au 
debut, les substrats ont ete enduits avec une couche mince de diedres polymeriques, d'un 
polymere obtenue d'un traitment plasma de n-hepthylamine (HApp) ou d'un polymere obtenu 
d'un traitment plasma d'acetaldehyde (AApp), contenant respectivement des groupes amines 
et des groupes aldehydes par la technique de depot d'une decharge par radio-frequence. Ainsi, 
le Carboxy-Methylique-Dextrane (CMD) a ete greffe de maniere covalente sur les groupes 
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amines disponibles sur les surfaces des substrats qui etaient enduits avec de l'HApp ou 
l'AApp-PEI, en utilisant la chimie des carbodiimides hydrosolubles. Des peptides ayant la 
sequence Gly-Arg-Gly-Asp-Ser (GRGDS) ont ete immobilises de fa?on covalente sur les 
surfaces de fibres enduites de CMD. La caracterisation de la composition chimique de surface 
en utilisant la spectroscopic par photoelectrons de rayons X (XPS), la topographie par la 
microscopie a forces atomiques (AFM) et par la microscopie electronique a balayage (SEM) a 
montre la possibility de reproduire ces etapes de multicouches lors de leurs fabrications et 
egalement la rugosite des surfaces produites par des enduits d'AApp-, d'AApp-PEI-CMD- et 
d'HApp-CMD. Par consequent, ces techniques de fabrication de multicouche en surface 
peuvent etre appliquees aux biomateriaux, en particulier des biomateriaux fibreux 
polymerique, avec des surfaces multifonctionnelles qui peuvent avoir une application 
importante en therapie et dans le genie tissulaire, comme materiel d'echafaudage pour la 
regeneration de tissu multicellulaire. 
Dans une deuxieme etape, des cellules endothelials de veine ombilicale humaine 
(HUVECs) ont ete ensemencees et par la suite evaluees en contact avec les fibres de polymere 
modifiees en surface pour etudier le comportement a moduler les cellules (par exemple, 
adherence, propagation, reorganisation du cytosquelette et orientation des cellules). Le 
comportement de cellules etait en accord avec les proprietes physico-chimiques des surfaces 
modifiees. L'adherence des cellules a ete reduite sur les fibres enduites de CMD-, tandis que 
les enduits aldehyde, amine et GRGDS ont favorise l'adherence des cellules, leurs 
propagations, et la formation de filaments d'actine et de points focaux d'adhesion. Par contre, 
l'adherence reduite des cellules sur les surfaces enduites de GRGES (controle negatif) suggere 
que les gains significatifs dans l'adherence des cellules endothelials sur les surfaces enduites 
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de GRGDS sont provoques par des reponses biologiques specifiques des integrines a la 
surface de cellules vers les ligands de RGD disponibles sur les surfaces des subtrats. 
L'adhesion des cellules augmentait en fonction de la concentration (de 0.1 mg/ml a 1 mg/ml) 
des GRGDS. Par rapport aux substrats plats, la courbure des fibres favorisait 1'orientation des 
cellules le long de l'axe des fibres. Par consequent, ces fibres de polymere modifiees en 
surface par des enduits adhesifs aux cellules, ou non-adhesifs et particulierement bioactifs 
peuvent avoir des impacts tres importants dans le genie tissulaire en particulier dans les 
modeles tridimensionnels avec des cellules. 
Dans une troisieme etape, des fibres PET modifiees ont ete evaluees pour leurs effets sur 
l'angiogeneese dans des modeles de construction de tissu 3D in vitro, en employant des trois 
methodes differentes d'ensemencement des cellules. Les resultats ont montre que 
l'angiogeneese est produite quand les fibres etaient soit pre-enduites d'HUVECs et 
incorporees dans un gel de fibrine soit que les HUVECs et les fibres sans cellule ont ete mis 
ensemble en sandwich entre deux couches de gel de fibrine. Ces resultats ont demontre que 
l'effet a la fois physique et chimique des surface des fibres induisait une angiogeneese et 
permettait d'augmenter la formation directionnelle in vitro de microvaisseaux (de structures 
angiogeniques) dans des modeles de gel de fibrine. En prolongeant la duree du temps 
d'incubation, le nombre de structures angiogeniques augmentait et un reseau se formait dans 
lequel des structures angiogeniques se connectaient d'une fibre a une autre, suivant un 
espacement optimal de 200 a 600jam entre les fibres. 
Ces resultats demontrent qu'en employant un materiel fibreux polymerique qui est enduit 
en surface d'un composant de la matrice extracellulaire, tel que le peptide de RGD ou de la 
gelatine, il devient possible d'augmenter et de diriger la formation de structures 
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angiogeniques. Ainsi, les deux objectifs principaux de cette etude, qui etaient (i) d'etablir la 
faisabilite de pre-vasculariser d'une reconstitution d'un tissu in vitro, et (ii) d'influencer le 
guidage des structures angiogeniques dans une direction predeterminee en utilisant le 
phenomene dit de 'contact guidance' et des molecules bio-actives a l'aide des fibres modifiees 
en surface, ont ete en grande partie realises. 
Dans cette etude, l'idee d'employer une fibre polymerique (100|am de diametre) pour 
moduler la cellule endothelial et pour induire l'angiogeneese est tout a fait originale. Par 
ailleurs, la modification de la surface des fibres polymerique en employant des enduits 
multicouches, y compris des traitements (adhesives) des polymeres au plasma (HApp et 
AApp), la presence d'un materiel non-fouling (CMD) et de molecules bioactives (RGD), n'a 
jamais ete rapportee par d'autres. De plus, la caracterisation physico-chimique de ces enduits 
sur la surface des fibres ainsi que leurs influences sur le comportement, tel que 1'adherence, 
l'etalement, et la modulation, des cellules endotheliales dans un systeme de culture en 
monocouche (2D) et sur l'angiogeneese dans des systemes de culture tridimensionnel n'ont 
pas ete rapportees auparavant. 
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Abstract 
The objective of this study is to investigate the possibility to produce surface modified 
polymeric fibres with the capability of both directional endothelial cell (EC) patterning and 
inducing angiogenesis in a 3D cell culture system. This is the goal for developing an in vitro, 
prevascularized 3D scaffold, made of a fibre network. This study was conducted in three steps 
as following: 1) surface modification and characterization of materials, and more specifically, 
polymeric fibre surfaces, involving a multilayer, surface modification approach, using plasma 
polymer deposition methods, dextran and certain bioactive compounds grafting, to induce 
predictable biological responses. 2) In vitro evaluation of the surface modified polymer fibres 
towards EC behaviour in a 2D cell culture system. 3) In vitro evaluation of surface modified, 
polymer fibres towards EC behaviour (angiogenesis) in three 3D cell culture systems. 
Initially, the surfaces of 100-|im diameter poly (ethylene terephtalate) (PET) or 
polytetrafluoroethylene (PTFE) fibres (as monofilaments) were coated, utilising a 
multilayered-surface modification strategy, performed in three steps. These substrates were 
initially coated, using the radiofrequency glow discharge deposition technique, with a thin, 
polymeric interfacial bonding layer, produced via n-hepthylamine plasma polymer (HApp) or 
an acetaldehyde plasma polymer (AApp), having amine and aldehyde groups, respectively. 
Carboxy-methyl-dextran (CMD) was then covalently immobilized, using water-soluble 
carbodiimide chemistry (EDC/NHS), onto the surface amine groups, present either on the 
HApp-coated or on AApp-PEI-coated substrate surfaces. In the last step, GRGDS peptides 
were covalently immobilized onto the CMD-coated fibre surfaces. The subsequent 
characterization of the applied, surface chemical composition, using X-ray photoelectron 
spectroscopy (XPS), topography examination by atomic force microscopy (AFM), and 
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scanning electron microscopy (SEM), showed that the multilayer fabrication steps were 
successful and that the surface roughness, generated by the AApp-, AApp-PEI-CMD- and 
HApp-CMD coatings, was present. 
Therefore, these multi-step surface fabrication techniques can be applied to produce 
specific biomaterials, particularly fibrous biomaterials supporting multifunctional surfaces that 
are likely to have important applications in "tissue engineering" and as "scaffolding material", 
used for multicellular tissue regeneration. 
The second research theme involves the in vitro evaluation of surface modified substrates 
towards EC behaviour. For this purpose, human umbilical vein ECs (HUVECs) were seeded 
and grown on surfaces to evaluate the cell responses such as cell adhesion, spreading, 
cytoskeleton reorganization and cell orientation. Some alternative substrates were also 
examined in order to further characterize the cell behaviour. The cell behaviour was related 
with the surface physicochemical properties of the test modified surfaces. On CMD-coated 
substrates, cell adhesion was reduced, in contrast the amine-, aldehyde- and GRGDS-coated 
substrates promoted cell attachment and spreading and actin filaments and focal adhesions 
formations. Conversely, the reduced cell adhesion on GRGES (negative control), 
demonstrates that the increased EC adhesion, on GRGDS-grafted surfaces were attributed to 
specific biological responses of cell surface integrins towards the RGD ligands present on the 
surfaces. Cell adhesion was enhanced as the GRGDS solution concentration was increased 
from 0.1 mg/ml to 1 mg/ml. In comparison with "flat" substrates, fibre curvature promoted 
cell orientation along the fibre axis. These observations demonstrate that these surface-
modified polymer fibres, bearing cell adhesive, non-adhesive and bioactive coatings, can have 
very important impacts in the success of tissue engineered devices. 
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In the third step, surface modified PET polymer fibres were evaluated towards 
"angiogenesis" in in vitro 3D tissue construct models, using three different methods of cell 
seeding. The result showed that angiogenesis process occurred when either HUVEC pre-
coated fibres were embedded in fibrin gel, or HUVECs and cell-free fibres were sandwiched 
together between two layers of fibrin gel. These results suggest that the physical effect of the 
fibres, in conjunction with the surface chemistry, promotes in vitro EC attachment, induces 
angiogenesis and enhances directional angiogenic structures formation in the fibrin-based 
models. By prolonging the incubation period, the number of angiogenic structures increased 
and a network was formed, in which angiogenic structures interconnected to each other, from 
one fibre to another, following an optimal fibre spacing ranging from 200 to 600 pm. 
These results demonstrate that through the use of a fibrous polymeric material that is 
surface coated with cell adhesive materials, in particular with extracellular matrix components 
such as RGD peptide or gelatin, it becomes possible to both enhance and direct the angiogenic 
process. Therefore, the two main goals of this study which were (i) to establish the feasibility 
of pre-vascularizing an in vitro tissue construct, and (ii) to influence the guidance of 
microvessel growth in a pre-determined direction, using phenomena known as "contact 
guidance" by means of polymer fibers and as "signaling molecules" by means of ligand-
integrin interactions were largely achieved. 
In this study, the idea of using polymer fibre (lOO-pm diameter) for both EC patterning 
and inducing angiogenesis is quite original. Moreover, polymer fibre surface modifications by 
using multilayer surface coatings, including cell adhesive plasma polymer (i.e. HApp and 
AApp), non cell adhesive material (i.e. CMD) and bioactive molecules (i.e. RGD), has not 
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been previously reported by others. In addition, the physicochemical characterization of these 
fibre surface coatings as well as their influence on EC behaviors (i.e. cell adhesion, spreading 
and patterning) in 2D cell culture system and toward angiogenesis in 3D cell culture systems 
(i.e. by using hydrogel) have not been reported elsewhere. 
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Chapter 1 
Introduction 
1.1. Problem statement 
Tissue engineering attempts to develop new techniques, as alternative therapies, for the 
repair or replacement of diseased or damaged tissues and organs. The goal of this approach is 
to overcome the scarcity problem in the supply of tissues and organs for transplantation 
therapy, by employing scientific and engineering principals to produce suitable biological 
tissues or organs (ATALA 2004; FUCHS, et al. 2001; MERTSCHING, et al. 2005, GOMES 
and REIS 2004). Though this field has been considerably advanced during past few years, the 
preserving of viable cells within thick and large tissue constructs both in vitro and in vivo is 
still a challenging issue. This is because the tissue construct needs a vascular system to at least 
supply oxygen for the transplanted cells before their longer term integration (i.e. 
vascularization) into the host tissue. However, the vascularization does not often promptly 
take place after implantation, resulting in cell death within the tissue construct 
(MERTSCHING, et al. 2005). Therefore, the in vitro development of a pre-vascularized tissue 
construct is one possibility to solve this problem. For the achievement of this aim, the 
development of scaffolding materials with the capability of induction angiogenesis, to enhance 
the vascularization, particularly in vitro, is the focus of attentions towards the fabrication of 
viable and functional tissue constructs. Therefore, in this thesis, it is proposed to use a fibrous 
polymeric material (as scaffolding material) and to coat them on surface with an ECM 
component in order to induce angiogenesis in a 3D tissue construct. In fact, this approach is 
1 
aimed at influencing the vascularization by means of scaffold material composition and 
architecture. These goals will be achieved through the use of the "contact guidance" 
phenomenon, to modulate 3D patterning of the EC by enhancing the ECs migration, 
proliferation and orientation, and the ECM components, to support the ECs attachment, and 
thereby to directe angiogenesis in vitro. 
The chemistry, topography and physics of polymeric materials at the cell-biomaterial 
interface strongly influence the function of the different cell types (WONG, et al. 2004). It has 
earlier been shown that most cell types self orient themselves and often move along fibres 
(WEISS and GARBER 1952) both biological (DUNN and EBENDAL 1978; SCHNELL, et al. 
2007; VERNON, et al. 2005) and synthetic (CURTIS and RIEHLE 2001; NEUMANN, et al. 
2003; SCHNELL, et al. 2007), having diameters in the nanometer or micrometer range, this 
behaviour being known as "contact guidance". Moreover, many studies have reported that 
micropatterned substrates, having parallel microgrooves of less than lOOjam in size, are able to 
orient different cell types (BARBUCCI, et al. 2002). However, in the transfer of these results 
from a 2D model study to a 3D tissue engineering scaffold lies a great challenge (BASHUR, et 
al. 2006; BARBUCCI, et al. 2002). Biomaterials, bearing micro-channels (YU and 
SHOICHET 2005) or porous (HURTADO, et al. 2006; PAPENBURG, et al. 2007) structures, 
are often used as 3D scaffolds for the induction and orientation of cell or tissue ingrowths. 
Nevertheless, synthetic or biological fibres could also be used to modulate cell patterning by 
performing the phenomenon of "contact guidance", when dispersed in a 3D environment. The 
use of polymer fibres to control and direct cell responses, either for 3D cell patterning or for 
directing microvessel network formation within tissue engineering scaffolds, can be an easy 
and very effective approach in the field of tissue engineering. Synthetic polymer fibres can be 
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used in various formats in tissue engineering scaffolds, such as individual dispersed fibres 
within a 3D composite or networked to a tissue engineering scaffold. 
However, the surfaces of a synthetic biomaterial often adsorb various proteins involved in 
biological media, resulting in the formation of an non-uniform protein layer on the implant 
surface (MCLEAN, et al. 2000b), in which the types of proteins and their conformations 
depend on the underlying surface properties. Moreover, the adsorbed proteins can exchange 
over time, thus producing unpredictable biological responses on the active surfaces (JUNG, et 
al. 2003; KRISHNAN, et al. 2004). In order to overcome such early stage, non-specific 
protein adsorption onto such biomaterial surfaces, these surfaces can be pre-coated with a 
layer of a bioactive compound that is able to exhibit predictable biological responses 
(MCLEAN, et al. 2000b). This has been conducted in many studies over the recent years 
(HADJIZADEH, et al. 2007; HERSEL, et al. 2003; MAHESHWARI, et al. 2000; 
RADOMSKI, et al. 1989; UNGER, et al. 2004). However, the use of proteins in medical 
applications is rather less demanding than peptides. This is because a protein may exhibit 
proteolytic degradation which makes it difficult for it to be used in long term applications 
(HERSEL, et al. 2003). Moreover, their biological activity may be influenced by the 
properties of the underlying substrate and their immobilization methods, causing difficulties in 
the comparison of the results obtained between one study and another (NEFF, et al. 1999). 
One solution employed to overcome the above mentioned problems is that of using cell 
binding motifs (i.e. small peptides) which exhibit greater stability towards environmental 
effectors (e.g. pH-variations, storage, conformational changes and heat treatments). In 
addition, in contrast with the large ECM proteins which normally comprise of many cell 
binding domains, the small peptides, by presenting only one single motif, can thus address one 
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specific type of cell adhesion receptor, resulting in the selective cell adhesion phenomenon 
(HERSEL, et al. 2003). Therefore, in order to create a selective bioactive surface, the small 
peptides are preferable to be employed. 
A bioactive substrate can be fabricated through the use of biomolecules in three ways; i.e: 
(i) physical binding (van der Waals or electrostatic) (ii) chemical reaction and (iii) simple 
mixing (HUANG 2002). Physical adsorption often occurs immediately upon contact of a 
surface with a protein containing solution (HORBETT 1981; HUANG 2002). However, such 
an adsorbtion process is often reversible; the adsorbed molecules may desorb from the surface 
over time (JUNG, et al. 2003; KRISHNAN, et al. 2004). In contrast, covalently attached 
molecules can be more stable under physiological conditions and may even be more resistant 
to interruption under harsh environments (HUANG 2002). However, it should be noted that 
covalently immobilized biomolecules on rigid surfaces may encounter a change in the 
conformation or orientation of the biomolecule which may disturb the bioactive center of the 
molecule. This will cause a reduction in the molecule's activity to occur, and therefore, in 
order to overcome this problem, a spacer layer, located between the target surface and 
biomelecule, will be needed for the immobilization of bimolecules on it (HUANG 2002). In 
addition, the material surface is often encountered with an absence of appropriate surface 
functional groups needed to support the covalent attachment. One possible solution to this 
obstacle is that of providing adequate surface functionalization to these materials. For this 
reason, chemical or physical surface modifications are needed (HERSEL, et al. 2003). 
Therefore, in the designing of bioactive surfaces, the use of a multilayer surface modification 
strategy consisting of surface functionalization, spacer molecule grafting and biomolecule 
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immobilization can be an effective approach for the provision of the desired bioactive surfaces 
with the capability of exhibiting predictable biological responses. 
Several published studies have reported on the surface modification of 2D substrates with 
cell-adhesive and cell-resistant coatings (HADJIZADEH, et al. 2007; HERSEL, et al. 2003; 
MASSIA and STARK 2001). However, there are only a few studies reporting investigations 
on the feasibility of fabricating and applying bioactive surfaces for 3D tissue development, 
with the aim of providing the particular surface chemistry within a 3D environment, desirable 
for directing cell responses and tissue culture. Therefore, it is possible that bio-active poymer 
fibres may offer a new approach first for cell patterning and then for tissue regeneration, this 
being one of the objectives of this thesis. 
In vitro angiogenesis, i.e. the tube-like structures formation with the presence of lumen by 
ECs, was first reported by Folkman and Haudenschild (1980) (VAILHE, et al. 2001). 
However, from a physiological viewpoint, a perfect in vitro angiogenesis model should be 
able to provide the environment desirable in order to perform all of the in vivo angiogenesis 
phases (i.e. those arising from the initial activation of ECs in the preexisting vessel, upto the 
final tube formation and the vascular network remodeling). Preferably, the system should also 
be easy to both generate and to use, as well as being both reproducible and quantifiable 
(VAILHE, et al. 2001). In the physiological condition, angiogenesis occurs in a 3D 
environment, thus an in vitro anogiogenesis investigation should be performed within a 3D 
system. To achieve thses aims, several 3D angiogenesis systems have been developed 
(FOURNIER and DOILLON 1992; NEHLS and DRENCKHAHN 1995b; VERNON and 
SAGE 1999; VAILHE, et al. 2001). Among the several EC culture systems, a most interesting 
model was presented by Nels in 1995, in which EC-seeded micro-carriers (beads) were 
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embedded in a fibrin gel. In this model, the capillaries are spread radially outwards from the 
beads by the invading fibrin gel in the presence of growth factors (NEHLS and 
DRENCKHAHN 1995a; NEHLS and DRENCKHAHN 1995b). Accordingly, I proposed, as 
reported in the present thesis, to develop a similar system by replacement of the micro-carriers 
by the above mentioned, surface modified polymer fibres to the design of a 3D in vitro pre-
vascularised tissue construct, consisting of fibrin gel and polymer fibres. These fibres can then 
be "networked" to form a scaffolding material for tissue engineering; in order to produce a 
pre-vascularized construct with directional microvessels. Therefore, this design is expected to 
be able to have a major impact in the regeneration of in vitro pre-vascularized, tissue-
engineered, constructs. 
1.2. The scope of this thesis 
The overall objective of this research project is that of fabricating a scaffolding material to 
both enhance and to guide the vascularization within a 3D environment, which, in turn, will 
create a desirable directional condition for the blood microvessel formation and the subsequent 
3D tissue development. In order to achieve the above mentioned aims, the following three 
specific objectives have been considered for this study: 
1. Surface modification and characterization of flat and fibrous materials, and more specifically, 
polymeric fibres surfaces, using a multilayer, surface modification strategy, generating the needed 
cell adhesive, non-adhesive and bioactive coatings, required to produce the desired biological 
response. 
2. In vitro evaluation of surface modified substrates towards EC behavior in a 2D cell culture 
system. 
6 
3. In vitro evaluation of surface modified polymer fibres towards the EC behavior 
(angiogenesis) in 3D cell culture systems. 
Objective 1: Surface modification and characterization of materials, and more 
specifically, the surfaces of polymeric fibres, with cell resistant and cell 
adhesion compounds. 
It is widely believed today that surface chemistry, physics and topography are all involved 
in the control of the behaviours of the different cell types present on polymeric materials at the 
cell-biomaterial interface. In order to achieve controlled and predictable biological responses, 
I propose to pre-coat the surface of polymer fibres with a layer of bioactive compounds that 
can exhibit predictable biological responses. To achieve this aim, one of the objectives of this 
study has been that of developing and then characterization of bioactive polymer fibres in 
order to both stimulate and direct the biological responses occuring within 3D environments. 
For this purpose, a thin polymeric layer, having either amine or aldehyde groups, was 
deposited onto the prepared substrates by means of "radiofrequency, glow discharge 
deposition" (RFGD). Plasma polymerization of n-heptylamine or acetaldehyde was performed 
within a custom-built plasma reactor. It has been demonstrated that by using this method it is 
possible to deposit a "cross-linked" organic thin film, with appropriate functional groups on 
various substrates (MOROSOFF 1990). Subsequently, carboxy-methyl-dextran (CMD), 
covalently grafted onto the n-heptylamine plasma polymer (HApp) or the acetaldehyde plasma 
polymer (AApp) coated surfaces, using the water-soluble, carbodiimide chemistry (ethyl 
(dimethylaminopropyl)-carbodiimide/N-hydroxysuccinimide) (EDC/NHS). CMD is a 
polysaccharide, with carboxyl groups that can be used as a "platform" for covalently grafting 
of bioactive compounds, and also as a low-fouling layer to limit undesirable protein adsorption 
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or cell adhesion (MCLEAN, et al. 2000b). Finaly, specific bioactive molecules (e.g. the 
arginine-glycine-aspartate peptide sequence or RGD) were covalently immobilized onto 
previously CMD coated surfaces, by the use of the carbodiimide chemistry, as described above, 
for the CMD coatings. The characterization of the coatings, in each step of the multi-layer 
surface modification sterategy, has been performed by X-ray photoelectron spectroscopy 
(XPS) analyses. Additional characterization of the multi-layer fabrication steps has been also 
carried out, using the AFM and SEM analysis techniques. 
Objective 2: In vitro evaluation of surface modified polymer fibres towards EC behavior 
in a 2D cell culture system. 
The control over cell functions (e.g. cell adhesion, spreading, orientation and proliferation), 
using biomaterial surface properties, could have a prominent impact on the design of smart 
biomaterials, prepared in order to generate functional tissues and organs. The presence of micro-
curvature and bio-signals on a surface may mediate cell patterning (i.e. orientation) by promoting 
the cell-cell and cell- matrix interactions (MAGNANI, et al. 2003). To this aim, in this phase of 
the study, the effect of fibre curvature in comparison to that of flat surfaces in addition to the 
chemical composition of the fibre surface on the ECs behaviours, were studied in terms of their 
adhesion, spreading, cytoskeleton reorganization and orientation, all within a 2D (monolayer) cell 
culture system. For this aim, human umbilical vein endothelial cells (HUVECs) were seeded 
and grown onto fibres and flat substrates to observe cell behaviour (i.e. cell adhesion in early 
culture, subsequent spreading, cytoskeleton reorganization, and cell orientation). 
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Objective 3: In vitro evaluation of the surface modified polymer fibres towards EC 
behavior (angiogenesis) in a 3D cell culture system. 
In the tissue engineering approach formation of a viable, thick and large-scale tissue 
construct (e.g. muscle) in vitro and in vivo is still one of the unresolved issues (LEVENBERG, 
et al. 2005). Therefore the development of a pre-vascularized tissue construct in vitro could be 
one of the more promising solutions to overcome this problem. This present study proposes to 
develop a vascularized in vitro 3D tissue construct, using surface modified polymer fibres to 
enhance and guide the microvessel formation within a 3D scaffold. In this part of the study, 
the above mentioned surface modified PET monofilaments were evaluated towards 
angiogenesis in 3D cell culture systems. To do that, three in vitro cell culture systems, using 
different cell seeding methods, were designed and constructed, having both untreated and 
surface-modified polymer fibres embedded in a fibrin gel, in order to demonstrate the 
feasibility of directing microvessel formation within a 3D environment. In these systems, 
HUVECs has been either introduced onto the whole surfaces of the fibres or dispersed around 
the cell-free fibres. 
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Chapter 2 
Literature review I: Biomaterials in tissue 
engineering 
2.1. Overview 
Biomaterials have been widely used in biomedical devices, and they are the subject of 
intensive research for their use in tissue engineering applications (e.g. in scaffolding 
materials). However, upon implantation, due to exposure to a multi-component biological 
media, various proteins may adsorb onto the surfaces of the implanted biomaterials 
(MCLEAN, et al. 2000b), with some exchange over time (Vroman effect) (JUNG, et al. 2003; 
KRISHNAN, et al. 2004), which affects the appropriate performance of the biomaterials. This 
problem can be solved by pre-coating a biomaterial surface with a layer of a bioactive 
compound which exhibits a predictable biological response (MCLEAN, et al. 2000b). For this 
reason, the role of biomaterials in tissue engineering is briefly reviewed in this chapter. Then, 
the cell-ligand interaction, surface modification and characterization, using biologically active 
molecules, e.g. RGD peptides, and the fabrication and characterization of cell resistant 
surfaces, have been studied. Next, the in vitro evaluation of the surface modified biomaterials 
has been presented. Finally, the explanations for the effect of material properties on cell 
behavior have been advanced. 
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2.2. Introduction to biomaterials used in tissue engineering 
Materials, having typical chemical, physical, mechanical or electrical properties, named 
biomaterials that are produced by employing or mimicking biological events. These materials 
are frequently used in medical devices, for example dental implants, artificial hip joints, artificial 
blood vessels, etc. (HANKER and GIAMMARA 1988; SCHACHT 2004). 
In the field of biomaterials the attentions have been focused on the production of materials 
with the capability of controlling cell responses at the molecular level with the aim of 
transforming cultured cells to form new tissues (MEDDAHI-PELLE, et al. 2004). Synthetic 
polymeric biomaterials, with such capability for controlling cell functions and cell-cell 
interactions, can be used either in cell-free implants as matrices to promote the tissue 
regeneration or those implants that support cells for transplantation (HUBBELL 1995). It has 
been demonstrated that upon contact with biological media a layer of proteins is formed at the 
biomaterial surface (BENMAKROHA, et al. 1995). Since in the healing process, the integration of 
an implant into the host tissue is required; therefore the adsorption of ECM proteins (e.g. FN or 
vitronectin (VN) in an active conformation) to an implant surface will be a beneficial event in this 
interaction (HUANG 20002). For this reason, these phenomena have been mimicked on the inert 
implant surfaces by incorporating extracellular matrix (ECM) components, or their functional 
domains (i.e small peptides such as RGD), to promote cell adhesion (HADJIZADEH, et al. 
2007; KOUVROUKOGLOU, et al. 2000; OLIVIERI and TWEDEN 1999). For example, the 
use of the small peptides containing RGD sequence has shown to accelerate the healing 
process and improve the quality of the regenerated tissue (STEED, et al. 1995). Conversely, in 
some other applications (e.g. contact lenses, artificial blood vessels, etc.) non-spesific adsorption 
of proteins from the surrounding biological media is required to be controlled (Haung 2002). 
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Towards achieving this aim, many studies have been conducted, using non-fouling materials, e.g. 
poly (ethylene glycol) (ALCANTAR, et al. 2000; PASCHE, et al. 2005), polysaccharides 
(HADJIZADEH, et al. 2007; MCLEAN, et al. 2000a; MASSIA and STARK 2001) to prevent 
the occurrence of undesirable biological events. 
Therefore, the surface-coated artificial biomaterials, developed in the biomaterials field, can be 
classified into two main categories, 1) biomaterials coated with a specific adhesive compound 
towards a typical biological entity and 2) materials coated with compounds resistant towards the 
biological entities present. By employing these two approaches, the creation of materials 
capable of exhibiting selective biological responses, is presently the subject of intense research 
activity. These materials may then be "patterned" in both 2D and 3D forms to generate multi-
cellular tissue constructs. These approaches continue to be assayed for application in both 
recent and future research to produce complex cellular arrangements, as found in natural 
tissues and organs (HUBBELL 1995). 
2.3. Basic biology of integrin stimulated cell adhesion (bioactivity) 
A material is described as being bioactive if it has interaction with or effect on any living 
cell or tissue. The paragraph below explains the basic mechanisms of this interaction. The 
interaction of a cell with neihgboring cells and surrounding ECM takes place via cell 
membrane receptors (Fig. 2.1). Among these membrane receptors, the integrins form the most 
multi-purpose group. These cell surface glycoprotein receptors are made by a heterodimer of 
a- and P-subunits (membrane proteins) (HERSEL, et al. 2003). These proteins, bearing large 
extracellular parts, couple together and create adhesive heterodimers (CAI, et al. 2006), which 
can match with a ligand (i.e. the ECM proteins or specific peptides) (Fig. 2.2) (HODIVALA-
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DILKE, et al. 2003). During cell aggregation and angiogenesis, the integrins play their role by 
binding to the ECM proteins (e.g. FN and VN) or to the cell surface immunoglobulin proteins, 
e.g. intercellular adhesion molecule-1 (ICAM-1) and vascular cellular adhesion molecule-1 
(VCAM-1) (DUNEHOO, et al. 2006). According to the literature, certain integrins play more 
roles than others in cell biology, for example; avP3 integrin binds many ligands, including 
FN, VN, von Willebrand factor (vWf), osteopontin, bone sialoprotein, tenascin, and 
thrombospondin (HERSEL, et al. 2003). 
Studies on the cell adhesion activities of ECM proteins such as VN, fibrinogen, collagen, 
vWf, and laminin, have shown that the small peptide sequences, including Arg-Gly-Asp 
(RGD) tripeptide involved in these proteins (Fig. 2.3), are cell adhesion sites towards the cell 
adhesion receptor present on the cell membrane (ENGEL1991). During the last several years, 
many studies have reported on the use of the RGD peptides as a small immobilized cell 
adhesion domain to promote cell attachment on the synthetic surfaces. This is because of its 
ability to bind to more than one cell membrane receptor (HERSEL, et al. 2003). Since after 
establishing FAs, cell contractile forces are able to displace weakly adsorbed ligands, leading 
to weak cell adhesions, for strong cell adhesion promotion, the covalently grafting of RGD 
peptides to synthetic surface is required. Moreover, in the case of presence of mobile ligands, 
these ligands will be removed by cell internalization (HERSEL, et al. 2003). 
For example, in our previously published study (HADJIZADEH, et al. 2007); it was found 
that covalently grafted RGD onto glass and PET, via dextran spacer layer, promoted HUVEC 
adhesion and spreading. Similarly, covalently linked RGD on glass (MANN, et al. 1999), PET 
and PTFE substrates (MASSIA and HUBBELL 1991a) or polystyrene plates (HOLLAND, et 
al. 1996) has been found to modulate HUVECs functions in terms of increasing cell adhesion 
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and spreading. Furthermore, Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide (found in laminin), an 
integrin receptor ligand, has also been covalently linked to glass substrates that have shown an 
increase in the spreading and proliferation of HUVECs (MASSIA and HUBBELL 1991a). 
Arg-Glu-Asp-Val (REDV) peptide (found in FN), has been found to be a specific EC adhesion 
peptide. Covalently grafted REDV on a PET surface, initially coated with polyethylene glycol, 
stimulated the attachment and spreading of ECs, but not that of the fibroblasts (HOLT, et al. 
1994; HUBBELL, et al. 1991), smooth muscle cells and platelets (HUBBELL, et al. 1991). 
Figure 2.1: Schematic illustration showing cell-cell and cell-ligand (ECM protein) interactions 
(adapted from WARY 2005) 
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Figure 2.2: Integrins (heterodimer of a- and P-subunits) and their ECM ligands (reproduced 
from HODIVALA-DILKE, et al. 2003) 
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Figure 2.3: The sequence, molecular formula and nomenclature of RGD tripeptide 
(reproduced from HERSEL, et al. 2003) 
2.3.1. Advantages of peptides to proteins (ligand selection) 
As mentioned above, substrate surface functionalization to obtain desired cell surface 
interactions has drawn the attention of many researchers. In cell-biomaterial interface, protein 
containing compounds mediate cell-substrate interactions. These compounds can be 
introduced onto substrate surface in three ways: (i) by pre-immobilization process onto the 
surface of the material, (ii) by adsorption process from medium that surrounds the substrate or 
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(iii) through the protein secretion by the cells during earlier culture (NEFF, et al. 1999). For 
this purpose, over the few last decades, ECM proteins have been widely incorporated onto 
synthetic biomaterials and used to promote interactions of the cell with the biomaterial (NEFF, 
et al. 1999) in both in vivo (SEEGER and KLINGMAN 1985) and in vitro (KAEHLER, et al. 
1989) applications 
The use of proteins, however, may cause some problematic conditions in the medical 
applications. Since these materials are susceptible to break down due to proteolytic 
degradation, their long-time applications, without continuous refreshment, are impossible 
(HERSEL, et al. 2003). Moreover, the effects observed for a certain protein depend on many 
factors including the underlying surface properties (e.g. chemical, topographical and charge), 
the method of immobilization and protein adsorption from the surrounding environment. All 
of these factors may cause diversity in the results obtained from one study to another. The 
protein conformation and/or orientation may change on different surface types, depending on 
surface chemical composition, wettability, topography and charge (NEFF, et al. 1999). Since 
cells bind to specific domains within their protein ligands (i.e. ECM proteins) through cell 
membrane receptors (i.e. integrins), the changes in either orientation or conformation of ligand 
on the surface relative to its cell binding domain will strongly influence the ability of cells to 
attach to these surface bound proteins. Moreover, additional non-specific proteins may be 
adsorbed from the surrounding biological media onto the test surface. These events will make 
it difficult to find a precise relationship between the ligand and the resulting cell behavior 
(NEFF, et al. 1999). Therefore, the use of small peptides instead of the large proteins, offers 
many advantages, including: (1) they exhibit higher stability towards heat treatment, storage, 
conformational changing and pH-variation, (2) able to be packed at higher density on their 
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surfaces, and (3) to bind to a specific cell surface receptor due to their representing only one 
single motif (HERSEL, et al. 2003). 
2.3.2. Bioactive molecule (ligand) immobilization 
Incorporation of bioactive ligands into a polymeric substrate can be achieved in four 
different ways: (i) physical adsorption, through the van der Waals interactions, (ii) adsorption 
through hydrophobic and electrostatic forces, (iii) inclusion in the input bulk composition, or 
(iv) immobilization via chemical reaction (HUANG 2002). As the immobilization of 
bimolecules via chemical reactions is the focus of the attention of this thesis, then a brief 
comparison between this method and that of physical adsorption is introduced in the paragraph 
below. 
It has been reported that, each approach may have both advantages and drawbacks. The 
physical adsorption of biomolecules onto surfaces is fast and generally allows for the maintenance 
of the biomolecule bioactivity, due to the process being performed under mild conditions 
(HORBETT 1981; HUANG 2002). Most proteins, adsorb on hydrophobic surfaces, via 
hydrophobic interactions (SCHAEFERLING, et al. 2002). However, on such protein adsorbed 
surfaces some exchanges may occur over time (Vroman effect) (JUNG, et al. 2003; 
KRISHNAN, et al. 2004). According to the explanation of this phenomenon, in the process of 
protein adsorption to a surface, the small proteins with low-molecular-weights first reaching a 
surface are displaced by the larger proteins that arrive late (VROMAN, et al. 1971). 
Covalent immobilization of a biomolecule onto the surface of a polymeric substrate 
produces an irreversible bond which is more stable under the physiological conditions 
(HUANG 2002). However, it should be noted that covalent grafting of a biomolecule onto a solid 
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surface may change the conformation or orientation of the biomolecule and thus disturb its 
bioactive center. As a result, a reduction in the molecule's activity is caused (HUANG 2002). 
Therefore, a spacer layer will be needed to be used as a platform on which to covalently 
immobilize the biomolecule. In addition, the material surfaces usually encounter an absence of 
the appropriate surface functional groups to support the covalent attachment. One possible 
approach for overcoming these problems is that of providing surface functionalization to these 
materials. For this reason, there are currently a large number of research groups that have 
focused on these chemical and physical surface modification methods, and are endeavouring 
to produce thereby surfaces that are capable of inducing successful immobilization of the 
biomolecules (HERSEL, et al. 2003). 
Chemical and physical treatments to introduce functional groups for covalent 
immobilization of ligands 
Several methods, based on chemical and physical treatments, have been employed to 
introduce functional groups onto the polymer surface. For example, track-etching, reduction, 
oxidation, or plasma deposition has all been used to produce appropriate surface chemical 
groups on PET and Teflon surfaces. For instance, PET has been modified by track-etching to 
generate a mixture of carboxyl and hydroxyl groups, which may then be treated, either by 
using reducing against (e.g. sodium borohydride) to obtain uniform hydroxyl 
functionalization, or they can be oxidized by using an oxidizing agent (e.g. potassium 
permanganate) to obtain the carboxylic acid end groups. As another example the surfaces of 
Poly (tetrafluoroethylene-co-hexafluoropropylene) (FEP) can be treated, by the reduction of 
this polymer with appropriate reducing agents (e.g. sodium naphthalide), to thereby generate 
carbon-carbon double bonds. These may then be converted to carboxyl groups within a further 
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oxidation step (HERSEL, et al. 2003). In addition to surface functionalization by means of "wet 
chemical" treatments, plasma-deposited polymeric thin films also offer an alternate route to 
create a platform having appropriate surface functional groups, for later use in the biomolecule 
immobilization performed on various materials (HADJIZADEH, et al. 2007). 
Surface modification by plasma polymerization 
The term "plasma" is used here to refer to the very high energy content of the "fourth state 
of matter" which includes equal numbers of oppositely charged species. Over recent decades, 
"cold plasma" has been increasingly used to induce chemical reactions on the surface of 
various substrates by active species generated in the plasma environment, including both 
organic and inorganic materials. It has also been demonstrated that the surface properties of 
materials, including their surface roughness, surface energy and their optical and electrical 
properties, can all be modified via the plasma process. Thus polymer surfaces can be treated in 
cold gas plasma in three ways, i.e. plasma treatment, plasma induced grafting, and plasma 
polymerization, leading to the creation of materials with new properties for biomedical 
applications (MOROSOFF 1990). 
Plasma treatment 
Surface treatment by plasma is a plasma reaction process employed for the surface 
modification of materials, by creating atomic substitution or by alteration of the molecular 
structure of the surface at low temperatures. In this process, both high energy ultraviolet light 
and charged species (i.e. high energy ions and electrons) are created in the gases present, such 
as oxygen, nitrogen, argon, etc. This energetic event provides the input energy necessary to 
fracture polymer bonds and thereby initiate chemical reactions at the polymer surface, altering 
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the top few atomic layers without significantly affecting the bulk properties of the polymer 
[website ref.l]. 
Plasma-induced grafting 
The plasma-induced grafting process takes place in two steps, the surface is initially 
functionalized by the use of a gas-plasma treatment, and then a desired monomelic chemical is 
grafted onto the functionalized substrate via polymerization treatment (GUPTA, et al. 2002). 
Plasma polymerization 
Plasma polymerization has now become widely accepted and used to modify the surfaces 
of a wide range of materials. In this process, the vapor of an organic chemical is polymerized, 
at low temperatures to produce a cross-linked thin film on the substrate surface. In the plasma 
polymerization, the plasma is initially created through the ionization of gases or vapors present 
in the reactor, and secondly, the fragmentation of monomelic chemicals (i.e. organic vapors) 
leading to the polymerization takes place. Various positive ions, e.g., C+, CH+, CH2+ etc.; 
radicals and other excited fragments are produced when high-energy electrons crash with 
hydrocarbon molecules, resulting in the formation of plasma polymer on the surface. The 
properties of these plasma deposited thin polymeric films can be influenced by the plasma 
polymerization parameters, such as the monomer flow rate, the system pressure and the discharge 
power (MOROSOFF 1990). 
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2.3.3. Methods for the covalent immobilization of RGD peptides to 
functionalized surfaces. 
Generally, peptides and proteins are grafted onto those particular polymers that contain 
carboxylic acid groups, via a stable, covalent amide bond. This union can be achieved by the 
reaction of an activated surface, carboxylic acid group with the nucleophilic N-terminus of the 
peptide. Carboxylic acid groups may be activated through the use of a condensing agent which 
can accelerate the reaction between the COOH groups at the surface and the NH2 groups of the 
protein or RGD peptide, e.g. l-ethyl-3-(3Dimethylaminopropyl)-carbodiimide (EDC, water 
soluble carbodiimide, WSC), dicyclohexyl-carbodiimide (DCC) or carbonyl diimidazole 
(CDI) (GAO, et al. 2003; HERMANSON 1996; HERSEL, et al. 2003). 
However, the use of this coupling method may lead to two problems being encountered, 
including: (i); intermolecular condensation of the RGD peptide. This event can take place due 
to the existence of further reactive groups within the RGD molecule (Fig. 2.3) (i.e. the two 
carboxyl groups, one at the C-terminus and the other in the aspartic acid side chain and also 
the nucleophilic guanidino group of the arginine side chain), and (ii); deactivation of carboxyl 
groups due to hydrolysis of the coupling reagent and activated carboxyl groups (HERSEL, et 
al. 2003). One possibility for overcoming these problems involves the use of protected RGD 
peptides (i.e. the reactive amino acid side chains are blocked with protecting groups) and to 
use non-aqueous solvents, such as dimethylformamide (DMF), dichloromethane or acetone. 
However, this immobilization strategy has to be performed under "harsh" reaction conditions 
in order that the protecting groups (HERSEL, et al. 2003) are satisfactorily removed. 
It should be noted that, the coupling process through the use of unprotected RGD peptides 
in water, is also possible. This approach is conducted via a two step procedure, as an 
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alternative. In this two step procedure, the carboxyl group is initially activated to produce an 
active ester, e.g. the N-hydroxysuccinimide (NHS) ester which is less prone to hydrolysis. The 
peptide is then coupled with the activated carboxyl group, either in water, dichloromethane or 
DMF, in the presence of EDC (Fig. 2.4) or DCC to activate the carboxyl groups for 
subsequent reaction with NHS (HERSEL, et al. 2003). The half-life of the NHS active esters 
can be affected by varying the pH of the aqueous solution. At near neutral pH values, the half-
life time ranges between several minutes and hours, depending on the substituents attached to 
the a-carbon atom. The higher pH values and salt concentrations can cause a reduction in the 
half-life time of the NHS active ester, bringing it down to less than 1 min. The coupling of the 
activated carboxyl groups with the amine groups is usually completed in a period of between 1 
and 2 hrs. The product yield may be controlled by varying the coupling condition, e.g., it can 
be increased by lowering the pH and/or temperature values over a longer coupling time. 
Moreover, the use of higher peptide solution concentrations may produce higher peptide 
densities on the surface (HERSEL, et al. 2003). 
RGD peptides can also be immobilized on polymer surfaces, via pre-activated amino or 
hydroxyl groups, or via some other methods. For more detailed discussions on these matters, 
see the following references (HERMANSON 1996) and (HERSEL, et al. 2003) respectively. 
Figure 2.4: RGD peptides linked via the N-terminus to carboxyl groups, carboxyl groups 
(COOH) being preactivated with a carbodiimide and NHS, to generate an active 
ester on the polymers (adapted from HERSEL, et al. 2003). 
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2.3.4. RGD surface arrangement 
A certain minimum spacing between the RGD sequence and the binding site of the integrin 
may sometimes be important for cell attachment, so that, in order to mimic the position of the 
RGD sequence in its distinct protein, the RGD peptide must project from an artificial surface in 
order to reach the binding site of the integrin. This can be achieved by the covalent grafting of the 
RGD, via a spacer molecule. However, despite the many reports that have been published about 
the effects of the spacer on the activity of RGD peptides, the role of the spacers on the activity 
of the RGD is still not fully understood. The revealed data are often in disagreement from one 
study to another. Therefore, more investigation is still needed to better clarify this issue 
(HERSEL, et al. 2003). 
Taken together, the best way to produce a stable bioactive surface is the covalent 
immobilization of the bioactive peptide, e.g. RGD peptides, via a two step procedure 
conducted on an initially functionalized surface. Among the several methods presented for 
surface functionalization, the plasma polymer deposition with an appropriate functional group, 
e.g. NH2 or CHO, can be the preferred method because the plasma deposition can be 
performed on a variety of substrates. In addition, in order to retain the maximal activity of a 
covalently immobilized biomolecule, a "spacer layer" is often introduced between the target 
surface and the biomolecule. To achieve this aim, those polymers with non-fouling properties 
and containing extra functional groups are the more demanding materials (LOFAS and 
JOHNSSON 1990; HERSEL, et al. 2003). Then, bioactive molecules, e.g. peptide sequences 
and growth factors, can be covalently attached to the surfaces containing these polymer chains 
so as to promote cell-surface interactions. 
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2.4. Low- fouling materials 
Besides the bioactive surfaces, protein-resistant or non-fouling surfaces are also important 
in many fields, including biomedical devices, tissue engineering and biosensors (HUANG 
2002). Protein adsorption and cell adhesion on biomaterial surfaces are known to be related to 
the interfacial forces present between the substrate surface and contacting biological entities. 
These interfacial forces (i.e. the electrostatic interactions, hydration forces, and steric-entropic 
effects) are generated by surface chemical groups, wettability, charge and surface structure of 
the biomaterial (MCLEAN et al. 2000a). To produce low-fouling surfaces, some polymers, 
such as poly (ethylene glycol) (PEG) (ALCANTAR, et al. 2000; ZHANG, et al. 1998; 
PASCHE, et al. 2005), poly (vinyl alcohol) (BARRETT, et al. 2001) and some 
polysaccharides, e.g. carboxymethyl dextran (CMD) (HADJIZADEH, et al. 2007; MCLEAN 
et al. 2002a), have been studied and have shown to possess the ability to minimize the 
adsorption of proteins (MCLEAN et al. 2002b) and cell adhesion (HADJIZADEH, et al. 2007; 
MCLEAN et al. 2002a). These polymers can be also employed as functional platforms for 
bimolecule immobilization, to produce specific biological responses. 
2.4.1. Polyethylene glycol (PEG) 
PEG is a polymer, having hydrophilic and electrically neutral properties that have been widely 
used for protein- and cell-resistant surface modifications. Un-modified, PEG polymer chains are 
linear, having only two terminal reactive groups (Fig. 2.5). Therefore, in using this polymer as a 
platform (spacer layer) for biomolecule grafting only one of the two reactive groups will become 
available for the biomolecule coupling. Subsequently, non-sufficient concentrations of covalently 
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attached bioactive molecules will be produced, to promote biospecific responses on their surfaces 
(MASSIA and STARK 2001). 
Figure 2.5: Polyethylene glycol polymer. 
2.4.2. Polysaccharides 
In addition to PEG, polysaccharides as low-fouling materials have also been the focus of 
attention in recent biomaterials research. Polysaccharide coatings can prevent the adhesion of 
mammal cells to synthetic biomaterials and reduce adhesion of bacteria in vitro and in in vivo 
applications (MORRA and CASSINELI 1999). Thus, dextrans, and their derivatives, have 
been used as low-fouling coatings (LOFAS and JOHNSSON 1990; MCARTHUR, et al. 
2000a). The interfacial forces involved in the interactions of polysaccharide coatings with 
biological molecules, and cells present in biological media, arise from their chemical 
composition and structure. In fact, polysaccharides mainly reject proteins or cells by their 
hydrated, hydrogel-like structure and the steric-entropic forces generated by their mobile 
molecular chains (MCLEAN, et al. 2000a). 
Carboxymethyl dextran (CMD) (Fig. 2.6) is a derivative, a carboxymethyl substitution of 
dextran, which is synthesized by the reaction of dextran with bromoacetic acid (LOFAS and 
JOHNSSON 1990). CMD has been of interest in this thesis study because of its low-fouling 
properties and the incorporated COOH groups which are able to be employed to covalently 
n 
PEG 
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immobilize biomolecules. A schematic of the CMD chains, grafted onto the substrate surface, 
having carpet-pile like structure is shown in figure 2.7. 
—CM 2 
COOH 
Figure 2.6: Carboxymethyl dextran (CMD) (adapted from MCARTHUR, et al. 2000) 
Figure 2.7: CMD chains having COOH groups (black dots) grafted on the surface with a 
carpet-pile like structure 
2.5. Physicochemical characterization of surface modified 
polymers 
2.5.1. Characterization of thin film coated surfaces 
The most recent physicochemical surface analysis methods that have been widely used 
for the analysis of thin film coated surfaces are: - XPS, AFM and SEM (See appendix for 
more details on the basics of these techniques). The elemental and chemical composition of 
surfaces can be analyzed by electron spectroscopy for chemical analysis (ESCA) or XPS 
(RATNER and CASTER 1997). The topography of the surfaces can also be quantitatively and 
qualitatively analyzed by AFM (LEGGETT 1997). SEM is still being used in morphological 
analysis because of having a more satisfactory depth of focus (~ 300 times greater than that of 
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a light microscope). Many studies have employed the XPS technique (GENGENBACH, et al. 
1996) and AFM (HARTELY, et al. 2000) for the measurement of surface elemental 
compositions and the surface topography of plasma coated surfaces, respectively. Similarly, 
XPS (MASSIA and STARK 2001; MCLEAN, et al. 2000a) has been employed to characterize 
the above-mentioned polysaccharide grafted surfaces. 
2.5.2. Characterization of RGD modified polymers 
The analyses of RGD grafted surfaces should be capable of revealing the presence of RGD 
peptides, either directly or indirectly. According to the literature, several methods have been 
employed for the qualitative and quantitative analysis of RGD coated surfaces (HERSEL, et 
al. 2003; GODDARD et al. 2007). Among the range of available spectroscopic base methods, 
XPS has been most frequently used for direct dectection of covalently grafted RGD on those 
surfaces, displaying a coating rich in both nitrogen and in C=0 carbons. Moreover, this 
technique is capable of detection the vertical distribution of nitrogen (by varying the take-off 
angle), revealing the presence of the peptide in at least 10 nm (the XPS analysis) depth 
(HERSEL, et al. 2003). By incorporating an elemental tag (e.g. fluorine or iodine) into the 
RGD peptide, the quantification of covalently grafted RGD will also be possible 
(BILTRESSE, et al. 2005; HERSEL, et al. 2003). Evaluation of the biological activity of the 
RGD-coated surfaces is another indirect method that has been used to determine the RGD 
densities on the surface, by measuring the amounts of attached cells (HERSEL, et al. 2003). 
Several other spectral and non-spectral methods have also been employed to analyse RGD-
coated substrates, both qualitatively and quantitatively. These methods have been explained in 
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detail in two excellent review articles provided by Hersel et al. (2003) and Goddard et al. 
(2007). 
2.6. In vitro evaluation of surface modified biomaterials towards 
cell behavior 
In vitro studies have been performed in order to evaluate the biological properties of the 
modified material surfaces for future medical applications. For the biomaterials that will be 
applied as matrix for anchorage-dependent cells; cell attachment, cell spreading, cytoskeletal 
reorganization, formation of focal adhesions, proliferation and cell motility are mainly 
evaluated (HERSEL, et al. 2003). The 4 first named events, which comprise the basic process 
of integrin-mediated cell adhesion (HERSEL, et al. 2003), have been explained in Chapter 6 
(section 6.2). 
Cell adhesion to artificial surfaces is important for its use in many biomedical and 
biotechnological applications. In the case of anchorage-dependent cells, adhesive interactions 
play important roles in cell functions such as cell survival, growth, and differentiation, by 
activating various signaling pathways (KESELOWSKY, et al. 2004). For instance, it has been 
shown that not only is the cell attachment but the cell morphology also is an important 
parameter in the EC growth, when cultured on adhesive plastic culture dishes (coated with 
poly (2-hydroxyethyl methacrylate)) (FOLKMAN and MOSCONA 1978) and FN coated 
substrates (INGBER 1990). According to the published reports, cell adhesion to RGD-coated 
polymers is time-dependent (HERSEL, et al. 2003). In many studies, cell adhesion is tested, 
usually 1-6 h, after cell seeding (BILTRESSE, et al. 2005; HADJIZADEH, et al. 2007; 
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HERSEL, et al. 2003; LARSEN, et al. 2006; MASSIA and STARK 2001). In order to quantify 
the cell adhesion, non-adherent cells can be eliminated through washing, shaking or 
centrifugation. The attached cells can be quantified by the use of different colorimetric 
methods (HERSEL, et al. 2003). Cell spreading can be qualitatively evaluated by the observation 
of cells under the microscope (optical microscope or SEM), and the use of specific fluorescent 
compounds makes it possible to visualize the actin filaments by fluorescence microscopy. By use 
of immunocytochemistry with specific antibodies, the components involved in focal adhesions can 
be detected. Cell motility can also be measured (e.g. by the use of time-lapse microscopy) and 
the physical processes involved in the migration of cell have been explained in the following 
references (LAUFFENBURGER and HORWITZ 1996; SHEETZ, et al. 1999). 
To ensure if cell adhesion on RGD coated surfaces is due to the biospecific interaction 
between the cells and RGD, the three following controls can be employed: (i) non-coated surface, 
(ii) surfaces coated with inactive peptides (or negative control peptide) and (iii) competition 
between covalently bound and un-bound RGD peptides. The unbound peptides can be introduced 
to the culture system before or after cell attachment, which may prevent cell adhesion or lead to 
cell detachment, respectively (HERSEL, et al. 2003). 
2.7. Effect of biomaterial properties on cell behavior 
Material properties, such as chemical, topographical, and mechanical features, can be 
classified into three groups of stimuli, to which a cell will respond (CURTIS and 
WILKINSON 1997; TAN and SALTZMAN 2002; WONG, et al. 2004). These three different 
types of cues exhibit almost similar effects; e.g. the cell shape has been changed by modifying 
the chemistry, topography, or mechanics of the substrate (Fig. 2.8) (WONG, et al. 2004). 
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Figure 2.8: The effect of substrate surface chemistry, topography or mechanics on cell 
response: A) Fibroblasts on type I collagen-coated polyacrylamide substrata. Top 
panel has lower surface concentration than bottom panel. B) Vascular smooth 
muscle cells on polydimethylsiloxane (PDMS) substrata; with no topographical 
features (top panel), and with microgrooved topography (bottom). Both textured 
and nontextured PDMS were treated with FN. C) VSMCs on polyacrylamide 
substrata with different elastic modulus. The lower panel is stiffer than the upper 
panel. Substrata have been modified with collagen (reproduced fromWONG, et 
al. 2004). 
2.7.1. Material stiffness 
There are several reports advising that cells are able to respond to the substrate stiffness 
(LO, et al. 2000; PELHAM and WANG 1998; YEUNG, et al. 2005; YAMAMURA, et al. 
2007). The stiffness of the surface, supporting cell attachment, influences cell behaviour in 
terms of cell morphology and protein expression. However, this effect, depending on cell 
membrane receptors, varies with different cell types. For example, fibroblasts and ECs spread 
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and form actin stress libers only when grown on surfaces with an elastic modulus greater than 
2,000 Pa. (YEUNG, et al. 2005). Lo et al. (2000) have demonstrated that fibroblast cells probe 
substrate rigidity to select their preferable direction to move. In addition, they believed that 
controlling the mechanical strain within a flexible substrate can be another concept to guide 
cell movement direction. It has been concluded that the cells may respond to substrate rigidity 
via their contractile forces by which they interpret the deformation in the substrate and 
determine a new preferable direction to move on a surface. In addition, it has been found that 
not only cell movement rate but also cell shape can be affected by substrate rigidity (LO, et al. 
2000). They found these by culturing the cells on substrates with different rigidities, but with 
the same chemical properties. The mechanical properties of substrates not only affect cell 
behaviour in 2D (monolayer) cell culture but have also been reported to regulate the 3D 
network formation by the ECs. For example, Ingber et al. (1989) have shown that the softer 
materials increased the formation of tube-like structures in 3D. Sieminski et al. (2004) 
suggested that the relative magnitudes of the forces generated by the ECs and the matrix 
stiffness may also play a regulatory role in the microvessel formation in vitro and in vivo. 
Moreover, bovine pulmonary microvascular ECs formed dense, thin networks in the flexible 
collagen gel, whereas thicker networks were formed in the rigid gel (YAMAMURA, et al. 
2007). 
2.7.2. Surface topography 
A range of studies have demonstrated that the surface topography directly affects cell 
behavior, such as its orientation, migration, cytoskeletal production and arrangements 
(ANDERSSON, et al. 2003; CURTIS and WILKINSON 1997; TAN and SALTZMAN 2002; 
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FLEMMING, et al. 1999). The topographical factors affecting cell behavior can be classified 
into two main categories, including the shape and scale factors. In the case of the shape factor, 
the surface topography, which can influence cellular interactions, includes the grooves, ridges, 
pores, steps, nodes, wells, and adsorbed protein fibres (BARBUCCI, et al. 2002; CURTIS and 
WILKINSON 1997; FLEMMING, et al. 1999; IBRAHIM, et al. 2007; PALMAZ, et al. 1999; 
LIU, et al. 2005). For the scale factor, many studies have appeared reporting on the effect of 
nanometer or micrometer range features on the cell responses (ANDERSSON, et al. 2003; 
BARBUCCI, et al. 2002; BARBUCCI, et al. 2005; PAPENBURG, et al. 2007; SCHNELL, et 
al. 2007; SENESI, et al. 2007). A review article describing the effect of the substrate surface 
topography with various shapes and scales on different cell types has been provided by 
Flemming et al. (1999). 
According to some published reports, EC behavior, mostly involving cell migration and 
orientation, can be influenced by the micro-topography of the substrate. For instance, the 
effect of micropatterned (10, 25, 50 and 100|_im stripes) materials on EC behaviour have been 
investigated in terms of cell attachment, migration and orientation. In decreasing the stripe 
dimensions, a more "fusiform" shape of the adherent ECs has been observed. At the same 
time, these stripes have promoted the cell migration and orientation (BARBUCCI, et al. 2002). 
A pattern of parallel grooves at micrometric scale increased (2x) the migration rate of the ECs 
over the metallic surfaces used for endovascular stent applications (PALMAZ, et al. 1999). 
However, it has been shown that the surface chemistry is dominant in modulating different 
cell responses (BARBUCCI, et al. 2003; PASQUI, et al. 2005). For example, Pasqui et al. 
(2005) have reported that the stripped micropatterns of hyaluronan (Hyal) and aminosilanized 
glass stimulated the lymphatic ECs orientation. However, they have shown that topographical 
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parameters in conjunction with surface chemistry become effective in controlling cell 
behaviour, but not solely. Barbucci et al. (2003) have also reported that the surface chemistry 
was dominant in modulating different cell behaviors on the grooves with 250 nm height and 
100, 50, 25 or 10 pm widths, obtained by the photoimmobilization of natural polysaccharide 
hyaluronic acid (Hyal) and its sulfated derivative (HyalS) fixed on silanized glass. In addition, 
it has been reported that nano scale surface features can influence the EC function. Miller et al. 
(2004) have shown that nano-structured substrates (i.e. cast PLGA) promoted the EC and 
smooth muscle cell growth. Furthermore, increased roughness of the biomaterial surfaces, 
even at the lO-lOOnm scale, promotes the adhesion and growth of the HUVECs on 
polyurethane coated by PEG-RGD (CHUNG, et al. 2003b). 
Contact guidance 
Guided cell movement is an important fundamental process occurring in the development 
and regeneration of cells and tissues. The surface topography, including the fibre diameter or 
its curvature, is an interesting concept to promote cell behavior, including cell movement and 
orientation (CURTIS and RIEHLE 2001; HADJIZADEH, et al. 2007; KHANG, et al. 1999; 
SANTOS, et al. 2007). For instance, different cell types have shown to be able to both initially 
orient and then move along the available biological or synthetic fibres with fibre diameters 
less thanlOOfim (CURTIS and RIEHLE 2001; KHANG, et al. 1999). This phenomenon, 
which is now called "contact guidance", was discovered by Paul Weiss (1945) (Figure 2.9) 
(CURTIS and RIEHLE 2001). Khang et al. (1999) investigated the interaction of fibroblast 
cells onto PET fibres with different diameters and observed that cells orient along the fibre 
axis (108 p,m diameter). Their study suggested that the degree of cell orientation depended on 
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the fibre diameter, the maximum cell orientation occured with fibres diameter in the range of 
21-108 (nm. Also, carbon fibres were able to orient migrating cells and thus enhance their 
movment (CURTIS and RIEHLE 2001). Further investigations into the effect of fibre 
diameter on cell behavior would be useful towards the better understanding of the role of 
dimensional patterning. 
Figure 2.9: Contact guidance, a scanning electron microscopy (SEM) image of two epitenon 
cells highly aligned to the "steps" previously created in a grooved silica substrate 
(reproduced from CURTIS and RIEHLE 2001). 
Therefore, the use of fibrous biomaterials can be an alternative to apply the phenomenon 
of "contact guidance" to modulate the cell responses. To further this aim, PET and 
polytetrafluoroethylene (PTFE) fibres are 2 representative biomaterials which can be the 
appropriate choices for studying the effect of curvature on cell behavior, or more specifically, 
the 3D cell patterning. Indeed, they have been utilized extensively as vascular prosthesis and 
also in many related studies (BILTRESSE, et al. 2005; LI, et al. 2001; LIU, et al. 2006; XIE, 
et al. 2002; ZHAO, et al. 2003). Most importantly, they are amenable to many of the surface 
modification methods to produce the more desirable surface chemistry. 
2D versus 3D cell patterning 
The two dimensional (2D) patterning of proteins and cells on the surface is of particular 
interest for use in many biotechnological and biomedical applications, including bioanalytical 
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devices, medical and dental implants, and in studies of cell material interactions in tissue 
engineering (THISSEN, et al. 2006). 2D cell patterning has been performed by means of cell 
adhesive and non-adhesive coatings on the surfaces, which has been provided with the aid of 
various techniques such as surface masking (THISSEN, et al. 2006) or lithography 
(MIRONOV, et al. 2003; RINGEISEN. et al. 2006). Lithographic methods have been used to 
provide patterns of pre-coated 2D surfaces to promote both cell adhesion and repulsion on the 
microscopic scale. The patterned surfaces are introduced to a concentrated cell solution by 
which areas with cell adhesion compounds trap cells in suspension, while areas with cell 
repulsive molecules are left acellular (RINGEISEN, et al. 2006). Recently, Thissen et al. 
(2006) have employed a similar method, called surface masking, by which means they have 
provided a surface with cell adhesive and a cell resistance area by means of a plasma polymer 
and a non-fouling material, respectively. 
However, in vivo cells live in a 3D environment in contact with the surrounding 3D mesh-
like fibres of the ECM, but not on a pure 2D surface (CUKIERMAN, et al. 2002; GEIGER, et 
al. 2001). The interactions of those cells with 3D ECM matrix play the main roles in 
regulating the cell functions, including cell growth, migration, differentiation and survival; and 
in mediating other physiological responses such as tissue organization and matrix remodelling 
(HYNES 1999). Flat and rigid 2D surfaces can influence the cell-matrix interactions, 
organized by integrins and the signals that they transmit. Thus, artificially rigid 2D substrates 
may not provide such condition to exhibit the in vivo reality by forcing cells to adapt to these 
surfaces (WOZNIAK, et al. 2004). In addition, 2D substrates also have limitations in 
transferring cultured cells to the tissue mass. 
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Regarding the influential role of the environment in which the cells are located, in respect 
of cell functions, control over this environment is needed in the scaffold design for both cell 
and tissue growth. To further this aim, the cells should be grown in a 3D environment, having 
proper and close characteristics such as chemical, topographical and mechanical to those of in 
vivo environments (CUKIERMAN, et al. 2002). However, fabrication of scaffolding material 
with 3D structures on the micrometric scale is still a real issue in the biomaterial field to 
thereby design an appropriate substrate. The majority of the current fabrication techniques are 
based on the related processes used in the microelectronics field. Up until now, the 4 
techniques that have been mainly used are the followings: lithography (i.e. photolithography, 
soft lithography), direct writing, and laser ablation (LIU, et al. 2005). However, lithographic 
methods are not able to provide heterogeneous patterns of cells or molecules in 3D tissue 
scaffolds because of the reliance of these techniques on covering the surface of the patterns by 
cell adhesion molecules to attach the cells to the surface (RINGEISEN, et al. 2006). 
3D structures can also be produced by the last two techniques, although these techniques 
are limited in the creation of complex patterns, due to the methodological restrictions. Readers 
interested in more information on the above mentioned 4 techniques are referred to the 
following publications (ENTCHEVA and BIEN 2005; LIU, et al. 2005). 
There are also several published reports studying cell behavior towards micro-fabricated 
substrates including patterns of grooves, pores, spheres, nodes, and cylinders which are close 
to 3D patterning (FLEMMING, et al. 1999; KHADEMHOSSEINI, et al. 2006; MATSUDA 
and NAKAYAMA 1996). Among these, groove structures have been utilized more than others 
in the study of controlling cell response by surface topography. Theses investigations have 
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demonstrated that cells orient themselves along the grooves long axis by establishing their 
cytoskeletal elements to lie parallel to these features (FLEMMING, et al. 1999). 
Cell printing, as an advanced technique in tissue engineering, has attracted much attention 
over the past few years. This technique has the capability of fabricating heterogeneous 3D 
scaffolds in a cell-by-cell printing fashion. The different methods of this technique have been 
described in a review article, provided by Ringeisen et al. (2006). However, although tissue 
engineering is optimistic to fabricate advanced tissue constructs and, as a result, to generate 
organ by using this technique, vascularization of these tissue constructs still remains a 
challenging issue (MIRONOV, et al. 2003). Electrospinning is another method for fabricating 
3D scaffolds, which can be used to fabricate fibrous scaffolds with nanoscale resolution 
(KHADEMHOSSEINI, et al. 2006). Fibrous scaffolds have recently become the focus of 
interest in tissue engineering to promote the EC adhesion, then growth, and subsequently, the 
angiogenesis stimulation (SANTOS, et al. 2007; UNGER, et al. 2005a; UNGER, et al. 2005b). 
When taken together, and in considering the cost and complexity of the fabrication and 
subsequent surface treatment of substrates, fabricated by means of methods explained above, 
the use of individual polymer fibres (monofilaments) in order to achive 3D cell patterning and 
3D scaffold fabrication, can be an alternative. Polymer fibres can be easily surface modified 
with the desired cell adhesive or non-adhesive compounds. Then, the surface modified fibers 
can be either used individually, networked to form a scaffold or join together in a composite 
with other desired scaffolding materials, e.g., hydrogels, to produce patterned constructs in 
various shapes and sizes. The latter can be also used as a model substrate to study cell 
behavior for involvement in different aims in tissue engineering. 
37 
2.7. 3. Surface chemistry 
The effect of surface biochemistry on cell function, being one of the objectives of this 
thesis, has been explained earlier in this chapter. Here, as a complement to that, the effect of 
surface functional groups, wettability and charge are briefly reviewed. 
Functional groups 
As mentioned earlier, the responses of different types of cells on polymeric materials 
depend on the surface chemistry. Usually, cells attach to biomaterial surfaces via a layer of 
adsorbed proteins such as VN and FN. On the other hand, the conformation and orientation of 
adsorbed proteins may be affected by the underlying substrate properties, e.g. surface 
chemistry and wettability (KESELOWSKY, et al. 2003). Subsequently, these events may 
influence integrin receptor binding and subsequent cell functions (KESELOWSKY, et al. 
2004; KESELOWSKY, et al. 2005). For a better understanding of the underlying molecular 
mechanisms governing these events, some studies have been undertaken by Keselowsky and 
others, by creating defined functional groups (i.e. CH3, OH, COOH, and NH2) by using self-
assembled monolayers (SAMs) of alkanethiols on gold. Then the effects of surface chemistry 
on FN adsorption, integrin binding, and cell adhesion have been studied by using these model 
surfaces. They found that all of the three following test parameters i.e., FN adsorption, (X5P1 
integrin binding to the adsorbed FN and subsequent cell adhesion strength to FN-coated 
surface were affected by surface chemistry, following the trend: OH > COOH = NH2 > CH3 
(KESELOWSKY, et al. 2003). However, in a similar study reported by Lee et al. (2006), the 
FN adsorption showed the trend: OH< COOH< NH2< CH3 on a model system of alkylsilane 
SAMs with the same functional groups (i.e. OH, COOH, NH2 and CH3) created. Therefore, 
the full understanding of the effect of surface chemical groups on protein adsorption and 
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subsequent events (e.g. cell adhesion) remains a challenging issue to fully understand and 
requires more intensive investigations. 
Two other surface characteristics, arising from the surface chemistry, may have influence 
on cell functions, and have been classified separately as 1) wettability (hydrophilicity) and 2) 
charge, in the literature. 
Wettability 
There are some published studies reporting the relationship between surface wettability 
and cell behavior, by culturing different cell types on polymers of different wettabilities. Most 
of the studies have shown that surfaces with a moderate wettability (40-50 degree, water 
contact angle) exhibit the highest levels of cell attachment (ARIMA and IWATA 2007; LEE, 
et al. 1998; VAN WACHEM, et al. 1985; WEBB, et al. 1998). Such surfaces may adsorb 
proteins present in serum or secreted by cells, resulting in the creation of a favorable surface to 
modulate the functions of the different cell types, e.g., adult human endothelial cells (HEC) 
(VAN WACHEM, et al. 1985). Arima and Iwata (2007) have also demonstrated that in 
addition to surface wettability which plays the main role in cell adhesion, the surface 
functional groups, its surface density, and the cell type also influence this phenomenon. 
Charge 
Some studies have shown that cell behavior also depends on substrate surface charges. 
Amongst them, as an example, Lee et al. (1997) have published a study in which acrylic acid 
(AA), sodium p-styrene sulphonate (NaSS), and N, N-dimethyl aminopropyl acrylamide 
(DMAPAA) were copolymerized to fabricate positively and negatively charged surfaces. In 
these surfaces the gradient of the grafted surface functional groups were changed. The surfaces 
having positive charge (DMAPAA-grafted) showed higher cell attachment than the surfaces 
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having negative charge (AA-grafted). The authors concluded that surface functional groups, 
charges and wettability all influence cell responses, including adhesion, spreading, and growth 
(LEE, et al. 1997). 
40 
Chapter 3 
Literature review II: Tissue engineering and 
vascularization 
3.1. Overview 
Recently, the development of new blood vessels around or in the interior of a tissue 
engineered device, in particular scaffold materials, has become a big challenge in order to 
repair or replace diseased or damaged tissues. To this aim, this study will focus on in vitro 
guided angiogenesis in a 3D culture system, comprising a filamentous polymeric scaffold, ECs 
and a hydrogel. Therefore, the present chapter is comprised successively of the description of 
blood vessels and microvessels in the normal situation, the mechanisms of blood vessels 
formation in adult that include both vasculogenesis and angiogenesis, the importance of 
vacuolization in tissue engineering, and then an overview of the literature on the different 
approaches employed to induce and develop a vascular network towards an implant. 
3.2. Blood vessels and capillaries 
Blood vessels supply oxygen and nutrients for most tissues in the body (CARMELIET and 
COLLEN 2000) by carrying the blood (rich in oxygen & nutrients) from the heart to the 
tissues and organs and inversely carrying the blood (poor in oxygen & nutrients but rich in 
wastes) from them to the heart (Fig. 3.1) (RATCLIFFE 2000; [website ref.2]). 
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Capillaries function to distribute blood within tissues and organs permitting the diffusion of oxygen 
and nutrition from the blood in to the tissue and diffusion of the waste products of the metabolism 
(such as carbon dioxide) from the tissue in to the blood 
Figure 3.1: Blood is carried by arteries, arterioles, capillaries from the heart to the tissues and 
by capillaries, venules, and veins from tissues to the heart, (adapted from 
RATCLIFFE 2000; [website ref. 2]) 
They form a branched system of arteries, of decrementing sizes, as they enter a specific 
organ or tissue to form a network of microvessels or capillaries. Capillaries are the major 
elements that perfuse the blood and allow the diffusion/exchanges of oxygen, nutrients, and 
wastes, due to their state to the cells composing the tissue/organ. Capillaries are then 
incrementing in size as they exit from the tissue/organ to form veins that return blood to the 
heart and lung. Capillaries are composed of an EC monolayer, surrounded by an EC basement 
membrane and pericyte cells, embedded within the basement membrane (Fig. 3.2) [website 
ref. 4]. Capillaries of different tissues can be different in their cellular morphology and they 
have been classified into three categories (Fig. 3.4), including capillaries with continuous 
walls, capillaries with small openings in their walls and discontinuous capillaries (CLEAVER 
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and MELTON 2003). Figure 3.3 shows the structure and the wall composition of small 
vessels. Nascent vessels are simple tubes formed by ECs, which then mature and specialize in 
structure to form capillaries, arterioles and venules (JAIN 2003). Small vessels (i.e. arterioles 
and venules) have an advanced coverage of mural cells compared to the capilaries 
(CLEAVER and MELTON 2003; JAIN 2003). 
Endothelial cell Lumen 
Pericyte / Basement 
_ Membrane 
a) b) 
Figure 3.2: Capillary blood vessels in cross-section a) [reproduced from website ref. 4] and b) 
[reproduced from website ref. 3] 
Small vessels 
Figure 3.3: Morphology and wall composition of small vessels: arterial, venules and 
capillaries. Capillaries consist of ECs surrounded by a basement membrane and a 
sparse layer of pericytes embedded within the EC basement membrane. 
Arterioles and venules have an increased coverage of mural cells compared with 
the capillaries (reproduced from CLEAVER and MELTON 2003). 
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Figure 3.4: Capillaries with different cellular morphologies: (a) continuous capillaries; (b) 
capillaries with small openings; and (c) discontinuous capillaries (reproduced 
from CLEAVER and MELTON 2003). 
3.2.1. Microvessel formation 
According to recently published reports, in both the developmental and the adult 
microenvironments, neovascularization probably takes place via two different processes called 
angiogenesis and vasculogenesis (UCUZIAN and GREISLER 2007; SHIU, et al. 2005). 
Vasculogenesis 
Vasculogenesis refers to the process by which angioblasts (EC precursors) proliferate and 
form a primitive network of vessels which is called the primary capillary plexus (Fig. 3.5). 
Then, this primitive vessel network plays the role of a scaffold for the angiogenesis (SHIU, et 
al. 2005). 
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Angioblasts 
Primitive Vascular Network 
Figure 3.5: Vasculogenesis: formation of a primitive network of vessels from angioblasts (EC 
precursors) during the early stage of embryonic development (reproduced from 
SHIU, et al. 2005). 
Angiogenesis 
In terms of a fundamental definition, angiogenesis is the development of new vessels 
from pre-existing vessels that occurs through two mechanisms called vessel splitting and 
sprouting (SHIU, et al. 2005). 
Vessel splitting (intussusception) 
In this process a single capillary divides into two capillaries from within. As shown in 
Figure 3.6, activated ECs from the capillary wall extend out contrarily into the lumen side and 
fuse. This event creates a pillar-like structure across the vessel, which then elongates along the 
vessel axis and generates two parallel microvessels (SHIU, et al. 2005). 
Vessel sprouting 
Sprouting (or tubular morphogenesis or sprouting angiogenesis) refers to the phenomena 
by which a new vessel forms from a pre-existing vessel (capillary or venule), when activated 
ECs migrate, proliferate and elangate through the surrounding matrix (Fig. 3.6) (SHIU, et al. 
2005). 
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Sprouting 
Figure 3.6: In the angiogenesis process (both in embryo and adult), the activated ECs of the 
preexisting vessels form new vessels, via two different mechanisms (i.e. splitting 
(intussusception) and sprouting) (reproduced from SHIU, et al. 2005). 
In considering the molecular mechanisms, the normal angiogenesis is a complex process 
that takes place through a complex interaction between vascular cells, the surrounding 
extracellular matrix and many angiogenic factors, including VEGF, fibroblast growth factors 
and, angiopoietin-1 (Ang-1). The following events occur during sprouting angiogenesis (Fig. 
3.7): 1) vessel destabilization, 2) matrix remodeling, 3) EC proliferation, 4) EC migration, 5) 
cell-cell contact, 6) tube formation, 7) mesenchymal cell proliferation and migration 8) 
recruitment of pericytes, 9) formation of the basement membrane around the new vessel 
(vessel stabilization) (PAPETTI and HERMAN 2002). The main effectors involved in 
angiogenesis are soluble molecules, extracellular matrices, cell-cell interactions, and 
mechanical forces (PAPETTI and HERMAN 2002; SHIU, et al. 2005). Readers interested in 
the mechanisms of angiogenesis, and the effectors involved in this process, are referred to the 
following references (BACH, et al. 1998; CARMELIET 2000; CARMELIET and COLLEN, 
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2000; COLLINSON and DONNELLY, 2004; FOLKMAN and D'AMORE 1996; RISAU 
1997; UCUZIAN and GREISLER 2007; YANCOPOULOS, et al. 2000). 
I) Soluble factors 
The process of angiogenesis is regulated by various soluble factors. These compounds 
contribute to angiogenesis; to its induction, acceleration or inhibition (PAPETTI and 
HERMAN 2002). An excellent review, describing the modulation of angiogenesis by soluble 
factors, has been provided by Papetti and Herman (2002). In paragraghs below only the 
definitions and functions of these factors have been briefly presented. 
Vascular endothelial growth factor (VEGF) 
Among many soluble factors, the most well-known angiogenic factor is VEGF. Six 
isoforms of VEGF have been known among whichVEGF165 is the most commonly expressed 
isoform. VEGF is a glycoprotein with a molecular weight of about 34-45 kDa. Many types of 
tissues produce VEGF (at low levels), but when angiogenesis is required the production of 
VEGF is increased. VEGF is one of the main effectors of the vascular ECs that play major 
roles in angiogenesis. These are: 1) increases in EC permeability, 2) stimulates uPA/PAI-1 
(plasminogen activators) production by EC, 3) stimulates EC proliferation, 4) inhibits EC 
apoptosis, 5) enhances EC migration, and 6) stimulates in vivo angiogenesis (LI, et al. 2003; 
PAPETTI and HERMAN 2002). 
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Fibroblast growth factors (FGFs) 
Basic FGF (b-FGF, pi = 9.6) and acidic FGF (a-FGF, pi = 5) consist of polypeptides (18-
25 kDa MW) that are the members of the family of angiogenic growth factors. FGFs play 
roles in EC proliferation, migration, EC production of collagenase and plasminogen activator. 
Moreover, bFGF contributes in ECs tube formation within 3D collagen matrices (PAPETTI 
and HERMAN 2002). 
Angiopoietins and Tie receptors 
Angiopoietins are known as EC specific growth factors acting as partners of the VEGF. 
Four types of angiopoietins have been identified (Ang-1 through Ang-4), among which Ang-1 
induces in vitro EC sprout formation and increases the stability of endothelium. Conversely, 
Ang-2 opposes Ang-1 signaling, resulting in the destabilization of endothelium. Tie receptors 
are the receptors of the above mentioned angiopoietins (LI, et al. 2003; PAPETTI and 
HERMAN 2002). 
Platelet derived growth factor (PDGF) 
Platelet derived growth factor, or PDGF, was originally identified in platelets. PDGF may 
play a role in the differentiation and proliferation of pericytes and, as a result, helping the 
capillary wall to be more stable (PAPETTI and HERMAN 2002). 
Other soluble factors 
During vacularization, a growth factor called transforming growth factor (TGF-p) is 
produced by both ECs and pericytes which plays a role in angiogenesis in vitro and in vivo 
(LI, et al. 2003; PAPETTI and HERMAN 2002). In addition, some other soluble factors 
contribute in angiogenesis, but it is not demonstrated that they play as prominent role as the 
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above growth factors on the vasculature. For example, other growth factors, such as tumor 
necrosis factor-alpha (TNF-a), transforming growth factor-alpha (TGF-a), epidermal growth 
factor (EGF), and the colony stimulating factors (CSFs), show angiogenic properties 
(PAPETTI and HERMAN 2002). 
II) Membrane-bound factors 
Membrane-bound proteins are also important in angiogenesis. The membrane bound 
factors play their roles when cells are in close contact with each other and their matrix. 
Endothelial membrane-bound factors that regulate many functions involved in the vasculature 
have been classified into 3 categories, including integrins, ephrins, and cadherins. Among the 
members of these 3 groups, the integrin avfb, VE cadherin, and ephrin-2B, respectively, play 
prominent roles in angiogenesis (PAPETTI and HERMAN 2002). 
Integrins 
Since in the process of angiogenesis ECs invade the ECM to migrate through it, the 
integrins are required to mediate the interaction of ECs with ECM in this event. Among many 
cell membrane integrin receptors, avP3 plays an important role in angiogenesis. This integrin 
binds to ECM proteins such as VN, FN, vWf, and fibrin, and is produced in vitro on ECs in 
the presence of growth factors such as VEGF and bFGF (PAPETTI and HERMAN 2002). 
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Table.3.1: The effect of integrins on EC and vasculature (PAPETTI and HERMAN 2002) 
Integrins Roles 
1 0CvP3 
• Mediates in vitro EC attachment, spreading, and migration 
• Mediates angiogenesis by: 
-expression on angioblasts before and during vasculogenesis 
-binding to matrix metalloproteinase-2 
-localizing the active form of the enzyme at the tips of the angiogenic blood 
vessels 
-regulating localized degradation of the ECM 
-mediating EC migration by adhering to the modulated matrix 
a ^ o c i P i and a2Pi • Regulating angiogenesis by: 
-adhesion to ECM 
-localization of proteases to capillary sprouts 
-enhancing EC survival 
Cell junction proteins 
The two most extensively studied EC junction proteins that are produced primarily at the 
cell-cell junctions of the ECs and are involved in angiogenesis, are VE-cadherin (a member of 
Ca+2 binding transmembrane molecules) and platelet EC adhesion molecule-1 (PECAM-1 or 
CD31) (a member of immunoglobulin superfamily of cell adhesion molecules) (SHIU, et al. 
2005). Studies have shown that cadherins stabilize EC junctions in the vessel wall and 
enhance EC survival (PAPETTI and HERMAN 2002). When ECs migrate during 
angiogenesis, cell-cell junctional compounds are temporarily disconnected, but then they are 
re-connected to form a new vessel (ILAN and MADRI2003; SHIU, et al. 2005). 
Eph-B4/Ephrin-B2 
Eph receptors and ephrin ligands are a class of receptor/ligand pairs which play a 
prominent role in blood vessel formation. Ephrin-B2 (a member of the ephrin family) is 
expressed on arterial ECs in embryo, and its receptor (eph-B4) is located on venous ECs. 
Theses two components mediate the contact and signaling between arterial and venous which 
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is necessary for the remodeling of the primary capillary plexus (PAPETTI and HERMAN 
2002). 
III) Extracellular Matrix (ECM) 
ECM plays many important roles in regulating angiogenesis, such as performing signaling 
activities, reserving and regulating growth factors and acting as scaffold support. It has also 
been reported that during the process of angiogenesis, migration of ECs and development of 
new capillary depends on the production and organization of the ECM components, including 
FN, VN, collagen, laminin, and tenascin (INGBER, et al. 1995). As mentioned earlier, ECs 
interact with one or more ECM molecules via their integrin receptors (e.g. 0 ^ 3 or otvPs) which 
transduce the signals between them (LI, et al. 2003; SHIU, et al. 2005). 
IV) EC migration 
EC migration is essential during angiogenesis. In the 3D environment of the ECM, this 
process is regulated by chemotactic (i.e. cell motility by chemical stimuli), haptotactic (i.e. 
directional motility of cells), and mechanotactic (i.e. cell motility by mechanical forces). In 
addition invasion of the ECM enables the cells to migrate. These events take place through 
cytoskeletal remodeling, resulting in cell migration in several steps through which the ECs 
extent, contract, and move their rears towards the front and finally advance (LAMALICE, et 
al. 2007). 
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Figure 3.7: Mechanisms of angiogenesis and related activators, adapted from (PAPETTI and 
HERMAN 2002; [website ref. 4]) 
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V) Biomechanical Forces 
In addition to the above described factors, divers mechanical forces, including forces 
generated by cells, forces that are applied to cells via ECM, and the forces applied by external 
causes ( e.g. blood flow and muscle activity) play prominent roles in angiogenesis (SHIU, et 
al. 2005). For example, laminar flow stabilizes and protects the vessel wall, by increasing 
stress fiber expression in ECs. Turbulent flow promotes blood vessel formation (PAPETTI 
and HERMAN 2002). 
3.3. Importance of vascularization and angiogenesis in tissue 
engineering 
Tissue engineering employs the principals of science and engineering to the design, 
construction, growth and treatment of living tissues (CURTIS and RIEHLE 2001; FUCHS, et 
al. 2001; GOMES and REIS 2004). Tissue engineering can be useful in plastic and 
reconstructive surgery for current clinical methods such as flap surgery (for the treatment of 
skin defects) or in production of materials for implantation (e.g. for breast reconstruction). 
Though engineered cartilage or thin tissue (i.e. skin) have currently been presented for clinical 
use (LASCHKE, et al. 2006), still many other tissue types for replacement or substitution 
remain under investigation, e.g. liver, bone, muscle, and nervous tissues. Interesting 
information about the progress, perspective and clinical applications of tissue engineering 
products can be found in the following references (ATALA 2004; LAVIK and LANGER 
2004; MUSCHLER, et al. 2004; VATS, et al. 2003). 
In tissue engineering applications, first a small part of tissue is taken from the patient, and 
the cells are then isolated and expanded to provide the required number of cells in culture. 
These cells are seeded into an appropriate 3D scaffold to form the tissue construct needed, 
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which will finally be implanted back into the patient's body (LASCHKE, et al. 2006; 
BORGES, et al. 2004). However, due to the lack of rapid vascularization of tissue construct 
after implantation, the seeded cells are not supplied adequately which leads to the death of the 
transplanted cells (BORGES, et al. 2004; KIRKPATRICK, et al. 2003; LASCHKE, et al. 
2006). Since the supply of oxygen via diffusion is limited to a distance of about 150 to 200 pm 
from the neighboring capillaries, the rapid vascularization of such 3D construct after 
implantation play a prominent role in cell survival and as a result in the function of 3D tissue 
constructs. Particularly, this issue must be addressed to the scaffold guided tissue generation 
for the creation of complex, large-scale structures such as large bone defect, liver, lung and 
etc. (EISELT, et al. 1998). In fact, the vascularization of the engineered tissues remains as a 
great challenge in clinical applications of tissue engineered products. For these reasons, 
fabrication of vascularized constructs has become one of the attractive research subjects in 
tissue engineering (UCUZLAN and GREISLER 2007; LASCHKE, et al., 2006). In addition to 
the above explained issues, the angiogenesis is the subject of an intensive research in current 
years because of its importance for the use in many clinical applications including (e.g. wound 
healing, oncology, ophthalmology, vascular disease, and etc.). As an example, cardiovascular 
diseases are one of the great causes of death worldwide. Therefore, the study of angiogenesis, 
particularly enhancing angiogenic capabilities of tissue engineered constructs in vitro, could 
considerably affect health care (UCUZIAN and GREISLER 2007). 
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3.4. Enhancing the vascularization of tissue engineering constructs 
As explained earlier, vascularization of the engineered tissue constructs is a challenging 
issue in the field of tissue engineering. This issue has been addressed since 1979 when Erol 
and Spira initiated the method of "arteriovenous shunt loops" in vivo, a method in which new 
blood vessel formation is promoted by the increased shear stress and wall tension, within the 
loops' vasculature (LASCHKE, et al. 2006). In addition to this approach which can be used to 
engineer vascularized tissue in vivo (BACH, et al. 2006; LOKMIC, et al. 2007), the research 
has been focused on new approaches. The most recent research tends to enhance the 
angiogenic properties of tissue engineered constructs by means of new approaches, such as: 
enhancing the ability of scaffolds to support vascularization by scaffold architecture (GAFNI, 
et al. 2006; YIM, et al. 2006); biomechanics (SHIU, et al. 2005; YAMAMURA, et al. 2007); 
and scaffolding materials, by using ECM components (BORSELLI, et al. 2007; HODDE 
2006; WILLIAMS, et al. 2006; WU, et al. 2007) and angiogenic growth factors (ELCIN and 
ELCIN 2006; ENNETT, et al. 2006; KAIGLER, et al. 2006; KURANE, et al. 2007; LAI, et al. 
2006; NILLESEN, et al. 2007). Moreover, stimulation of vasculogenesis by means of 
endothelial progenitor cells (EPCs) within the construct (HUMPERT, et al. 2005; MADEDDU 
2005; MCCLOSKEY, et al. 2005; SUURONEN, et al. 2006b; YI, et al. 2006) and inducing of 
angiogenesis by external mechanical forces (BILODEAU, et al. 2005; SHIU, et al. 2005) have 
been reported. However, in this thesis I will focus on the role of scaffolds in the 
vascularization of tissue engineered constructs. 
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3.4.1. Enhancing the vascularization of tissue engineering scaffolds 
A tissue engineering scaffold is a 3D framework made of an implantable biomaterial 
which should have the following three capabilities: (i) providing a space for tissue growth, 
(ii) containing a space-filling matrix for cell localization, and (iii) enhancing vascularization of 
the forming tissue (EISELT, et al. 1998). More details on this subject can be found in a review 
provided by Yarlagadda et al. (2005). 
In order to fabricate scaffolding materials with a capability for enhancing angiogenesis, 
some studies have been performed to produce biomaterials that modulate EC responses 
(HADJIZADEH, et al. 2007; UNGER, et al. 2004; UNGER, et al. 2005b). In addition, the 
recent research has focused on the enhancing the vascularization of a polymeric scaffold by 
means of the scaffold's composition (by incorporating ECM components and GFs), 
architecture and biomechanics. 
Enhancing the angiogenic ability of scaffolding material by ECM components 
One of the more interesting concepts for developing scaffolds, used in tissue engineering, 
is to mimic the architecture and composition of the ECM of the tissue to be regenerated. To 
further this aim, specific ECM compounds with angiogenic properties have been introduced 
into the biomaterials to enhance microvessel formation and tissue ingrowths (BATTISTA, et 
al. 2005; CRONIN, et al. 2006; FOURNIER and DOILLON 1992; FOURNIER and 
DOILLON 1996; WU, et al. 2007). ECM molecules can be simply mixed with scaffolding 
material, immobilized on the surface of these materials or even to employ naturally occurring 
scaffolds composed of ECM proteins. 
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ECM molecules mixing with scaffolding material 
Biomaterials, when combined with ECM molecules, have shown a potential to induce 
microvessel formation in vivo and in vitro. Fournier and Doillon (1992) have investigated the 
effect of FN and hyaluronic acid (HA) on tube formation in fibrin gel by means of an in vitro 
model. Their study has shown the formation of tube-, branch- and capillary-like structures 
within the fibrin. In addition, it has been currently reported that a portfolio of crosslinked 
chitosan-collagen blends, seeded with pre-adipocytes, could induce vascularization and form 
adipose tissue in vivo (WU, et al. 2007). Furthermore, EC differentiation and vascularization 
in 3D collagen constructs were strongly promoted by the introduction of FN to this system 
(BATTISTA, et al. 2005). Biological-based hydrogels, such as laminin-1, type I collagen, 
fibrin glue and HA, are resorbed and replaced by vascularized connective tissue in vivo 
(CRONIN, et al. 2006). Collagen-based matrices have effectively delivered endothelial 
progenitor cells (EPCs) to ischemic tissue in vivo in which EPCs integrated into the vascular 
structures (SUURONEN, et al. 2006a). 
ECM molecules immobilization 
Enhancing angiogenesis, by means of biological molecules (e.g. ECM compounds) coated 
onto the surface of synthetic polymeric materials, has rarely been reported. Fournier and 
Doillon (1996) have shown that composite fibrin matrices consisting of angiogenic 
compounds such as HA, FN and FGFs adsorbed onto Dacron meshes, enhanced the 
angiogenesis in vivo. As another example the ECM-coated ePTFE induced both angiogenesis 
in implant-associated tissue and the neovascularization of the pores within the ePTFE, while 
uncoated ePTFE did not (KIDD, et al. 2002). Porous polyethersulfone hollow fibres (having 
pore diameters of about 100pm) coated with gelatin or FN were investigated toward 
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angiogenesis using HUVECs. Cells attached onto gelatin and FN coated surfaces formed 
microvessel-like structures when introduced into an angiogenesis model (UNGER, et al. 
2005b). Thus, the attachment of ECM proteins to the surfaces of target materials creates a 
desirable surface for cells, mimicking a close approximation to their natural cell environment. 
Naturally occurring scaffolds composed of ECM compounds 
In addition to synthetic scaffolds, biological scaffolds composed of ECM components (e.g. 
small intestinal submucosa (SIS)), have also been studied for potential tissue engineering 
applications (BADYLAK 2007; LASCHKE, et al. 2006). It has been suggested that these 
scaffolds show a rapid interaction with the host tissue. Since the scaffolds naturally consist of 
angiogenic components (i.e. growth factors and structural elements such as FN, elastin, 
collagen, etc.), they may thus accelerate angiogenesis (LASCHKE, et al., 2006; HODDE 
2002). Readers interested in this subject are referred to the review article provided by Hodde 
(2002). 
Gelatin 
Gelatin is a biodegradable and biocompatible compound that is composed of denatured 
polymers derived from collagen. This "compound" has been long successful in being used for 
pharmaceutical and medical applications and is the focus of attentions for use in tissue 
engineering products (CHOONG, et al. 2006; YOUNG, et al. 2005). Gelatin hydrogels have 
been used for sustained release of growth factors to promote tissue regeneration and 
vascularization in tissue engineering (DOI, et al. 2007; YOUNG, et al. 2005). Moreover, it has 
been demonstrated that the gelatin-coated surfaces promote cell adhesion. But the gelatin 
coating, via physical adsorption, is not stable with time, it dissolves easily in the culture 
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medium, resulting in the cell detachment. Therefore in order to produce a stable gelatin-
coating on a surface, immobilization of the gelatin by means of chemical reaction is required 
(CHOONG, et al. 2006). Covalently gelatin-coated materials have promoted EC adhesion and 
proliferation (CHOONG, et al. 2006). However, there are few instances in the literature that 
demonstrate the enhancement of angiogenesis through the use of this kind of substrate 
(UNGER, et al. 2005b). 
RGD-containing peptides 
There are many published reports describing the effects of tripeptide RGD on tissue 
regeneration, in vivo and in vitro. For example, the RGD-containing matrix has the potential to 
accelerate the healing reaction and improve the quality of regenerated tissue in orthopedics 
(KARDESTUNCER, et al. 2006), cardiovascular (TWEDEN, et al. 1995), diabetic (STEED, 
et al. 1995; WETHERS, et al. 1994), and brain tissue repair investigations (CUI, et al. 2006). 
However, there is presently little evidence showing the effect of the RGD peptide on the 
enhancement of the angiogenesis (CUI, et al. 2006). 
By way of contrast, it has been reported that RGD peptides inhibit angiogenesis 
(BUERKLE, et al. 2002; HAUBNER and WESTER 2004; KIM, et al. 2006; MEEROVITCH, 
et al. 2003; SHEU, et al. 1997; WESTLIN 2001). For targeting of angiogenic vessels, av 
integrin antibodies have been produced and are under investigation for use as antiangiogenic 
compounds. In addition to these compounds, small peptides such as RGD, which binds to 
(XyPi, can target this integrin receptor. In the testing of both linear and cyclic RGD peptides, 
in order to target the ocvP7t integrin, the cyclic peptides, having a ring system, have exhibited 
higher resistant to proteolysis and higher affinity to the target than their linear equivalents 
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(ZHANG, et al. 2007). In fact, the RGD sequence is a cell binding system that mediates the 
ECs attachment to the ECM by means of specialized cell membrane receptors i.e., cc5f3{ and 
av(53 integrins. It has been demonstrated that the RGD-containing peptides are able to detach 
the ECs from their plastic or ECM-coated substrate, by competing with the binding of the 
RGD-containing ECM compounds to integrins. As mentioned earlier, during angiogenesis, the 
ECs interact with RGD-containing ECM compounds i.e., FN, laminin, and collagen. VWf and 
VN are other RGD-containing molecules that have been shown to be present in the ECM 
when wound healing and tumor angiogenesis occur (SHEU, et al. 1997). These interactions 
play prominent roles in the EC functions, i.e., adhesion and migration. Since the EC adhesion 
and migration are two important factors in the angiogenesis, the RGD sequence thus 
modulates the interactions between the sprouting ECs and the ECM molecules during 
microvessel development (SHEU, et al. 1997). Although RGD coated implants accelerated 
wound healing, there are insufficient studies showing the effect of such implants on the 
enhancement of the angiogenesis phenomenon. 
Enhancing the angiogenic ability of scaffolding material by growth factors (GFs) 
GFs are the most important effectors in the process of blood vessel formation. As 
explained earlier, over recent decades, many types of GFs have been identified and are now 
available for the use in related applications. Among them more important factors are VEGF, 
PDGF and FGFs. These factors may play the main role in the vascularization of the implanted 
tissue constructs, by accelerating the penetration of the newly formed vessels from the 
surrounding tissue into the implant. However, the inclusion of GFs into the scaffolding 
material and the subsequent sustained delivery of these compounds to an appropriate tissue 
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site can be an alternative (LASCHKE, et al. 2006). GFs can be incorporated into synthetic 
scaffolds in three different ways: (1) blending of the GFs with particles of the polymer before 
the polymer being processed into the scaffold. In this way, the GFs release rapidly, within 
days to weeks (HUANG, et al. 2005; HOSSEINKHANI, et al. 2006; LASCHKE, et al. 2006), 
(2) incorporating spheres, in which GFs have been initially encapsulated, into the scaffolds, 
resulting in growth factor release over a longer time (KEDEM, et al. 2005; ROYCE, et al. 
2004; LASCHKE, et al. 2006), (3) physical or covalent immobilization of growth factors into 
the scaffolding materials (CHUNG, et al. 2006; KOCH, et al. 2006; STEFFENS, et al. 2004; 
YAO, et al. 2004). 
Influence of scaffold architecture on the induction of angiogenesis 
In addition to the scaffold composition, the structure of the scaffold has also been shown 
to influence the vascularization of a tissue construct (LASCHKE, et al. 2006). For example, 
higher levels of angiogenic activity have been observed in dermal equivalent tissue in 3D 
cultures than in monolayer cultures (LASCHKE, et al. 2006). This has been concluded to be 
due to the cellular content of the VEGF messenger, ribonucleic acid (mRNA), produced by 
fibroblasts cultured on a 3D scaffold made of PLGA, which was much higher than that of 
fibroblasts grown on a 2D surface (as monolayers) (PINNEY, et al. 2000). Moreover, Koike et 
al. (2004) reported that the HUYECs-seeded 3D construct induced a network of stable blood 
vessels formation in vivo. In addition, the pore size of the scaffolds has been shown to play 
some role in the microvessel formation (CHOU, et al. 2006; DZIUBLA and LOWMAN 2004; 
KARAGEORGIOU and KAPLAN 2005; LASCHKE, et al. 2006). According to some reports, 
angiogenesis occurs faster within those porous structures bearing pores with a size above 250 
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microns, than in those with pores below 250 microns (LASCHKE, et al. 2006). For example, 
pore sizes of greater than 300 microns have been recommended in bone tissue engineering for 
bone regeneration and the formation of capillaries (KARAGEORGIOU and KAPLAN 2005). 
Moreover, fibrous scaffolds have recently been investigated in order to enhance the tissue 
vascularization (GAFNI, et al. 2006; IGARASHI, et al. 2007; YIM, et al. 2006). For instance, 
fibres composed of chitosan-alginate-heparin fabricated by means of interfacial 
polyelectrolyte complexation (PEC) fibre showed good cell infiltration and vascularization in 
vivo (YIM, et al. 2006). Very recently, nanofibrous materials made from bioabsorbable and 
biocompatible polymers mimicking the ECM structure have been investigated for use in 
tissue-engineered scaffolds (IGARASHI, et al. 2007). 
Directional control of microvessel formation 
Directional control of vascular sprout is of interest in tissue engineering in order to 
engineer directional tissues. Recently, directional control of microvessel formation, by means 
of chemical or physical stimuli, has become an attractive research subject (BORSELLI, et al. 
2007; GAFNI, et al. 2006). ECs that had been cultured on a specifically designed filamentous 
biodegradable polymeric scaffold, and then implanted in mice, resulted in a guided 
angiogenesis with subsequent functional blood vessel formation. This method can also be 
applied for vascular engineering (GAFNI, et al. 2006). In addition, it has been recently shown 
that the control of directional vascular sprouting is possible by a spatial distribution of the 
matricellular cues. In the 3D semi-interpenetrated network of collagen-HA, the increase in the 
amount of HA within the matrix led to a reduction in the sprout formation, demonstrating the 
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possibility of being able to control vascularization by creating HA gradients within the 
collagen network (BORSELLI, et al. 2007). 
Influence of scaffold biomechanics on the induction of angiogenesis 
Various mechanical forces, such as externally applied forces (e.g. generated by blood flow 
and muscle contractions) (BONGRAZIO, et al. 2006; CULLEN, et al. 2002; MIYATA, et al. 
1991; SHIU, et al. 2005), cell- and ECM-generated forces (SHIU, et al. 2005), all regulate the 
blood vessel formation. 
In addition, 2D and 3D angiogenesis systems have shown that the stiffness of substrates 
influences the angiogenic activity of the ECs. In the 2D (monolayer) angiogenesis system, 
when the stiffness of the gel increased network formation on the gels surface reduced. 
Similarly, in 3D angiogenesis system, stiffer matrix decreased sprout formation. Therefore, 
capillary sprouting demands a more malleable environment (SHIU, et al. 2005). On the other 
hand, tube formation may not occur in very soft ECM gels, due to the contraction of the gels 
by the cell contractile forces, and cells may undergo apoptosis when they are not capable of 
developping an adequate tension that they need for their shape stability and survival. 
Therefore, a matrix with a moderate level of malleability will be required to be used in the 
study of angiogenesis phenomena (SHIU, et al. 2005). 
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3.5. Stimulation of vascularization by stem cells 
In general, for the tissue regeneration three basic elements, i.e. scaffold, growth factors and 
cells are required. Recently, the use of stem cells (primal cells found in multicelluar 
organisms), as the EC source, is a particular interest in the development of vascularized tissue 
constructs. Endothelial propgenitor cells (EPCs), derived from bone marrow, have been shown 
in cultures, to differentiate into three important blood vessel cell types, being: ECs, pericytes, 
and vascular smooth muscle cells (LASCHKE, et al. 2006). A review describing the bone 
marrow-derived EPCs, and their capability for vascular regeneration, has been provided by 
Murayama et al. (2002). Bone marrow cells and EPCs have been seeded onto vascular grafts 
to create tissue-engineered vascular grafts, with a long-term functionality (LASCHKE, et al. 
2006; ASAHARA and ISNER 2002). In addition, the use of bone marrow cells in the 
investigation of angiogenesis and the tissue regeneration, has drawn the attentions of many 
researchers over recent years (HUANG, et al. 2005; HUMPERT, et al. 2005; MARKOWICZ, 
et al. 2006; SUURONEN, et al. 2006b; UENO, et al. 2006; ZHOU, et al. 2007). For example, 
ECs derived from EPCs, when seeded with human smooth muscle cells, have stimulated 
angiogenesis on porous biodegradable (i.e. PGA-PLLA) scaffolds (WU, et al. 2004). 
Similarly, ECs derived from stem cells, in vitro, once embedded in 3D collagen gel, have been 
shown to induce vasculogenesis (MCCLOSKEY, et al. 2005). In addition to stem and/or 
progenitor cells used to achieve vasculogenesis, the CD 133+ progenitor cells, incorporated 
into injectable collagen-based matrix, promoted vascularization capability of the implanted 
construct in vivo (SUURONEN, et al. 2006b). 
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3.6. Engineering vascularized tissues in vitro 
Recently, more attention has been focused on the in vitro vascularization methods 
(LEVENBERG, et al. 2005; SUURONEN, et al. 2006a; TREMBLAY, et al. 2005). This is 
because, the major problem for the application of an in vitro tissue-engineered construct, such 
as skin (TREMBLAY, et al. 2005) or thick and complex tissues such as muscle 
(LEVENBERG, et al. 2005), is the slow rate of vascularization, which may lead to tissue 
death after implantation (TREMBLAY, et al. 2005). Therefore, fabrication of a pre-
vascularized tissue in vitro can be a promising way to prevent this obstacle. The idea behind 
this approach is that a network of newly formed microvessels may be engineered in vitro by 
the seeding of a scaffold with ECs. After implantation of the engineered tissue constructs, the 
ECs involved in newly formed networks within the construct should be able to connect to the 
vasculature system of the surrounding tissues. However, even by adopting this approach, a 
number of problems still remain to be solved (LASCHKE et al. 2006). The process of 
vascularization under in vivo conditions is a complex phenomenon which depends on the 
variety of signalling factors (e.g. VEGF and PDGF) and involves other cell types (i.e. smooth 
muscle cells and pericytes). Thus, the seeding of a scaffold with ECs only is not enough to 
enable new functional blood vessels in vitro to develop. Therefore, the current techniques 
employed for the fabrication of tissue constructs should be improved so as to produce tissue 
constructs having their own functional vascular system, prior to implantation (LASCHKE, et 
al. 2006). To address this issue a few relevant reports have recently been published. For 
example, a pre-vascularized reconstructed skin through the culturing of human keratinocytes, 
fibroblasts and ECs in a collagen sponge in vitro has been developed. This construct has 
shown successful interconnections made to host blood vessels in less than 4 days following 
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implantation (LASCHKE, et al. 2006). Moreover, Levenberg et al. (2005) have produced a 
vascularized engineered skeletal muscle tissue constructs by the co-seeding of myoblasts, 
embryonic fibroblasts and ECs, on biodegradable, porous polymer scaffolds. In this construct 
the embryonic fibroblasts has increased the VEGF expression, and also influenced the 
formation and stabilization of the microvessels. The vascularization, perfusion of blood and 
survival of the muscle tissue construct, have been achieved after the transplantation of tissue 
constructs in vivo (LEVENBERG, et al. 2005). It also has been noticed that the scaffold 
composition of the 3D matrix plays an important role in this approach (HELM, et al. 2007). 
3.7. In vitro angiogenesis models 
Formation of tube-like structures with the presence of lumens by ECs in vitro has been 
observed since 3 decades ago and called angiogenesis (FOLKMAN and HAUDENSCHILD 
1980). However, from a physiological viewpoint, a perfect in vitro angiogenesis model should 
be able to perform all of the in vivo angiogenesis phases (i.e. initial activation of ECs in the 
preexisting vessel, ECs proliferation, migration, cell-cell attachment, final tube formation and 
vascular network reorganization). Moreover, the fabrication, application and quantification of 
the system should also be easy (VAILHE, et al. 2001). Under physiological conditions, 
angiogenesis occurs in a 3D environment, thus an in vitro angiogenesis investigation needs to 
be performed within a 3D system. To match this aim, many 3D ECs culture system 
(angiogenesis models) have been developed (FOURNIER and DOILLON 1992; NEHLS and 
DRENCKHAHN 1995b; VERNON and SAGE 1999; VAILHE, et al. 2001). Among the 
several EC culture systems, one interesting model was presented by Nels in 1995, in which 
EC-seeded micro carriers (beads) were embedded in a fibrin gel. In this model, the capillaries 
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spread out radially from the beads by invading the fibrin gel in the presence of growth factors 
(NEHLS and DRENCKHAHN 1995a; NEHLS and DRENCKHAHN 1995b). Accordingly, I 
propose in the present thesis study, to develop a similar system by replacing the microcarriers 
by polymer fibres that can also be used as scaffolding material in tissue engineering, in order 
to produce a pre-vascularized construct with directional microvessels. This design could 
therefore have a major impact in the generation of tissue engineered constructs for directional 
tissue regeneration. 
3.8. Polymeric scaffolding materials 
A polymeric tissue engineering scaffold may be either synthetic or naturally derived, that 
can perform various functions including: space filling, delivering bioactive molecules and 
cells, and providing desirable 3D environments for tissue growth (DRURY and MOONEY 
2003). Thus, in respect of the requirements of each application, the materials selected for the 
scaffold should exhibit appropriate physical, chemical and structural properties (DRURY and 
MOONEY 2003). For this reason, several types of polymeric materials have been previously 
investigated to be used in tissue engineering applications in various formats, including 
polymer fibres and hydrogels. 
3.8.1. Polymeric fibres 
Among the biocompatible polymers, some can be used in a fibre format, as listed in Table 
3.2. In this present thesis, I propose to use PET fibre because of its good amenability for 
surface treatment, its semi transparency which eases the in vitro visualization under culture 
conditions, and its commercially availability in a desired range of fibre diameters. Another 
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choice could be PTFE fibre, these two polymers being selected because they are two 
representative biomaterials, due to their wide range applications in vascular prosthesis, and 
also in many related studies (BILTRESSE, et al. 2005; LI, et al. 2001; LIU, et al. 2006; XIE, 
et al. 2002; ZHAO, et al. 2003). Moreover, by enhancing their ability to support controlled EC 
adhesion, proliferation, migration, and particularly angiogenesis, a promising route to address 
their drawbacks in vascular prosthesis applications can be envisaged. 
Table 3.2: Some commercially available biocompatible polymers that can be used as fibres 
Polymer Typical applications 
Polyethylene terephthalate (PET) Vascular grafts, sutures (CHINN, et al. 1998; KHANG, et al. 1999) 
Polytetraflouroethylene 
(Teflon®) 
Vascular grafts, sutures (CATANESE, et al. 1999; THOMSON, et al. 
1991) 
Polylactic / polyglycolic acid Sutures (MATTHEW 2002) 
Polyamides (nylons) Sutures (SHIMAMURA, et al. 2006 ) 
PHAs Vascular grafts, sutures, heart valve (SHISHATSKAVA, et al. 2004; VALAPPIL, et 
al. 2006; WILLIAMS, et al. 1999 ) 
Polypropylene Vascular grafts, sutures (KONSTANTINOVIC, et al. 2006) 
Silk Sutures (CALKINS, et al. 2007; UNGER, et al. 2004) 
Carbon fibre Sutures (BROWN and POOL 1983; EVANS, et al. 1987 ) 
3.8.2. Hydrogels 
Hydrogels are network of polymers that have been crosslinked through typical chemical 
and physical bonds and employed as scaffold materials in tissue engineering. Theses materials 
are composed of either synthetic or naturally derived highly hydrated polymer chains (with a 
water content > 30% by wt). Attention has been focused on the utilization of hydrogels in 
tissue engineering applications, due to their typical characteristics, including being degradable, 
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being soft similar to many tissues, and having a mesh-like structure similar to that of the 
surrounding ECM (DRURY and MOONEY 2003). Hydrogels can be used as: space filling 
agents, bioactive molecule- and cell/tissue- delivery vehicles (DRURY and MOONEY 2003). 
Since softer materials have been shown to be a suitable matrix for angiogenic-like structure 
formation, hydrogels can be used as vascularizable implant materials (DZIUBLA 2003). Some 
synthetic hydrogels such as poly (2 hydroxyethyl methacrylate) (PHEMA) (DZIUBLA and 
LOWMAN 2004) and natrualy-derived including gelatin (DOI, et al. 2007), HA (CUI, et al. 
2006), collagen (YAMAMURA, et al. 2007) and fibrin (FOURNIER and DOILLON 1992; 
NEHLS, et al. 1994) have been used to investigate angiogenesis. Among the above mentioned 
hydrogels, both collagen and fibrin have been widely used in tissue engineering applications to 
date. 
Collagen is a well-known and important biomaterial, used in tissue engineering for various 
soft-tissue replacements. However, there is one drawback to the use of collagen gel for soft-
tissue construct fabrication. The collagen gel is contracted by cultured cells over time, 
resulting in a major reduction in the construct size and cell death. To overcome these problems 
short collagen fibres have been incorporated into the collagen gels (GENTLEMAN, et al. 
2007). Fibrin and collagen gels have been used mainly as cell delivery and localization agents 
in the applications that the initial mechanical functionality is not so important (CUMMINGS, 
et al. 2004; HA YEN, et al. 1999; NAKATSU, et al. 2003). 
Fibrin has been widely used in investigations related to tissue engineering products, 
particularly in angiogenesis investigations (FOURNIER and DOILLON 1992; 
JOCKENHOEVEL, et al. 2001; NEHLS, et al. 1994). For instance, it has been used as a 
natural matrix for EC growth and has been also used as a coating for ePTFE vascular grafts to 
69 
promote EC adhesion and resistance to prevent EC loss due to shear stress (GOSSELIN, et al. 
1996). The precursor of fibrin gel is fibrinogen which is purified from blood. The degradation 
of the fibrin gel occurs within a few days by the plasminogen present in the culture medium, 
thus a degradation control will be required to make the use of fibrin gel possible 
(JOCKENHOEVEL, et al. 2001). Moreover, the structure of fibrin gel and its long-term 
maintenance are influenced by the parameters involved in gel formation process. For example, 
low pH value and ionic strength increases the gel permeability coefficient (Ks) and creates 
large pore sizes. In contrast, high pH and ionic strength decrease of the gel pore sizes and Ks 
(BLOMBACK and OKADA 1982). 
To sum up briefly, malleable substrates (e.g. hydrogels) having chemical, mechanical and 
structural properties similar to those of soft tissues, and the ECM, can be excellent candidates 
to support microvesssel formation. Fibrin gel has been widely employed in tissue engineering 
applications because of its ease of use and appropriate properties for blood vessel formation. 
Therefore, I propose to use the fibrin gel in tissue construct design as space filling material. 
Moreover, it is hypothesized that the PET fibre and fibrin gel by different mechanical 
properties to be appropriate candidates in order to orient the ECs and, as a result, to stimulate 
ECs tube formation. 
3.9. Conclusion 
Overall, in order to achieve a vascularized tissue construct, several methods are currently 
under investigation. These include the induction of vascularization capability of scaffolds by 
means of ECM components, angiogenic growth factors, the architecture and the biomechanics 
of scaffolds. In addition, pre-vascularized tissue substitutes can be engineered through the use 
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of progenitor ECs and stem cells. However, none of the above mentioned approaches can 
provide the prompt vascularization required for at least oxygen supply for transplanted cells at 
early stage implantation. Therefore, the existing techniques should be further developed to 
generate microvascular networks within the 3D tissue constructs in vitro, prior to implantation. 
For achieving this aim, the development of scaffolding material with an angiogenic capability 
to enhance vascularization, particularly in vitro, can be an alternative approach. Thus, this 
thesis proposes to use a fibrous polymeric material which will be surface coated with an ECM 
component such as RGD peptide or gelatin, for induction of angiogenesis. This approach aims 
to use the phenomena of contact guidance to modulate 3D patterning of the EC by enhancing 
EC migration, proliferation and orientation and ECM components to support EC attachment. 
This approach results in the formation in vitro of a directional angiogenesis which can be 
applied to many applications in tissue engineering such as therapeutic angiogenesis and pre-
vascularised tissue construct fabrication. In addition, this strategy aims to evaluate the 
angiogenesis ability of ECM components, e.g. RGD in vitro. Moreover, as explained earlier in 
Chapter 2, in order to fabricate these fibres I propose to employ a multilayer surface 
modification strategy using plasma polymerization, non-fouling material coating and 
biomolecule immobilization. The fibres fabricated in this way can be used for various 
applications in tissue engineering, i.e. plasma coated fibres can be used as cell adhesive, non-
fouling material coated fibres, as cell-resistant and bimolecular coated fibres as predictable 
cell adhesive fibres. 
71 
Chapter 4 
Materials and methods 
4.1. Overview 
In this chapter, the materials and methods utilized for surface modification, 
characterization and evaluation of the surface modified substrates, towards the behaviour of 
HUVECs, in 2D and in 3D cell culture system, will be explained. The surfaces of polymer 
fibres, PET monofilament with a 100-|am diameter, were first coated with a thin film of 
plasma polymer to produce amine groups, by HApp. The procedure was followed by 
covallently grafting of CMD onto the surface amine groups using water-soluble carbodiimide 
chemistry (EDC/NHS). Then, GRGDS were covalently immobilized onto the CMD-coated 
fibre surfaces. In the adhesion assay, the surfaces of various other substrates such as expanded 
PTFE monofilaments, and flat surfaces (e.g. borosilicate glass, microscope cover slips or FEP 
films) were modified in the same way (i.e. using the same multilayer surface, modification 
sterategy) as explained above and used for some complementary studies. 
Moreover, CMD and RGDS grafting has also been performed, via the AApp method, onto 
the surfaces of the same polymer fibres, as well as on flat surfaces. The AApp plasma-coated 
surfaces were then amino-functionalized, using polyethylenimine (PEI). Then, CMD and 
finally RGD were grafted onto amino-functionalized surfaces by the same method as 
previously explained. 
X-ray photoelectron spectroscopy (XPS) was utilised to analyze the multi-layer surface 
fabrication steps. AFM and SEM were also used to provide topographical maps of the plasma-
and CMD- coated surfaces. 
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In order to test these modified surfaces towards the HUVECs behaviour, the modified 
surfaces were initially evaluated in a 2D (monolayer) cell culture system, in vitro. HUVECs 
were seeded and grown on the fibres to evaluate the cell behaviour in terms of cell adhesion, 
spreading and orientation) as well as on flat surfaces, which were used for detailed 
characterization of cell behaviour (i.e. focal adhesion (FAs) and stress fibers formation). Phase 
contrast microscopy, epifluorescence microscopy and laser scanning confocal microscopy 
were used to observe the cell seeded surfaces. 
For the testing of surface modified fibres towards ECs patterning, and subsquent, 
microvessel formation, the surface modified PET fibres were tested in a 3D environment 
containing fibrin gel. Three different in vitro systems have been used to investigate 
microvessel formation. In the first system, both HUVECs and the fibres were embedded in the 
fibrin gel simultaneously. In the second system, the HUVECs, and fibres having various 
coatings, were sandwiched between two layers of fibrin gel. In the third arrangement, cell 
adhesive fibres were pre-coated with HUVECs and then embedded in the fibrin gel. The 
visualization of the systems was directly performed, using phase contrast microscopy, 
epifluorescence microscopy, and confocal microscopy during the culture period or through the 
provision of histology sections and immunohistochemistry. 
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4.2. Multilayer surface modification and characterization of flat 
and fibrous substrates with cell adhesive, cell non-adhesive 
and bioactive compounds 
4.2.1. Materials 
Various substrates (Table 4.1) were employed for the surface coating, depending on the 
intended end-use. Commercially available, 100-|am diameter monofilament made of PET (cat. 
# ES305910, Good fellow, Devon, USA) were used for most of the experiments performed in 
this study. PET fibres were selected for this role because of; a) their commercial availability as 
monofilaments, b) their amenability to withstand the multi-step surface modification used in 
this study, c) their biocompatibility, and d) their resistance towards standard autoclave 
sterilization methods, and moreover, e) in being "semi transparent". 
Table 4.1: Materials utilized for the multilayer surface modifications. 
Substrates Plasma polymers Dextrans Biomoleculs 
PET fibre N-Hepthylamine plasma MW 70 kDa GRGDS 
polymer (HApp) 
ePTFE fibre MW 500 kDa GREDS 
Acetaldehyde plasma 
Borosilicate glass polymer (AApp) Gelatin 
FEP film FN 
Perfluorinated poly (ethylene-co-propylene) tape from Dupont (Teflon FEP Type A, 
Mississauga, ON, Canada) were used as additional substrate for the surface topography 
characterization of coatings, and borosilicate glass substrates (Assistent, Sondheim, Germany) 
were used for monitoring the cell behaviors in more details, that were otherwise difficult to 
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perform directly on the polymer fibres. These substrates were chosen mainly for their ease of 
use. 
ePTFE (Sutures from W.L Gore & Associates (CV-7, mean dia.109 pm) (measured 
diameter under microscope was about 200-pm) were used as complementary substrates for the 
cell adhesion and spreading tests. TV-heptylamine (99.5% purity, cat. # 126802, Oakville, ON, 
Canada) and Acetaldehyde (> 99.9% purity, cat. # 00070 Saint-Louis, MO, USA), used in 
plasma polymerization, were obtained from Sigma-Aldrich. Dextrans of 70 and 500 kDa 
molecular weights were purchased from Amersham Bioscience (cat. # 17-0280 and # 17-0320, 
Uppsala, Sweden). GRGDS (cat. # 44-0-23) and GRGES (cat. # 44-0-51) peptides were 
purchased from American Peptide Company (Sunnyvale, USA). FN (cat. # f4759 Saint-Louis, 
MO, USA) and gelatin (cat. # G9391 Saint-Louis, MO, USA) were obtained from Sigma-
Aldrich. 
4.2.2. Fibre holder designing 
Manipulation of the single and thin (100-pm) polymer monofilaments was difficult during 
the multi-step procedures of this study, i.e., surface modification; characterization and in vitro 
evaluation. To overcome this problem, Teflon frames (Fig. 4.1), in two different sizes and 
shapes, were designed to be used as fibre holders during the process of fibre surface 
modification, characterization and biological evaluation. Non-conductive, 3-ram thick Teflon 
frames [~5 x 7 cm rectangular holder (Fig. 4.1 A) and ~2-cm diameter circular holder (Fig. 4.1 
B)] to hold the fibres in the plasma zone steady. The rectangular frame was designed and used 
for the purpose of facilitating the sample preparation (i.e. as either ~5- or 7-cm fibre lengths) 
for the XPS characterization. The circular frame was designed and used in order to hold the 
75 
fibres within 12-multiwell culture plates in cell culture tests. Teflon was selected as the 
appropriate material from which the frames were constructed because it is "workable" and 
non-conductive, in addition to being both chemically and biologically inert. The above 
mentioned work has been previously published (HADJIZADEH, et al. 2007) 
Figure 4.1: A) Picture of the "rectangular" frame used to hold polymer fibres (as single 
filaments) within the plasma zone, during fiber surface modification to modify 
the fibre surfaces and subsequently, to perform XPS analyses. B) Picture of the 
circular frame used to hold single filaments within the plasma zone, to modify 
the fibre surfaces, subsequently to use in the cell culture experiments. Picture I 
(photograph) shows the position of the fibres on the frames (as an example). This 
picture has been previously published (HADJIZADEH, et al. 2007). Picture II, 
showing the isometric view of the frames, was drawn with the aid of SolidWork 
software (drawn by Marc G. Couture). 
4.23. Polymer fibre placement onto the holders 
Fibres (PET and ePTFE monofilaments) were manually fixed onto the support holders. By 
means of a needle, the test fibres were passed through the holder holes and secured to the 
holder such that all fibres were "aligned" on the same side of the holder (Fig. 4.1 IB). This 
• 
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made it possible that all fibres to stay at the same level, so as to rest on the base of the cell 
culture plate which was essential in the cell culture tests. The above mentioned work has been 
previously published (HADJIZADEH, et al. 2007) 
4.2.4. Substrate cleansing 
In the cleaning procedure, all substrates, including fibres secured onto the frames, were 
initially immersed in a surfactant solution (RBS® Detergent 35, Pierce Biotechnology, 
Rockford, IL, cat. # 27952), overnight. The substrates were then "sonicated" for 10 minutes in 
the RBS solution, followed by a further 10 minute "rinsing" in ethanol (ACS grade). The 
substrates were then properly rinsed in "Milli-Q" water (having a resistivity about 
18.2 MQcm) and in final step, blow-dried using a flow of 0.2-p.m filter-sterilized, compressed 
air. The above mentioned work has been previously published (HADJIZADEH, et al. 2007). 
4.2.5. Introduction of amine groups onto substrates by means of plasma 
polymer deposition 
Polymer fibres (PET and ePTFE monofilaments), firmly secured into fibre holders, and the 
previously mentioned flat substrates, were exposed to a Radio Frequency Glow Discharge 
(RFGD) plasma of n-heptylamine vapour, to produce surface functional groups, which can be 
used as a platform for immobilization of further layers by wet chemistry. The reactor 
employed for the plasma polymerisation was a custom-built batch reactor (Fig. 4.2), in which 
the plasma was produced in vacuum via a radio frequency supply. The substrates, including 
the holders bearing the fibres, were placed on the lower circular electrode, having a diameter 
of 9.5 cm. The thin plasma polymer film was deposited by using n-heptylamine vapour. The 
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experimental parameters selected for the n-heptylamine plasma deposition were as follows: -
RF frequency, 50 kHz, RF power, 80 W and initial monomer pressure, 0.040 Torr. The thin 
film deposition time was set at 70 s, and the distance between electrodes was fixed at 10 cm. 
The above mentioned study has been previously published (HADJIZADEH, et al. 2007). 
4.2.6. Deposition of reactive acetaldehyde groups on substrates by means of 
plasma polymerization 
In order to produce aldehyde functional groups on the target surfaces, surface 
functionalization was initially performed by acetaldehyde plasma deposition in the same 
fashion as described for the HApp, with the treatment conditions being set as follows :-
frequency, 50 kHz, power load, 80 W, and initial monomer pressure, 0.300 Torr. The 
deposition time was set at 70 s and the electrode distance set at 10 cm. The above mentioned 
study has been previously published (HADJIZADEH and VERMETTE 2007). 
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4.2.7. CMD synthesis and characterization 
CMD was prepared by using dextrans, of two different molecular weights (MW 70 kDa, 
500 kDa ), that were carboxy methylated up to a substitution level of around 50% of using 
bromoacetic acid (cat. # 3016, Lancaster Synthesis Inc., Pelham, NH), by the performance of 
previously published reaction procedures (LOFAS and JOHNSSON 1990; MCLEAN, et al. 
2000a). In this process, CMDs, with about a 50% ratio of carboxyl groups per glucose ring 
unit, were prepared by dissolving 10 g of dextran in 50 ml of 2 N NaOH, also containing 1 N 
bromoacetic acid. The solution was stirred overnight, dialysed against Milli-Q water, 0.1 N 
HC1, and finally Milli-Q water for 24 h each. The solution was then lyophilized and stored at -
20°C until needed. The degree of carboxylation achieved was determined using 1H NMR. 
According to these analyses, the ratios obtained were ca. 1 carboxyl group per 2 sugar units. 
The above mentioned study has been previously published (HADJIZADEH, et al. 2007). 
4.2.8. CMD immobilization onto plasma-modified substrates 
CMD was grafted directly to the HApp-coated fibres, using water soluble carbodiimide 
chemistry (MCLEAN, et al. 2000a), using one (1) and 2 mg/ml CMD solutions prepared with 
Milli-Q water. Following dissolution, of CMD in Milli-Q water, 19.2 mg/ml of l-ethyl-3-
(3Dimethylaminopropyl) carbodiimide (EDC) and 11.5 mg/ml of /V-hydroxysuccinimide 
(NHS) were added to the CMD solutions. Holders holding the HApp-coated fibres 
(monofilaments) as well as HApp-coated flat substrates were then immersed in the resultant 
CMD solution and allowed to react overnight under gentle agitation conditions. In order to 
remove any non-covalently attached CMD, the substrates were immersed into an agitated 1M 
NaCl solution for 24 hrs, followed by immersion into Milli-Q water for 24 hrs under vigorous 
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agitation, and then rinsed in Milli-Q water for subsequent use. All the steps of this procedure 
were performed at room temperature. The above mentioned study has been previously 
published (HADJIZADEH, et al. 2007). 
In the case of the acetaldehyde plasma coated surfaces, the CMD was immobilized via a 
plasma step and the PEI spacers by two solution reaction steps (MCLEAN, et al. 2000a). The 
aldehyde groups present on the surface were reacted (via reductive amination) directly with a 
solution of polyethylenimine (PEI, Polyscience Inc., PEI 3 mg/ml in Milli-Q water at pH 7.4), 
using sodium cyanoborohydride (3 mg/ml, reducing agent). To remove any non-covalently 
attached PEIs, the substrates were immersed in 1M NaCl solution for 24 hrs under vigorous 
agitation condition, followed by immersion in agitated Milli-Q water for 24 hrs and finally 
rinsed in Milli-Q water. Amine groups, provided by the PEI on the substrates surfaces, were 
then used for covalent attachment of CMD in the same way as described earlier for HApp-
coated surfaces. This procedure was also performed at room temprature. The above mentioned 
study has been previously published (HADJIZADEH and VERMETTE 2007). 
4.2.9. Biomolecules (e.g. RGD) grafting onto CMD-coated substrates 
Peptide (i.e. GRGDS and GRGES) immobilization was performed, according to a 
sequential (i.e. two-step) procedure, being similar to those described elsewhere (GAO, et al. 
2003; HERSEL, et al. 2003). In order to limit the possibility of any damage to the GRGDS 
and GRGES peptides due to substrate sterilization, the peptide immobilization was conducted 
under sterile conditions, using autoclaved CMD-coated substrates. CMD-coated substrates, 
including the fibres, were immersed in Milli-Q water and autoclaved at 121°C for 25 minutes. 
The autoclave-sterilized CMD-coated fibres were then immersed in filter-sterilized (low-
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binding 0.22-|im syringe filters, Millipore corporation, Bedford, MA, USA) solutions of EDC 
(19.2 mg/ml) and NHS (11.5 mg/ml) in PBS (IX, pH 7.4), at room temperature for 4 hrs, 
followed by further rinsing with PBS (pH 7.4; 2 x 15 minutes). The substrates were then 
incubated in a filter-sterilized (0.22-pm) peptide solution of 0.1, 0.5 or 1 mg/ml GRGDS or 
GRGES, made in PBS (pH 8) for 2-3 hrs at room temperature. Following rinsing with PBS 
(pH 8, 3 x 15 minutes) to remove "unbound" free peptides, the substrates were allowed to dry 
under a sterile hood. This two-step sequential procedure is advantageous in order to avoid the 
inter-molecular condensation of the RGD peptides, because in using this procedure, the 
carboxyl groups of the aspartate side chain are not activated for coupling (GAO, et al. 2003). 
Furthermore, FN (100 pg /ml) and gelatin (100 pg /ml) were immobilized on the substrates in 
the same way as previously described for the RGD immobilization. The above mentioned 
study has been previously published (HADJIZADEH, et al. 2007). 
Figures 4.3A and 4.4 show, schematically, the multi-step procedure for biomolecule 
immobilization, via the HApp or the AApp and the CMD interlayers, onto a PET 
monofilament, respectively. 
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Figure 4.3: A) Schematic diagrams for the methods used for the covalent surface 
immobilization of GRGDS and GRGES peptides, via HApp and CMD 
interlayers. B) The chemical sequence of the GRGDS and GRGES peptides. 
These diagrams have been previously published (HADJIZADEH, et al. 2007). 
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Figure 4.4: Schematic diagrams of the methods used for the covalent surface immobilization 
of biomolecules (proteins/peptides) via AApp-PEI and CMD interlayers 
4.2.10. Surface characterization by XPS 
Fibres were fixed onto a particular fibre holder made of stainless steel for the XPS 
analysis. XPS analyses were performed on an AXIS HS spectrometer (Kratos Analytical) with 
a monochromatic Al K a (X-ray source, with operating power of 120 W). The total pressure in 
the main vacuum chamber was set at 2x10~8 mbar during the analysis. The chemical elements 
were detected from survey spectra. Collection of the Cls high-resolution spectra were 
performed at 40-eV pass energy for those individual peaks of interest. Atomic percentage for 
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each element was determined by calculating its integral peak area. The calculations of peak 
intensities were conducted by use of a Shirley-type background and the sensitivity factors 
provided by the instrument manufacturer. A value of 285 eV (the Cls hydrocarbon (CHX) 
peak) was used as a reference to correct surface charging effects (created due to the charging 
of the surfaces under X-ray irradiation) for all binding energies. In elemental quantification, a 
random error for the instrument has been considered (a range between 1 and 2% of absolute 
values for atomic percentages >5%). In addition, by considering electron attenuation length of 
~3 nm for a Cls photoelectron in a polymeric substrate and setting the angle of the emission 
normal to the surface the XPS analysis depth has been assumed to be about 10 nm. This value 
has been approximated from which about 95% of detected signal originates (MCLEAN, et al. 
2000a). The above mentioned study has been previously published (HADJIZADEH, et al. 
2007). 
4.2.11. AFM analyses 
In order to perform the AFM measurements, surface coated and un-coated substrates were 
placed on microscope slides covered with "double-sided" tape adhesive. These samples were 
treated with 0.2-|im filter-sterilized compressed air for the removal of free particles and dust 
from the surface. A Bioscope (Digital Instruments, Santa Barbara, CA), coupled to a Zeiss 
inverted microscope, connected to a Nanoscope Ilia controller, was employed to scan the 
surface of the samples in air by "contact mode", using Si_3N4 cantilevers with a spring constant 
of 0.12 N/m. AFM scan controls were appropriately set (to provide sufficient contact force and 
high gains) to avoid tip artifact generation during scanning of the samples. The "height 
images" obtained were processed with n-surf (1.0 beta) software. 
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4.2.12. SEM analysis 
A Cold Field Emission Gun Scanning Electron Microscope (FEGSEM) (HITACHI S-4700 
SEM) was employed to examine the surface morphology of the coatings and to evaluate their 
homogeneity over the entire sample surface. As the specimens were non-conductive, their 
surfaces were coated with a thin layer of platinum (Pt) using a plasma sputtering apparatus, 
prior to SEM observation. 
4.3. In vitro evaluation of the surface modified substrates towards 
EC behavior in a 2D (monolayer) cell culture system. 
4.3.1. Cell culture 
HUVECs were provided from Dr. C.J. Doillon (Universite Laval, Quebec City), isolated 
from human umbilical cord veins, as previously described (JAFFE 1980). HUVECs were 
cultured in Ml99 culture medium (cat. # M5017, Sigma-Aldrich, Saint-Louis, MO, USA) 
containing 2.2 mg/ml sodium bicarbonate (Fisher, Fair Lawn, USA), 90 (ag/ml sodium heparin 
(cat. # HI 027, Sigma-Aldrich, Saint-Louis, MO, USA), 100 U/100 |ag/ml 
penicillin/streptomycin (cat. # 15140-122, Invitrogen Corporation, NY, Grand Island, USA), 
10% fetal bovine serum (FBS, cat. # F1051, Sigma-Aldrich, Saint-Louis, MO, USA), 2 mM 
L-Glutamine (cat. # 25030149, Invitrogen Corporation, NY, Grand Island, USA), and 25 
fig/ml endothelial growth factor supplement (ECGS, cat. # 356006, BD Biosciences, San Jose, 
CA, USA). The above mentioned study has been previously published (HADJIZADEH, et al. 
2007). 
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4.3.2. Cell seeding onto polymer fibres 
Cell cultures on the polymer fibres were performed by adapting procedures, described 
previously (NEUMANN, et al. 2003; UNGER, et al. 2004). In order to evaluate the effect of 
surface-modified polymer fibres towards the HUVEC responses, fibres were positioned in 
parallel onto a circular Teflon holder (~2 cm in diameter, Fig. 4.1 IB). In this holder, fibres 
were distanced from each other by approximately 0.1 to 2.0 mm. Fibres were then surface-
modified, and subsequently they were sterilized directly on the holders; the non-coated PET or 
ePTFE fibres, HApp- and CMD-coated fibres were placed in Milli-Q water and autoclaved at 
121°C for 25 minutes. Three specimens of uncoated, cleaned PET or ePTFE monofilaments, 
along with PET or ePTFE monofilaments coated with 1) HApp, 2) HApp + CMD, 3) HApp + 
CMD + GRGDS, 4) HApp + CMD + GRGES interlayers were investigated. Holders holding 
the fibres were placed into wells of 12-multiwell tissue culture polystyrene (TCPS) plates, 
then rinsed in sterile PBS (pH 7.4), and incubated in Ml99 culture medium for 1-2 hrs to keep 
fibres hydrated until the cells were seeded. Then, 1 ml of Ml99 culture medium, containing ~ 
lxlO6 cells, was directly poured into the well, containing the fibre secured on the holder. Cells 
of passages 3 to 5 were used in all experiments. Fibres were incubated for 1 hr and shaked 
gently. Afterwards, the holders holding the fibres were transferred to new 12-multiwell culture 
plates, containing fresh Ml99 culture medium or they maintained in their previous conditions 
and incubated in a CO2 incubator at 37°C and 5% CO2. Controls were carried out with 
HUVECs, grown directly onto the plastic surface of the 12-multiwell culture plates. The above 
mentioned study has been previously published (HADJIZADEH, et al. 2007). 
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4.3.3. Cell attachment test 
Cell attachment tests were performed following the initial 4-hrs incubation period as 
reported previously (HERSEL, et al. 2003; MAHESHWARI, et al. 2000). The culture media 
were removed from wells and cells were incubated with a solution of Hoechst 33258 (cat. # 
H1398, Molecular Probes Inc., Burlington, ON, Canada) at a concentration of 10 pg/ml in 
fresh M199 culture medium for 30 minutes. Samples were then visualized under an inverted 
microscope (Nikon, Eclipse TE 2000-S), using fluorescence and phase contrast imaging. 
Images were captured using a 10X objective and a digital CCD camera (Regita 1300R, 
QIMAGING, Burnaby, BC, Canada), and imaging software (Simple PCI, Compix Inc., 
Cranberry, state, USA). The number of attached cells (stained for nuclei) per fibre length were 
counted, using SigmaScan5 software. Cell adhesion was studied on all samples and expressed 
as relative cell adhesion percentages. The relative cell adhesion was defined as the ratio of the 
cell number on surface coated PET fibres to that of uncoated PET fibres (as control). The 
number of attached cells (stained for nuclei by Hoechst) per fibre length were counted, 4 hrs 
after cell seeding. The comparison of groups were performed by using ANOVA (by using 
SigmaStat software), and a P value < 0.05 was considered statically significant. The 
percentage of relative cell adhesion was calculated by taking ratios of average numbers of 
adherent cells on untreated PET, HApp-, CMD-, and peptide-grafted fibres to the average 
number of adherent cells found on untreated PET fibres, multiplied by 100. Similarly, the 
relative standard deviations (SD) were calculated by taking the ratio of SDs of adherent cells 
on untreated PET, HApp-, CMD-, and peptide-grafted fibres to the average number of 
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adherent cells found on untreated PET fibres multiplied by 100. The above mentioned study 
has been previously published (HADJIZADEH, et al. 2007). 
4.3.4. Cell spreading test 
In order to monitor cell spreading, HUVEC-seeded fibres were maintained in culture 
within an incubator (37°C, 5% CO2) for 4 days. The culture medium was replenished every 
2 days. For the cell staining, cell-seeded fibres were gently washed with PBS (3 times) and 
then fixed in a formaldehyde solution (3.75 % wt/v) in PBS for 15 minutes. Following 
washing with PBS (x3), cells adhered on fibres were then permeabilized, using a Triton X-100 
solution (0.5 % v/v in PBS) (Sigma Chemical Co.) for 5 minutes. Following two further rinses 
in PBS, the samples were incubated in a mixture of TRITC-phalloidin (1:100 dilution, cat. # 
PI951, Sigma Chemical Co.), to stain for actin filaments, and SYTOX Green Nucleic Acid 
Stain (lfiM, cat. # S7020, Molecular Probes, OR, USA) or with Hoechst 33258 (at 1:100 
dilution), to stain for nuclei, in a blocking buffer solution (a solution containing 20% bovine 
serum albumin(BSA) (in PBS)) for 1 hr at room temperature and in darkness. The staining 
solution was removed and, after 3 washes with PBS, the preparations were then visualized on 
an Olympus Fluoview 300 confocal microscope, and also on an epifluorescence microscope. 
Images were captured using a COOLSNAP-Procf camera on Image-pro plus imaging software 
or by means of digital CCD camera and imaging software (Simple PCI). All experiments were 
replicated two or more times. The above mentioned study has been previously published 
(HADJIZADEH, et al. 2007). 
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4.3.5. Dil-acetylated LDL staining 
To ensure cell maintenance on GRGDS (at concentrations of 0.5 mg/ml and 1 mg/ml)-
coated fibres, the live cells were initially stained with Dil-acetylated LDL (Acetylated low-
density lipoproteins) (cat. # BT-902, Biomedical Technologies Inc., Stoughton, MA, USA) at 
day 2. Then, the samples were observed, by phase contrast or confocal microscope, every day. 
This experiment was performed in order to qualitative evaluate the growth and stability of 
HUVECs on the RGD coated surfaces in culture for a period of 10 days to verify the stability 
of RGD coating under cell culture conditions. The above mentioned study has been previously 
published (HADJIZADEH, et al. 2007). 
4.3.6. Cell seeding onto surface-modified flat substrates 
Observation of actin filaments and focal adhesion structures 
Detailed observation of actin filaments and focal adhesion structures was very difficult to 
perform directly on the polymer fibres, because of the lack of full "transparency" within these 
fibres. Therefore, surfaces of borosilicate glass substrates were modified and sterilized, under 
the same experimental conditions as those used to activate polymer fibres surfaces, with the 
aim of gathering more information on the effects of surface coatings on the actin filament and 
the focal adhesion formation of cells seeded on various coatings. 
Borosilicate glass substrates, with the different modified surfaces, were placed in the wells 
of a 12-multiwell culture plate. HUVECs were then seeded onto these samples at a density of 
lxlO4 cells/cm2 and cultured, as for the polymer fibres. Following 4 days of culture, the 
samples were fixed and "permeabilized" by the same procedure as described previously 
(section 4.3.4), and then incubated for 1 hr with a primary antibody (Monoclonal Anti-
90 
Vinculin, Sigma, cat.# V4505), at a dilution of 1:25 within the same blocking buffer as 
described above (section 4.3.4). Each sample was then washed three times with the PBS for 5 
minutes, and then incubated with secondary antibody (1:250 dilutions of Anti-Mouse IgG, 
Sigma, and cat. #A2304), within the same blocking buffer, for 1 hr. Samples were twice 
washed with PBS (5 min each), then mounted in mounting fluid with a coverslip. The edges of 
samples were sealed with "nail polish" and stored in a dark enclosure until observation by 
epifluorecence microscopy. The experiments were replicated two or more times.The formation 
of actin filaments and FAs on each substrate was observed at least in 4 microscopic fields. The 
above mentioned study has been previously published (HADJIZADEH, et al. 2007). 
4.4. In vitro evaluation of surface modified PET fibres towards 
microvessel formation in 3D cell culture systems. 
4.4.1. Cell culture 
HUVECs were purchased from Cambrex (cc-2519, Walkersville, MD USA) or provided 
from Dr. Doillon as mentioned in section 4.3.1. HUVECs were cultured (in the same condition 
as explained in section 4.3.1), i.e. at 37°C and 5% CO2 in a M199 culture medium containing 
2.2 mg/ml sodium bicarbonate, 90 (ig/ml sodium heparin, 100 U/100 (ig/ml 
penicillin/streptomycin, 10% fetal bovine serum 2 mM L-glutamine, and 25 jig/ml ECGS. 
HUVECs between passages 2 and 4 were used in all experiments. Human fibroblasts extracted 
from human foreskin were cultured in Ml99, containing 2.2 mg/ml sodium bicarbonate, 
90 [ig/ml sodium heparin, 100 U/100 |a.g/ml penicillin/streptomycin, 5% fetal bovine serum 2 
mM L-glutamine, at 37°C and 5% CO2. Fibroblasts between passages 5 and 10 were used in 
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all experiments. Fibroblasts were provided from Dr. Vermette's laboratory that was obtained 
from Dr. C.J. Doillon (Universite Laval, Quebec City). 
Fibrinogen (cat. # F8630), Thrombin (cat. # T3399) and Aprotinin (cat. # Al 153), used in 
3D angiogenesis models, were provided from Sigma-Aldrich. 
4.4.2. Construction of the three in vitro cell culture systems 
First system: System containing polymer fibres and HUVECs dispersed in fibrin gels 
In this system (Fig. 4.5), fibres were embedded in a fibrin gel mixed with HUVECs; 
uncoated, cleaned PET monofilaments and PET monofilaments coated with i) HApp + CMD, 
ii) HApp + CMD + RGD, and iii) HApp + CMD + gelatin were tested. Fibres were placed in 
the wells of 12-multiwell culture plates, then rinsed in sterile PBS (pH 7.4), and incubated in 
Ml99 culture medium for 1-2 hours to keep fibres hydrated until they embedded in fibrin gel. 
To construct the culture system containing fibrin gel, HUVECs and fibres; fibres were first 
transferred into the wells of 12-multiwell culture plates and then 500 pi of fibrinogen solution 
(containing 2.5 mg fibrinogen) in Ml99 medium was placed in each well of a 12-multiwell 
culture plate. HUVECs, at a density of lxlO5 cells/ml suspended in serum free M199, were 
added (500 pi) to the wells, followed by a thrombin solution (1 unit/ml). After polymerization 
of fibrinogen into fibrin gel (5 min at room temperature and 20 min at 37°C and 5% CO2), one 
ml of supplemented medium Ml99 was added to each well. Then, the assembled system was 
incubated at 37°C and 5% C02 for at least 10 days. 
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Figure 4.5: Schematic diagram of the procedure used in the first system, fibres were 
combined in fibrin gel containing dispersed HUVECs. 
Second system: System with HUVECs sandwiched between fibrin gels containing cell-
free fibres 
In this system (Fig. 4.6), uncoated cleaned PET monofilaments and PET monofilaments, 
coated with: - i) HApp, ii) HApp + CMD, iii) HApp + CMD + RGD, iv) HApp + CMD + 
gelatin and v) HApp + CMD + RGE, were investigated. Holders supporting the fibres were 
placed in the wells of 12-multiwell culture plates, then rinsed in sterile PBS (pH 7.4), and 
incubated in the Ml99 culture medium for 1-2 hours to keep the fibres hydrated until the cells 
seeded. This system was produced by an adaptation of a previously described procedure 
(BACH, et al. 1998). To make the underlying fibrin gel, 500 (il of fibrinogen (2.5 mg/ml) 
(solution) in Ml99 medium was placed in each well of a 12-multiwell culture plate and 
thrombin (1 unit/ml) was added. After polymerization of the fibrinogen into fibrin gel (5 min 
at room temperature and 20 min at 37°C and 5% CO2), holders supporting the fibres were then 
transferred onto the top of the gel and HUVECs suspended in the serum free Ml99 were 
seeded at a density of lxlO5 cells/well onto the underlying fibrin gel. One milliliter of medium 
Ml99 supplemented as indicated in section 4.3.1, was added to each well. Once a confluent 
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monolayer (~24hrs after seeding) formed, the culture medium was removed and the same 
procedure was repeated to generate a second fibrin gel layer over the cell surfaces. After fibrin 
gel polymerization, a 1 ml of supplemented medium Ml99, along with 0.15 units/ml aprotinin 
was added to each well. 
Polymer 
Fibers 
V « 
V , 
Media 
Fibroblast 
Fibrin gel 
Fiber 
HUVECs 
Monolayer 
Figure 4.6: Schematic diagram of the procedure used in the study in second system in wich 
fibres were maintained parallel in a Teflon holder ring (A), HUVECs and holders 
supporting polymer fibres were sandwiched between two layers of fibrin gel on 
which a layer of fibroblast was seeded and then culture medium added (B). 
Third system: System with cell-pre-coated fibres embedded in fibrin gel 
Preparation of the fibres covered by HUVECs 
Cell cultures on the PET fibres with different cell-adhesive coatings, were performed by 
the application of procedures previously described in section 4.3.2. Three specimens of the 
cleaned, uncoated PET monofilaments (controls) and of the PET monofilaments coated with: -
i) HApp, ii) HApp + CMD + RGD and iii) HApp + CMD + gelatin were investigated. Holders 
supporting the fibres were placed in the wells of 12-multiwell culture plates, then rinsed in 
sterile PBS (pH 7.4), and incubated in M199 culture medium for ~ 1-2 hr to keep the fibres 
hydrated until the cells were seeded. Then, 1ml of Ml99 culture medium, containing IxlO6 
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cells (between passages 2 and 4), were directly poured into the well containing the fibre 
holder. The fibres were incubated in a CO2 incubator at 37°C and 5% CO2, HUVECs were 
allowed to attach to the cell adhesive polymer fibres by incubating cells with fibres in Ml99 
for about 4 hrs, then the medium was replaced with a fresh one, supplemented as indicated in 
section 4.3.1, and the samples were kept in the culture up to its confluence. When the entire 
surfaces of the fibres were covered with HUVECs, they were then used for the angiogenesis 
experiments. The procedure is summarized on Figure 4.7. It should be noted that cell 
confluency on both uncoated PET and surface coated PET, as mentioned earlier (i-iii), will not 
be achieved in the same time period, because the initial cell uptake of uncoated PET fibre, in 
comparison to surface coated fibre, is too low as we have previously reported 
(HADJIZADEH, et al. 2007). 
Embedding of HUVEC -pre-coated fibres in fibrin gel 
This method (Fig. 4.7) has been adapted from a previously reported method (NAKATSU, 
et al. 2003). In brief, the holders supporting HUVEC-precoated fibres were embedded in a 
fibrin matrix, prepared as follows: holders supporting HUVEC- coated fibres were placed in a 
12-multiwell culture plate, then 1 ml of fibrinogen solution (2.5 mg/ml) in Ml99 culture 
medium (pH 7.4) with or without aprotinin (0.15 units/ml) was added to each well of the 12-
multiwell culture plate, and then thrombin (1 unit/ml) was added to each well. The fibrinogen 
solutions were left to polymerize for 5 min at room temperature and then incubated at 37°C 
and 5% C02 for 20 min. One (1) ml of EGM-2 (Cambrex, cc-3162) (containing 2% FBS) was 
added to each well and 4 x 104 fibroblast cells were "seeded" on the top of the gel (as 
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monolayer). The culture medium was replenished every other day and the culture system was 
monitored each day for 20-30 days. 
Fiber 
Figure 4.7: Schematic diagram of the procedure used in the third system, and observations 
made under the microscope. Fibres were maintained parallel within a Teflon 
holder ring (A); HUVECs were then seeded and grown on the fibres until 
confluence (in this example, cells on the fibre were stained for actin filaments, 
using TRITC-phalloidin, and counterstained with Sytoxgreen to highlight the 
position of the nuclei) (B). The holder was embedded in a fibrin gel, on which a 
layer of fibroblast was seeded, and the culture medium then added (C). Fibre 
diameter: 100pm. 
4.4.3. Observations 
For the observation of the EC behaviour (i.e. tube-like structure formation) during the 20-
30 days cell culture period, specimens were observed daily by the use of phase contrast or 
confocal microscopy. In addition, cells were stained with Dil-acetylated LDL (BT-902, 
Biomedical Technologies Inc., and Stoughton, MA, USA) at day 2 or 3 and the formation of 
tube-like structures was periodically observed. Images were recorded by means of a digital 
Endothelial 
cells covered 
fiber 
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CCD camera (Regita 1300R, QIMAGING, and Burnaby, Canada) and imaging software 
(SimplePCI, Compix Inc., Cranberry, USA). The 3D systems were also observed through an 
Olympus Fluoview 300 confocal microscope, the images being captured using a COOLSNAP-
Procf camera on Image-pro Plus imaging software. Test fibres were observed at different 
magnifications (i.e. X4, X10 and X20 objectives) and the images recorded as high-resolution 
files. 
4.4.4. Images and processing 
In the third system, fibres were photographed at low magnification (by using the X4 and 
X10 objectives) and recorded into the high-resolution files (*.TIFF) in order to identify and 
quantify the effects of fibre distance and incubation time on angiogenic-like structure 
formation. An image-processing software (i.e. Image J, Scion Co., Frederick, Maryland) was 
employed for counting the number of angiogenic-like structures. Angiogenic-like structures 
(regardless their lengths) that originated from the initially formed tube-like structure, situated 
along the fibre, were counted. The number of vessels was reported per unit length of the fibre 
(i.e. vessel number /mm). 
4.4.5. Statistical analysis 
Statistical analysis was performed using SigmaStat software (Systat Software, Inc., Point 
Richmond, CA). Vessel number per unit length of fibre was determined; comparison between 
groups was performed by using ANOVA (one-way analysis of variance) with a p value set at 
< 0.05. The data were reported as mean values ± standard errors of the mean (SEM). 
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4.4.6. Histological sections 
Constructs (i.e. fibrin gels, involving the fibres on the holders) were "fixed" in a 10% 
neutral buffered, formalin solution overnight. The constructs were gently removed from their 
wells, and then proceeded in order to provide the paraffin wax sections. Sections with a 6-pm 
thickness were cut and the immunohistochemistry was performed, using a vWf (Factor VIII) 
anti-body with hematoxylin as a counterstain (this test has been processed at the Department 
of Pathology of University of Sherbrooke). 
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Chapter 5 
Results and discussion I: Surface modification and 
physicochemical characterization 
5.1. Overview 
In biomedical applications, surface modifications aim to improve biomaterial surface 
properties, for example, non cytotoxic, adhesion, and non fouling performances towards cells 
response. In the study of scaffolding materials for use in the tissue engineering, the chemistry 
and physics (e.g. surface roughness) of the implant's surface must be studied in depth as these 
two parameters can affect cell and tissue response. For this reason, one of the objectives of this 
thesis is the surface modification exploring a multilayer fabrication strategy to change the 
surface properties of the biomaterials on which new surface functional groups and the 
topography are generated for better cell adhesion or repulsion without affecting the bulk 
properties of the polymer. This multilayer surface modification consists of the following steps 
and aims: 
1) HApp or AApp was deposited on the surfaces as a thin polymeric interfacial 
layer containing amine or aldehyde groups respectively, by RFGD deposition. 
These coatings offer two advantages i) introducing new functional groups (i.e. 
amine or aldehyde) to covalent grafting of a second desired layer (e.g. CMD), 
and ii) altering physicochemical properties of the surface to enhance cell 
adhesion and growth. 
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2) CMD was then covalently attached onto the amine groups present on the 
material surfaces using water-soluble carbodiimide chemistry (EDC/NHS); 
prior to CMD grafting, the acetaldehyde coated surfaces were amine 
functionalised by grafting PEI via aldehyde groups. The CMD graft layer will 
play two roles i) non-fouling towards proteins and cells, and ii) introducing 
carboxy functional groups in order to covalently immobilize bio-active 
molecules. 
3) In a final step, RGD peptides or other biological molecules were covalently 
grafted onto the surface carboxylic groups available on those surfaces using 
water-soluble carbodiimide chemistry with the aim of inducing an integrin-
mediated cell adhesion. 
The performance of multi-layer fabrication steps was confirmed by XPS analyses which 
were performed for providing detailed quantitative results of the surface elemental 
composition. In addition to the XPS analysis, the existence of thin films obtained by plasma 
deposition, and the subsequent CMD immobilization on the surfaces were visualized by SEM 
and AFM which produced topographic maps of the analyzed surfaces and provided qualitative 
results of the different coatings. The AApp plasma-deposited and CMD coated surfaces 
presented the roughest surfaces among others. Therefore, these multi-step surface fabrication 
techniques can be applied to fabricate biomaterials with multifunctional surfaces, and thus that 
can have important applications in tissue engineering such as scaffolding materials for 
multicellular tissue regeneration. 
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5.2. Surface elemental composition analyses by XPS 
In tissue engineering applications, the chemistry of the biomaterial surface must be studied 
in depth because the cell-material interactions take place at the atomic scale. XPS has been 
employed to quantify the elemental composition of surfaces, by introducing a surface to an X-
ray beam. In this event, the core level electrons of the atoms are ejected (RATNER and 
CASTER 1997). Kinetic energies corresponding to these electrons are detected and employed 
to produce analytical results as survey spectrum, elemental percentage and high resolution Cls 
spectra of the surface (RATNER and CASTER 1997). Therefore, in this present thesis, XPS 
analyses have been performed at all stages of the multilayer surface fabrication. 
5.2.1. Plasma polymer deposition 
As indicated in Table 5.1, the elemental composition determined by XPS analyses revealed 
the successful surface modification of substrates by HApp and AApp. XPS analyses of clean 
untreated PET fibres show C-C, C-O and C=0 components in the Cls high-resolution spectra 
(Fig. 5.1 A), located at 285, 286.5 and 289 eV, respectively. This is in agreement with the PET 
polymer chemical bonds and XPS analyses of the PET polymer obtained from other studies 
(WEN, et al. 2006; [Website ref.5]). 
HApp coating 
HApp was deposited onto the surfaces as a thin, polymeric interfacial layer having amine 
groups by RFGD deposition, previously explained in Chapter 4 (see section 4.2.5). XPS 
analysis of HApp layers on PET fibres (Fig. 5. IB and Table 1.1) show a polymer comprised of 
hydrocarbon- and nitrogen-containing species, which is identical to the data previously 
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obtained by others on different substrates (MCLEAN, et al. 2000a; GRIESSER, et al. 2002). 
The oxygen atomic concentration reduced from 25.1% for an uncoated PET monofilament to 
3.1% for a HApp-coated PET monofilament, showing the presence of a uniform and thick 
plasma polymer layer on HApp-coated PET monofilament. 
In addition to PET fibres, HApp was deposited on various substrate surfaces, such as 
ePTFE fibres and PCL membrane, and characterized by XPS. The fluorine atomic 
concentration was reduced, from 76.54 % for an uncoated PTFE monofilament to 0 % for a 
HApp-coated PTFE monofilament (Table 5.1), and also the shift related to the fluorine atom in 
the Cls high-resolution spectra (Fig. 5.21), located at 292eV, totally disappeared, indicating 
the existence of a uniform and thick plasma polymer layer on the HApp-coated PTFE fibres. 
Therefore, these results demonstrate that the HApp layers were thicker than the 10-nm 
analysis depth of the XPS instrument. 
Moreover, to verify the performance of this coating on substrates with various shapes, the 
same HApp coating was generated on the PCL porous membrane. The elemental composition 
(Table 5.1) and the XPS high resolution spectra of PCL (Fig. 5.211) all were in agreement with 
those obtained for the PET fibre (Table.5.1) and (Fig. 5.1). 
Therefore, HApp can be deposited onto different materials, with of different geometries, 
such as fibrous or flat polymeric substrates, with porous or nonporous surfaces, thereby 
producing a uniform film and thicker than 10 nm. Plasma polymerization has been widely 
utilized for the surface modification of biomaterials, in the field of biomaterials. This is due to 
the typical characteristics of the plasma polymer films, such as: - being smooth, free of 
pinhole and other defects, and displaying good adhesion towards various substrates 
(MOROSOFF 1990; GENGENBACH, et al. 1996). However, since these plasma polymer 
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films rapidly oxidize in air, they should be used promptly after their preparation 
(GENGENBACH, et al. 1996; GENGENBACH, et al. 1994). 
AApp coating 
AApp was deposited onto the surfaces as a thin, polymeric interfacial layer; having 
aldehyde groups, by the RFGD deposition route as previously explained in Chapter 4 (see 
section 4.2.6). As listed in Table 5.1, the successful surface modifications, achived by use of 
AApp on the PET fibres, were obvious after determination of the elemental composition by 
XPS analyses. XPS elemental ratios (Table5.1) and Cls high-resolution spectra for the 
aldehyde plasma surface (Fig. 5.3B) were identical to those reported earlier (MCLEAN, et al. 
2000a). The decreases in the oxygen atomic concentration, from 26.6% in PET to 16.69% on 
the AApp-coated surface (Table 5.1) along with the disappearance of shifts in the 286.5eV and 
289eV spectral lines (Fig. 5.3B) show a thick plasma polymer coating on the AApp-coated 
substrates. 
In addition to PET fibres, AApp was also deposited on various surfaces such as PTFE 
fibres and flat surface borosilicate glass (used as references), and was characterized by XPS. 
The reduction in the fluorine atomic concentration, from 76.54 % for an uncoated PTFE 
monofilament to 0% for an AApp-coated PTFE monofilament (Table 5.1), indicated the 
presence of a uniform and thick plasma polymer layer. In addition, the XPS Cls spectra (Fig. 
5.2IV) of the PTFE fibres, coated with AApp layers, showed the disappearance of the spectral 
shift, related to the fluorine in 292 eV, demonstrating that the AApp layer was thicker than the 
10-nm analysis depth of the XPS instrument. Similarly, the disappearance of the shift related 
to the silicon in AApp-coated borosilicate glass (Table 5.1 and Fig. 5.2 III), is additional proof 
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of the successful surface coating with Aapp, as well as the applicability of use of this coating 
on rigid, non-polymeric substrates. Therefore, AApp deposition can be performed on various 
substrates, such as: flat, fibrous, polymeric and non-polymeric surfaces, producing a uniform 
and thicker coating than earlier mentioned 10 nm films. 
Table 5.1: Elemental compositions, determined by XPS of HApp- and AApp-coated 
substrates. 
Samples Atomic concentrations (%) ± Standard deviation Atomic ratios (%) Exposure 
to oxygen C I s O I s N I s F l s S I l s N / C o / c 
PET fibres 74.8 ± 2 25.1 + 2 0.0 ± 0 . 0 0 0 0.000 0.34 NA 
PET+HApp 88.6 ± 0.4 3.1 ± 0.5 8.3 ± 0.4 0 0 0.094 0.03 > 1 hour 
PTFE fibre 23.46 0 0 76.5 0 0 0 NA 
PTFE +HApp 91.6 2 6.4 0 0 0.07 0.022 > 1 hour 
PCL* film 78.5 21.5 0 0 0 0 0.27 NA 
PCL film+HApp 85.25 8.15 6.6 0 0 0.08 0.1 >lday 
PET fibre +AApp 80.5 19.5 0 0 0 0 0.24 >1 hour 
PTFE fibre +AApp 81.08 18.92 0 0 0 0 0.23 >1 hour 
Borosilicate glass 4.25 63.15 0 0 22 0 14.85 NA 
borosilicate +AApp 83.9 16.1 0 0 0 0 0.19 >1 hour 
* PCL porous film was prepared by the immersion precipitation method, using chloroform (solvent) and 
water (non- solvent). 
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Figure 5.1: High-resolution XPS Cls spectra of: (A) clean untreated PET fibres, (B) PET 
fibres + HApp layer, (C) HApp + CMD (70kDa, 1:2, 2 mg/ml), and (D) HApp + 
CMD + GRGDS (0.5 mg/ml). The spectra have been displayed relative to each 
other in the Y-direction to allow for comparison of the peak positions. This figure 
has been previously published (HADJIZADEH, et al. 2007). 
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Figure 5.2: High-resolution XPS Cls spectra of HApp and AApp-coated substrates: I) clean, 
untreated PTFE fibre (A) and PTFE fibre + HApp (B) this figure has been 
previously published (HADJIZADEH and VERMETTE 2007). II) Clean, 
untreated PCL membrane (A) and PCL membrane + HApp (B) this figure has 
been previously published (HADJIZADEH and VERMETTE 2007). Ill) Clean, 
untreated borosilicate glass (A) and borosilicate glass + AApp (B), IV) clean, 
untreated PTFE fibre (A) and PTFE + AApp (B) 
106 
Binding Energy (eV) 
Figure 5.3: High-resolution XPS Cls spectrum of A) PET monofilament, B) PET + AApp, 
C) PET + AApp + PEI, D) PET + AApp + PEI + CMD, E) 
PET+AApp+PEI+CMD+GRGDSP, the spectra have been displaced relative to 
each other in the Y-direction to allow comparison of peak positions This figure 
has been previously published (HADJIZADEH and VERMETTE 2007). 
5.2.2. CMD immobilization 
CMD immobilization via HApp interlayer 
CMDs were synthesized from dextrans of two distinct molecular weights (70 and 500 kDa 
MW), according to previously reported procedures (LOFAS and JOHNSSON 1990; 
MCLEAN, et al. 2000a), as previously explained in Chapter 4 (see section 4.2.7), with about a 
50% ratio of carboxyl groups to the sugar units. The degree of carboxylation achieved was 
examined, using 1H NMR. The experimentally determined ratios were ca. 1 carboxyl group 
per 2 sugar units (the results of the NMR analyses can be seen in the Appendix, section 10.3). 
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CMD was then covalently grafted onto the surface amine groups available on the surfaces, 
using water-soluble carbodiimide chemistry, as previously explained in Chapter 4 (see section 
4.2.8). The increase in atomic concentration, from 3.1% for a HApp-coated PET 
monofilament to about 18.2 % for a CMD-coated PET monofilament, indicates an uniform 
CMD layer (Table 5.2). The appearance of chemical shifts related to the C-O (286.5 eV) and 
C=0 (289 eV), observed in the high-resolution Cls spectra, also prove the successful grafting 
of the carboxy-methyl-dextrans onto the HApp interlayer (as shown in Fig. 5.1C). The 
presence of a nitrogen signal demonstrates that the CMD graft layer (in the dry state and under 
vacuum) was much thinner than the XPS analysis depth (i.e. 10 nm). These results are 
identical to those of a previous study, using the same multilayer structure (MCLEAN, et al. 
2000a). 
The effects of the CMD molecular weight and CMD solution concentration on the 
effectiveness of this coating were examined on the effectiveness of the CMD coating. To this 
aim, CMDs, with two different molecular weights (i.e. 70 and 500 kDa) and two CMD 
solution concentrations (i.e. 1 mg/ml and 2 mg/ml) were used. As shown in Figure 5.4, the 
XPS surface chemical compositions of the four CMD coatings were similar. As shown in 
Figure 5.5, only for the autoclaved CMD coating (70 kDa, 1:2, and 2 mg/ml) a significant 
reduction in atomic O/C ratio in comparison to the control (i.e. CMD, 70 kDa, 1:2, 2 mg/ml) at 
P<0.05 was observed. However, CMD-coating of 70 kDa molecular weight and CMD 
solution concentration of 2 mg/ml shows a lower Nls/Cls ratio (0.062) among the other CMD 
coatings (Table 5.2 and Figure 5.5 B), demonstrating that the CMD coating in this condition 
generates a thicker CMD layer on the surface. As a result, CMD with a 70 kDa molecular 
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weight, a carboxylation ratio of 1:2, and a CMD solution concentration of 2 mg/ml, were 
selected to produce the CMD-coated PET fibres for use in biological testing of these fibres. 
To permite the use of these fibres in cell and tissue culture applications, they need to be 
sterilized, using standard sterilization procedures. As autoclaving is the optimal and desirable 
method for the sterization of biomedical devices, the effect of autoclaving on the CMD 
coating on the fibres was evaluated by XPS. XPS analyses of autoclaved samples showed an 
alteration in the surface elemental composition of this coating (Table 5.2 and Fig. 5.5C). These 
observations suggest that some CMD molecules have detached themselves during the 
autoclaving conditions, though extensive rinses with 1M NaCl solution were used to remove 
physisorbed CMD molecules from the fibres, following CMD immobilization. Another 
possibility is that the CMD coatings collapsed during autoclaving. A decrease observed in the 
atomic O/C ratio, following autoclaving of the CMD-coated fibres, supports these two 
suggestions (Fig. 5.5C). The above mentioned results and discussions, about CMD, have been 
previously published (HADJIZADEH, et al. 2007). 
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Table 5.2: Elemental compositions determined by XPS of the CMD immobilized PET fibres 
Samples Atomic concentrat ions (%) ± Standard 
deviation 
Atomic ratios (%) Exposure 
to 
C Is O Is N Is 
N/C o/c 
oxygen 
PET+HApp 88.6 ± 0.4 3.1 ± 0.5 8.3 ± 0.4 0.094 0.03 >lhour 
PET+HApp+CMD( 1:2, 70 kDa, 1 mg/ml) 75.8 ± 2 18.2 ± 0.5 6.0 ± 1.3 0.079 0.24 >3days 
PET+HApp+CMD( 1:2, 70 kDa, 2 mg/ml) 77.4 ± 0.6 17.8 ± 0.6 4.8+ 0.7 0.062 0.23 >3days 
PET+HApp+CMD(l:2, 70 kDa, 2 mg/ml) 
following autoclave 
81.0± 1 13.5 ± 1.5 4.9 ± 0.2 0.061 0.17 >3days 
PET+HApp+CMD( 1:2, 500 kDa, 1 mg/ml) 77.2 ± 0.3 17.1 ± 0.6 5.7 ± 0.2 0.073 0.22 >3days 
PET+HApp+CMD( 1:2, 500 kDa, 2 mg/ml) 77.1 ± 1.7 18.1 ± 0.1 6.0 ± 1.7 0.078 0.24 >3days 
PET +AApp 80.5 19.5 0.0 0.0 0.24 > 1 hour 
PET +AApp +PEI 78.8 ± 1.3 16.6 ± 4.4 4.5 ± 3 0.057 0.21 >5hours 
PET+Aapp +PEI+CMD 
1:2(70 kDa) 1 mg/ml 
PET+AApp+PEI +CMD 
1:2(70 kDa) 2 mg/ml 
67.51 
7 1 . 9 ± 4 . 4 
26.4 
24.8 ± 4 . 4 
6.12 
3.3 ± 0 . 0 
0.09 
0.045 
0.4 
0.34 
>ldays 
>1 days 
1:2 means a carboxylation degree of 1:2. 
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Figure 5.4: High-resolution XPS Cls spectra of (O) PET + HApp + CMD (70kDa, 1 mg/ml), 
(+) PET + HApp + CMD (70kDa, 2 mg/ml), (x) PET + HApp + CMD (70kDa, 2 
mg/ml) (autoclaved), (-) PET + HApp + CMD (500kDa, 1 mg/ml), and (*) PET + 
HApp + CMD (500kDa, 2 mg/ml). CMD with a ratio of 1 carboxyl group to 2 
sugar units was used. This figure has been previously published (HADJIZADEH, 
et al. 2007). 
Ill 
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Figure 5.5: Atomic O/C and N/C ratios of CMD-coated PET fibres produced under various 
conditions. A) PET + HApp + CMD(70kDa, 1:2, 1 mg/ml), B) PET + HApp + 
CMD(70kDa, 1:2, 2 mg/ml), C) PET + HApp + CMD(70kDa, 1:2, 2 mg/ml) 
(autoclaved), D) PET + HApp + CMD(500kDa, 1:2, 1 mg/ml), and E) PET + 
HApp + CMD(500kDa, 1:2, 2 mg/ml). Error bars represent the standard 
deviations, * indicates those values significantly different from the control (PET 
+ HApp + CMD (70kDa, 1:2, 2 mg/ml)) by ANOVA at p <0.05. This figure has 
been previously published (HADJIZADEH and VERMETTE 2007). 
CMD immobilization via AApp interlayer 
In this method, the CMD was grafted onto the AApp layer via the polyimine (PEI) 
(generates surface amine groups) spacer layer. So this method consists of immobilizing the 
CMD via a plasma step, and the PEI spacers, by the two solution reaction steps. Immediately 
after the plasma polymer deposition, the aldehyde groups (CHO), generated by AApp on the 
surface, were reacted (via the reductive amination reaction) with a solution of PEI and sodium 
cyanoborohydride (NaBH3) acting as the reducing agent (MCLEAN, et al. 2000a). Then the 
CMD, with 70kDa MW were immobilized onto the PEI spacers, via the use of carbodiimide 
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chemistry in the same way as conducted for the CMD immobilization, via HApp (see section 
4.2.8). Then, all the product layers (i.e.AApp, the PEI and CMD) were analyzed by XPS 
(Table 5.2). The XPS Cls spectrum of the PEI grafted onto the AApp is shown in Figure 5.3C. 
The increased in nitrogen content (but not oxygen) shown in table 5.2 suggests that the height 
increase of the Cls shoulder at 286.5eV can be attributed to the introduction of the C-N 
species of the PEI. The increase in the atomic concentration of oxygen by the CMD coating 
(Table 5.2), and the presence of C-0 (286.5eV), C=0 (289eV), observed in the high-resolution 
Cls spectra, revealed the presence of covalently grafted CMD on the AApp-PEI-coated 
surface (Fig. 5.3D). The observation of the nitrogen signal, following the CMD grafting, 
shows the presence of the PEI chains at the outer surface of the coating (among the CMD 
chains), a situation identical to that reported elsewhere (MCLEAN, et al. 2000a). This can be 
either because of a thin CMD coating or it may be due to an artefact, created by the 
rearrangement of the CMD chains caused by the vacuum prior to the XPS analysis. The XPS 
Cls spectrum of the CMD (Fig. 5.3D) shows that the CMD graft layer was thicker when the 
CMDs were immobilized by means of a PEI spacer layer grafted onto the Aapp, in comparison 
with the case of direct grafting onto the HApp surface (Fig. 5.1C). 
As shown in Table 5.2, the CMD of 70 kDa molecular weight with a CMD solution 
concentration of 2 mg/ml, shows a lower Nls/Cls ratio (0.045) than that of CMD, with a 
CMD solution concentration of 1 mg/ml (0.09). This suggests that the CMD coating in this 
condition may produce a thicker CMD layers on the surface. This is identical to the result of 
the same experiment, performed on HApp (Table 5.2). As a result, the concentration of 2 
mg/ml, CMD of 70 kDa molecular weight, with a carboxylation ratio of 1:2, can be an optimal 
concentration, when using this method. 
113 
5.2.3. RGD immobilization 
RGD peptide immobilization via HApp and CMD interlayer 
In the final step, RGD was covalently grafted onto the surface carboxylic groups, available 
on the surfaces using water-soluble carbodiimide chemistry which was conducted using a two 
step, sequential procedure. To avoid any (expected) damage to the RGD peptides during the 
substrate sterilization before the cell culture, peptide immobilization was performed under 
sterile conditions; using autoclaved CMD-coated substrates (see Chapter 4, section 4.2.9). 
The XPS analyses showed the emission of Cls at 286.5eV and 289 eV (Fig. 5.ID), which 
correspond to the C-N and C-O-NH emission lines, respectively (PORTE-DURRIEU, et al. 
1999). Moreover, the Nls/Cls ratio, determined on the GRGDS-coated samples was higher 
than that of CMD (Table 5.3), which confirms the presence of covalently immobilized 
GRGDS on the CMD-coated PET fibres. In addition, the atomic N/C ratio increased when the 
GRGDS concentration, from 0.1 mg/ml to 1 mg/ml (Table 5.3). The above mentioned results 
and discussions, about RGD, have been previously published (HADJIZADEH, et al. 2007). 
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Table 5.3: Elemental composition of RGD immobilized PET fibre 
Samples Atomic concentrations Atomic ratios Exposure 
(%) ± Standard deviation (%) to oxygen 
C I s O I s N I s 
N/C o/c 
PET+HApp+CMD(l:2, 70 kDa, 2 81.0± 1 13.5 ± 1.5 4.9+ 0.2 0.061 0.17 >2days 
mg/ml) 
following autoclave 
PET+HApp+CMD( 1:2, 70 kDa) 
+GRGDS (0.1 mg/ml) 78.0 ± 3.5 16.8 ± 3.2 5. 2± 0.4 0.067 0.22 >2days 
PET+HApp+CMD( 1:2, 70 kDa) 
+GRGDS (0.5 mg/ml) 76.3 ± 1 18.2 ± 0.75 5.5+ 2 0.072 0.24 >2days 
PET+HApp+CMD( 1:2, 70 kDa) 
+GRGDS (1 mg/ml) 72.0 ± 1.4 21.7 ± 0.5 6.4 ± 0.7 0.089 0.30 >2days 
PET+Aapp +PEI+CMD 1:2(70 kDa) 1 
mg/ml 67.51 26.4 6.1 0.09 0.4 >2days 
PET+Aapp +PEI +CMD( 1:2(70 kDa) 1 
mg/ml) +GRGDSP (0.1 mg/ml) 69.6 22.5 7.9 0.11 0.32 >2days 
PET+Aapp +PEI +CMD( 1:2(70 kDa) 1 
mg/ml) +Gelatin (0.1 mg/ml) 78.9 17.7 3.4 0.04 0.22 >2days 
1:2 means a degree of carboxylation of 1:2. 
RGD peptide immobilization via AApp and CMD interlayers 
XPS analysis of samples containing the covalently grafted GRGDSP peptide, on the 
surface of immobilized CMD, is shown in Figure 5.3E. A decrease in the height of the Cls 
shoulder at 286.5eV (Fig. 5.3E) is related to the presence of RGD. In addition, an increase in 
the N/C ratio, from 0.09 in CMD-coated to 0.11 in RGD-coated surface, was observed (Table 
5.3). It should be noted that these experiments were performed, using GRGDS peptides in a 
manner similar to the GRGDS immobilization, via HApp. However, due to some practical 
errors with GRGDS, only thex data related to the GRGDSP peptide are reported hereinafter. 
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The GRGDSP peptide has one additional amino acid [i.e., proline (P)]. The result 
demonstrates the existence of covalently grafted RGD, via AApp and CMD, on the surface. In 
addition to the RGD peptides, gelatin was also grafted onto the CMD-coated PET fibres, the 
coating being analyzed by XPS (Table 5.3). When layered together (i.e. HApp, PEI, CMD, 
gelatin or RGD), it is difficult to characterize precisely the biological molecules, such as the 
gelatin or RGD because of the similarity in the chemical composition between the two 
neighbouring layers. To overcome this problem, several other methods are able to be 
employed (HERSEL, et al. 2003) amongst them one is the evaluation of cell attachment 
capability of RGD-coated surfaces, in which the number of attached cells indicates the density 
of the RGD on the surface. I have selected this technique to study cell attachment to the fibers 
(see Chapter 6). However, as a perspective, tagged molecules, such as the fluorine-labeled 
RGD, could provide better characterization of the RGD immobilization by XPS. 
5.3. Surface topographical analyses by SEM and AFM 
Topographical analyses were essential to provide (i) additional proof of existence of the 
distinct coatings on the material (fibre) surface, and (ii) providing a topographical map of the 
modified surfaces that may affect cell-biomaterial interactions. As discussed earlier in Chapter 
2, substrate surface topography, at micrometric and nanometric scales, is an important 
parameter that affects cell behavior (SENESI, et al. 2007; BARBUCCI, et al. 2003). 
Therefore, in addition to the chemical properties of the surface, the topographical properties 
are also important in cell-biomaterial interactions and these should be investigated in 
formulating the designs of new biomaterials. 
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Surface topographical characterization offers the following parameters: 
1) qualitative determination of micrometric and nanometric scale features, created by 
the manufacturing techniques, on PET fibres that may affect cell behavior; 
2) the effect of plasma polymer deposition on the alteration of these features on fibre 
surfaces; 
3) providing additional proof of successful surface coating by means of plasma 
polymerization, produced by RFGD fed with N-hepthylamine or acetaldehyde 
vapors and the subsequent CMD grafting; 
4) observing the nanometeric scale topography generated by mutilayer surface 
fabrication via two different plasma polymers, HApp and AApp that may affect the 
cell function in contact with these surfaces. 
To further this aim, SEM and AFM were used to evaluate the morphological features of 
the untreated PET fibre and FEP film and the same substrates coated by HApp, Happ-CMD, 
AApp and AApp-CMD. FEP film used for providing an additional source of data to prove that 
the surface features observed on the PET fibres were due to the surface coatings and that the 
SEM and AFM techniques were applicable to detect the surface texture of surface coated and 
uncoated PET fibres also. Yet, RGD-coated surfaces were not topographically analyzed 
because of their low molecular weights and low concentration, as used in this study. 
Therefore, I believe that RGD should not considerably alter the topography of the surface. 
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5.3.1. CMD immobilization via AApp 
Both SEM and AFM analysis of the uncoated PET fibres showed relatively clean surfaces, 
as shown in Figures 5.6A and 5.7A and 5.8A. These analyses showed that uncoated clean PET 
fibres have some random groove-like defects at the micrometric or nanometric scale, 
generated by the manufacturing techniques (Fig. 5.7A and 5.8A). The AApp coating was 
found to exhibit a rough surface on both the PET fibre (Fig. 5.7 and Fig. 5.8) and the FEP film 
(Fig. 5.9), in comparison with the uncoated surfaces. The presence of some AApp-generated 
features at nanometric scale can be seen on the PET fibre in Figures 5.7B and 5.8B, and on the 
FEP film in Figure 5.9B, which may result from the plasma process. These features appear to 
be distributed on the surface. However, it was also observed that, in some areas, peaks of 
AApp accumulate on the surface (Fig. 5.7IIB), generating randomly distributed features. Since 
the XPS results showed the formation of a uniform thick AApp layer on the substrate in the 
AApp deposition, this suggests that accumulation of AApp on the surface occurred after 
generating a saturated uniform AApp film on the surface. As observed in Figure 5.8C, the PEI 
coated surface shows a similar topography as the AApp coated surface. The CMD coated 
sample also exhibits a rough surface (Fig. 5.7C and 5.8D), similar to the AApp and PEI 
surfaces. Therefore, AApp deposition generates nanometric scale features (i.e. roughness) on 
the surface, as demonstrated by both SEM and AFM analyses on two different substrates (i.e. 
PET fibre and FEP film). Moreover, subsequent CMD coatings applied on the AApp-coated 
surface increases the surface roughness through either creating new features or in following 
features previously created by the Aapp, and which are detectable by both SEM and AFM 
techniques. 
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A) PET Fiber 
Figure 5.6: A) Surface topography of a clean PET fibre (Scan size area = 20x20pm2), B) 
position of AFM tip on the PET fibre during surface imaging of the PET fibre 
using AFM. 
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Figure 5.7: SEM images of CMD coated PET fibres via AApp: I) Magnification: xl50 k, II) 
Magnification: x35k. These analyses were performed for samples from two 
experiments at different magnifications and over at least two areas of the sample. 
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Figure 5.8: AFM images of CMD coated PET fibres via AApp. A) PET fibre, B) PET fibre 
+ AApp, C) PET fibre + AApp + PEI, D) PET fibre + AApp + PEI + CMD 
(Scan size area =1x1 ju/n2), These analyses were performed at least twice. 
121 
Figure 5.9: AFM images of AApp coated FEP film: A) Uncoated FEP film (Scan size area = 
5x5jum2), B) FEP film + AApp (Scan size area = 5x5 jum2), C) FEP film + AApp 
(Scan size area = lxl jum2). These analyses were performed once. 
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5.3.2. CMD immobilization via HApp 
SEM analysis showed that surfaces became smoother after the HApp coating, because the 
surface fine features had disappeared. The surface texture on the HApp coated PET fibre had 
changed, following the HApp deposition, towards decreasing the surface roughness (see Fig. 
5.10). This change can be seen more clearly on the HApp-coated FEP film, on which the fine 
surface features have almost disappeared (Fig. 5.10). Conversely, AFM analysis did not show 
any difference between the HApp coated surfaces and the unncoated surfaces (Fig. 5.11). This 
observation suggests that the HApp coating produces a very smooth thin film on the surface, 
which follows the features already present. Some particles observed in the AFM images of the 
PET fibre shown in Figure 5.1 IB are probably air born dusts, electrostatically attracted to the 
PET fibres. The surface roughness is likely increased after the CMD coating (Fig. 5.10), while 
the nanometric scale features present are more clearly displayed on the FEP film, 
demonstrating that the CMD coating increases the roughness of the surfaces. 
Taken together, the AApp increased the surface roughness at the nanometric scale, 
whereas HApp decreased it. CMD coating, via both AApp and Happ, generated a uniform 
rough coating on the surface which was particularly effective when the CMD was grafted, via 
AApp and PEI. Therefore these observations act as additional proof of successful performance 
of the different coatings employed in this study. 
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Figure 5.10: SEM images of CMD coated FEP film (left) and PET fibres (right) via HApp. 
These analyses were performed for 1 experiment (n=l) for each sample in 
different magnifications and at least 2 areas of the sample were analyzed. 
Magnification is at 35,000 
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Figure 5.11: AFM images of HApp coated PET fibres. A) Uncoated clean PET, B) HApp 
coated PET fibre. Scan size area = 3x3 f jm 2 . This analysis was performed at least 
twice in different scan size areas. 
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5.4. Conclusion 
The characterization of the surface chemistry and the topography shows that the multilayer 
fabrication steps are effective. XPS analyses revealed that, by using the RFGD method, HApp 
and AApp can be deposited on various substrates, such as polymer fibre, porous and non-
porous polymeric film and borosilicate flat surface, with distinct rigidity and shape. Moreover, 
the XPS characterization of PTFE and borosilicate, which have specific elemental signals 
(fluorine and silicon respectively), clearly demonstrated the formation of a uniform film, 
thicker than 10 nm, on both the HApp and AApp surface coatings. Such coatings can offer two 
applications i) altering the physicochemical properties of the surface to increase both cell 
adhesion and growth; and ii) introducing new functional groups (i.e. amine and aldehyde ) to 
covalently graft the desired secondary layer (e.g. CMD). 
Covalent grafting of CMD, using water-soluble carbodiimide chemistry, onto the surface 
amine groups available on the HApp and AApp + PEI coated surfaces was successful, as 
demonstrated by the XPS analysis. It was also found that CMD, with a molecular weight of 70 
kDa and a CMD solution concentration of 2 mg/ml, generates a more uniform and thicker film 
than the same molecular weight CMD at a solution concentration of 1 mg/ml, in immobilizing 
via both the HApp and AApp. The XPS Cls spectrum of the CMD showed that the CMD graft 
layer was thicker when the CMDs were grafted by means of the PEI spacer layer onto the 
Aapp, in comparison with the direct grafting onto the HApp surface. This layer will also play 
two roles i) being non-fouling towards proteins and cells, and ii) introducing COOH functional 
groups in order to covalently immobilize biological molecules, particularly those producing 
selective cell adhesion (e.g. GRGDS). 
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XPS analysis has shown the successful performance of covalent immobilization of RGD 
onto CMD coated surface by demonstrating an increase in the N/C atomic ratio on RGD 
immobilized surface, in comparison with the CMD coated surface. In addition, this technique 
can be applied to produce surfaces that provide an integrin-stimulated cell adhesion, or more 
specifically, selective cell adhesion. 
The existence of thin films obtained via plasma deposition and subsequent CMD 
immobilization on the surfaces, were visualized by means of SEM and AFM, which produced 
topographic maps of the analyzed surfaces and provided qualitative results of the different 
coatings. The AApp plasma-deposited and CMD-coated surfaces exhibited the roughest 
surfaces, among all others. 
Therefore, these multistep surface fabrication techniques can be applied to produce 
biomaterials with multifunctional surfaces that can have important applications in tissue 
engineering, e.g., as a scaffolding material for multicellular tissue regeneration. 
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Chapter 6 
Results and discussion II: In vitro evaluation of 
surface modified substrates toward EC behaviour in 
2D cell culture system. 
6.1. Overview 
The behaviours of different cell types on polymeric materials depend largely on the 
chemistry and topography of the surface at the cell-biomaterial interface (CURTIS and 
RIEHLE 2001; WONG, et al. 2004). Surface topography, as well as fibre curvature, is of 
particular interest in modulating the patterning of cells in 3D environments (CURTIS and 
RIEHLE 2001). However, on making contact with biological media, containing various 
proteins, protein adsorption processes occur on the surfaces of synthetic biomaterials, forming 
a heterogeneous biofilm in which the type of proteins and their conformations may vary 
depending on the underlaying surface properties (MCLEAN, et al. 2000b). One possible 
solution to prevent such early stage, nonspecific protein adsorption onto biomaterial surfaces, 
and for the goal of achieving controlled and predictable biological responses, is that a 
biomaterial surface can be pre-coated with a polymeric material that can exhibit predictable 
biological responses (HERSEL, et al. 2003). To this aim, to encourage and control directional 
biological responses, GRGDS peptides were immobilized via plasma polymer and CMD 
interlayer onto the surface of 100-pm diameter PET and ePTFE fibres (monofilaments). 
HUVECs were used to evaluate in vitro the biological responses towards each of multilayer 
step surface coating (i.e. plasma polymer, CMD and RGD peptide). HUVECs were seeded and 
grown on the fibres to examine the cell behaviour (i.e. adhesion, spreading and orientation). In 
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addition, flat surfaces were coated in the same way as fibres and used for detailed 
characterization of cell behaviour (i.e. formation of FAs and stress fibers). Phase contrast 
microscopy, epifluorescence microscopy and confocal microscopy were used to visualize cells 
seeded on the different surfaces. 
In the present chapter, the results obtained from the testing of HApp- and AApp- coated 
substrates (i.e. Borosilicate glass, PET and ePTFE fibres) towards HUVECs are first presented 
and then discussed. These coatings promote cell adhesion, maintenance and stress fibre and 
FA formation. Secondly, the cell response to CMD coating, via both HApp and AApp on the 
same substrates, is presented. The results showed that, by using either HApp or AApp 
interlayer, CMD-coated substrates dramatically reduced cell adhesion. Thirdly, the response of 
HUVECs to the GRGDS-coated substrates, via plasma and CMD interlayers on the different 
substrates, demonstrate that covalently immobilized RGD via HApp and CMD interlayers 
promoted cell adhesion and spreading. More specifically, cell adhesion was enhanced as 
GRGDS solution concentration increased over a range of 0.1-1 mg/ml. The strong spots of 
vinculin (typical of FAs) and well-defined stress fibers were observed by epifluorescence 
microscopic visualization of cells on RGD-coated substrates. Finally the effect of surface 
topography such as fibre curvature and surface roughness have been discussed, suggesting that 
fibre curvature (with a lOO-pm diameter) promots cell orientation along the fibre axis, in 
comparison with the flat substrates. 
6.2. In vitro evaluation of biomaterials 
Every newly fabricated biomaterial for the use in tissue engineering needs to be evaluated 
with respect to their biological interactions with the target cells, using cell cultures prior to 
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their application in tissue engineering. The testing of biomaterials towards the ECs responses 
can be a valuable approach, not only for cytotoxicity testing of these materials 
(KIRKPATRICK, et al. 1999), but also within the concept of developing new biomaterials to 
support tissue engineered functional tissues (KIRKPATRICK, et al. 1999). For this purpose, 
the investigation of the EC-biomaterial interactions is of interest in the biomaterial field. For 
these reasons, in this thesis, the surface modified materials have been tested towards their 
HUVEC response in vitro. For the biomaterials that will be applied as a substrate for 
anchorage-dependent cells in particular ECs, the in vitro studies include investigations of cell 
attachment, cell spreading, cytoskeletal reorganization and formation of FAs. 
For anchorage-dependent cells (e.g. EC), cell adhesive events stimulate several 
intracellular signaling pathways that control cell functions. For instance, EC adhesion to ECM 
and spreading in an appropriate cellular shape is important for EC growth, differentiation, and 
survival, as shown on poly (2-hydroxyethyl methacrylate)-coated plastic (FOLKMAN and 
MOSCONA 1978) and FN-coated substrates (INGBER 1990). 
The basic process of integrin-stimulated cell adhesion involves four different overlapping 
phases (Fig. 6.1): 1) contact phase: the cell makes contact with the surface and forms some 
ligand bindings with the surface, 2) adhesion phase: the cell plasma membrane spreads over 
the substrate, 3) spreading phase: actin organizes into stress fibers, and 4) FA formation: FAs 
are formed, resulting in the linking of the ECM to the actin filaments. These events have been 
mainly observed with anchorage-dependent cells seeded on either plastic plates or on ECM-
grafted surfaces for cell cultures (HERSEL, et al. 2003). 
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Figure 6.1: The basic process of integrin-mediated cell adhesion comprises four different 
overlapping events: 1) cell attachment, 2) cell spreading, 3) actin filament 
organization, and 4) focal adhesion formation. 
6.3. The effect of surface chemistry and biochemistry on EC 
response 
6.3.1. HApp and AApp coated surfaces 
HApp (bearing amine) or AApp (bearing aldehyde groups), as a thin polymeric, interfacial 
layer, was deposited onto the surface of borosilicate glass surfaces, 100-pm diameter PET 
fibres and 200-pm ePTFE fibres by RFGD deposition (see Chapter 4, sections 4.2.5 and 
4.2.6). HUVECs were seeded on surface coated materials to investigate cell behavior (i.e. 
adhesion, spreading and cytoskeleton organization) (see Chapter 4, sections 4.3.2-6). EC 
functions in terms of cell adhesion and maintenance (for a cell culture period of 3-4 days) 
were tested on both polymer fibres and flat surfaces coated by HApp and AApp. However, 
because of partial opacity of polymer fibres, actin filaments and FA formation were studied on 
both HApp- and AApp-coated borosilicate glass surfaces (see Chapter 4, section 4.3.6). 
Interestingly, it was found that both HApp and AApp coatings enhanced HUVECs adhesion, 
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maintenance, actin filament and FA formation which, to my knowledge, have not been 
investigated in such detail before. 
Cell adhesion and growth 
EC adhesions assay were first performed on HApp- and AApp-coated borosilicate glass 
surfaces because fibres were not transparent. HUVECs were seeded at a density of l x 104 
cells/cm2 on glass substrates. Samples were kept in culture for 4 days. Images of cells were 
recorded every day using phase contrast microscopy. Both HApp- and AApp-coatings 
supported cell adhesion by 2 hrs and reached sub-confluence by 72 hrs (see Fig. 6.2). Cell 
adhesion promotion and maintenance followed the pattern AApp > HApp > Glass (Fig 6.2) by 
day 4. Whereas, as shown in rows 3 and 5 of figure 6.2, on HApp + CMD- and AApp + PEI + 
CMD-coated glass surfaces, respectively, in the same cell culture period no cell adhesion was 
observed. 
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Figure 6.2: Cell adhesion on AApp-, HApp- and CMD-coated borosilicate glass surfaces (4 
days following cell seeding), the pictures represent at least 2 experiments with 
triplicate samples. 
In order to quantify the cell adhesion on HApp-, AApp- and CMD-coated borosilicate 
glass after a 4-day cell culture period, the numbers of cell nuclei (stained by SYTOX Green) 
2 that corresponded to the number of attached cells per mm were counted (on the pictures 
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obtained with X4 or X10 objectives); using SigmaScan Pro5 Software. The comparison 
between groups were performed with ANOVA (using SigmaStat software), P < 0.05 was 
considered statistically significant. The values were presented as means ± standard deviations 
(Fig. 6.3). AApp-coated surfaces significantly promoted the cell adhesion and growth (when 
compared to untreated glass surface at P < 0.05). As expected, cell adhesion was significantly 
reduced on CMD-coated surfaces. Since the cell seeding density on the untreated and treated 
glass surfaces was 100 cells/ mm , growth of cells was evident during the 4-day culture period 
on specific surfaces following the pattern AApp > HApp > Glass (Fig 6.3). 
Surfaces 
Figure 6.3: Cell number/mm2 on AApp-, HApp- and CMD-coated borosilicate glass surfaces 
(4 days following cell seeding). Error bars represent standard deviations. N 
represents the number of samples (i.e. pictures obtained by using X4 or X10 
objectives) from at least two separated experiments. * indicates the values 
significantly different from control (untreated borosilicate glass) by ANOVA at 
p <0.05. 
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In a second step, HUVECs were seeded onto PET and ePTFE fibres, according to the 
procedure explained in Chapter 4 (section 4.3.2). After cell seeding, the holders having the 
fibres were kept in the same culture plate for 4 days. Cell nuclei were stained with SYTOX 
Green and samples were visualized under epifluorecence microscope (Ex = 488 nm; Em = 530 
nm) [website ref.6]. Adhesion of HUVECs to HApp-coated ePTFE fibres was evident in 
comparison with the uncoated fibres (Fig. 6.4). Similarly, more cells were observed on the two 
plasma-treated (i.e. HApp and AApp) PET fibres compared to the uncoated PET fibres (Fig. 
6.6). 
Quantitative analysis of cell adhesion was performed on ePTFE fibres with different 
coatings and the results expressed as relative cell adhesion values. The numbers of cell nuclei 
(stained by SYTOX Green), corresponding to the number of adherent cells, per fibre length 
were counted, following a 4 day culture period. The comparison of groups were performed by 
using ANOVA, P < 0.05 was considered statistically significant. The data were presented as 
relative cell attachment (Fig. 6.5). The relative cell adhesion was calculated by taking ratios of 
the average numbers of adherent cells on untreated PTFE fiber, HApp-, CMD-, and peptide-
grafted fibres, to the average number of adherent cells found on untreated PTFE fibres. 
Similarly, the relative standard deviations (SDs) were calculated by taking the ratio of the SDs 
of attached cells on untreated, HApp-, CMD-, and peptide-grafted fibres, to the average 
number of attached cells found on untreated PTFE fibres (control). As expected, in 
comparison to untreated fibres, HApp- and RGD-coated fibres significantly promoted cell 
adhesion (P < 0.05) (Fig. 6.5). 
135 
Figure 6.4: Cell adhesion on HApp- and CMD- coated ePTFE fibres (4 days following cell 
seeding); the pictures represent at least 2 experiments with duplicate samples. 
HUVECs were stained for nuclei with SYTOX Green Nucleic Acid Stain. This 
figure has been previously published (HADJIZADEH and VERMETTE 2007). 
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Figure 6.5: EC adhesion (4 days following cell seeding) on cleaned, untreated ePTFE fibres 
and surface coated ePTFE fibres. The relative cell attachment was calculated as 
the ratio of the average cell number on surface coated ePTFE fibres to that of 
uncoated ePTFE fibres. Cleaned, untreated PTFE fibres were set at 1 (control). In 
these experiments, CMD at 70kDa, a carboxylation degree of 1:2, and 2 mg/ml 
CMD solution concentration were used. The concentrations of GRGDS and 
GRGES in solution were both set at 0.5 mg/ml. N indicates the number of fibres 
from at least 2 separate experiments, except *N from one experiment. Error bars 
represent standard deviations. >K indicates the values significantly different from 
control (untreated ePTFE) by ANOVA at p < 0.05. 
As can be observed from figures 6.6A and 6.7, the adhesion of HUVECs on un-treated 
PET polymer fibre is low, and even on un-treated ePTFE polymer fibres almost impossible 
(6.4A and 6.5), this is due to their hydrophobic nature in surface. This inability towards cell 
adhesion makes it possible to observe the cell adhesion promotion generated due to surface 
modification. Therefore, the results from the cell adhesion experiments, over a 4 day cell 
culture period, has demonstrated that HApp and AApp treatments could be used to modify the 
PET and ePTFE surfaces to support the HUVEC attachment 
137 
Figure 6.6: Cell adhesion on HApp- and AApp- and CMD- coated PET fibres (4 days 
following cell seeding); the pictures represent at least 2 experiments with 
duplicate samples. HUVECs were stained for nuclei with SYTOX Green Nucleic 
Acid Stain. 
Similarly, cell adhesion was evaluated on PET fibres with different coatings produced via 
AApp and the results expressed as relative cell adhesion in the same way as previously 
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adhesion was defined as the ratio of the cell number on surface coated PET fibres to that of 
uncoated PET fibres (as control). The numbers of cell nuclei, stained by SYTOX Green and 
corresponding to the number of adherent cells per fibre length, were counted, following a 
4 days culture period. Significant differences were compared with untreated fibre at p < 0.05. 
The AApp-PEI-CMD-coated fibres showed significantly less cells (P < 0.05) adhering than 
untreated fibres. Cell adhesion promotions were not significant on AApp- and AApp-PEI-
coated fibers (when compared to untreated PET fibres at p < 0.05). This may be due to ability 
of PET polymer to adsorb serum-born ptoteins in culture environment, resulting in some cell 
uptake in early cell culture. 
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Figure 6.7: EC adhesion (4 days following cell seeding) on cleaned, untreated and treated-
PET fibres, 70kDa CMD, carboxylation degree of 1:2, and 2 mg/ml CMD 
solution concentration were used in these experiments. The relative cell 
attachment was calculated as the ratio of the average cell number on surface 
coated PET fibres to that of uncoated PET fibre. Cleaned, untreated PET fibres 
were set at 1 (control). N indicates the number of fibres from at least two 
separated experiments. Error bars represent standard deviations. * indicates the 
values significantly different from control (untreated PET fibres) by ANOVA at 
p <0.05. 
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Formation of stress fibers and focal adhesion (FA) 
The formation and distribution of both actin stress fibers and FAs in HUVECs in contact 
with plasma polymers derived from acetaldehyde and heptylamine were examined under 
epifluorescence microscopy. Under those conditions, the organization of cytoskeletal fibers 
and the presence of strong spots of vinculin (representing FA formation) were observed, 
characteristic of the appropriate attachments to the substrate (Fig. 6.8). Thus, these HApp- and 
AApp-treated substrates have the ability to support HUVECs at all of the 4 steps of strong cell 
adhesion (i.e. cell attachment, cell spreading, stress fiber organization, and FA formation). 
Cell functions including cell adhesion and spreading are controlled by the cell 
cytoskeleton (a dynamic network of protein filaments) (SANBORN, et al. 2002). Since ECs 
are anchorage dependent cells, they adhere to the ECM proteins or a substrate at their FAs, 
also known as focal contacts (SANBORN, et al. 2002). FAs are specialized sites where cell 
cytoskeleton is linked to the ECM by means of integrin receptors (Fig. 6.9). These points are 
composed of integrin clusters, cytoskeletal proteins (e.g. talin, vinculin, and a-actinin) and 
other signaling molecules (SASTRY and BURIDGE 2000). FAs play two important roles in 
cellular functions: (i) to transfer cellular forces to the ECM matrix at the adhesion points, 
resulting in the maintaining of strong attachments to the ECM (ii) to act as signal transducer 
center transmitting extra- and intra-cellular signals to regulate cell functions, including 
growth, survival, and gene expression (SASTRY and BURIDGE 2000).The study of FAs 
makes it possible to provide information on cell-matrix interactions. FAs gradually form 
between 1 and 2 hr after cell contact with an ECM component containing surface. First focal 
complex forms, as a cell spreads (at periphery) or migrates (at leading edge). Then, focal 
complex mature into FAs when cells establish their strong attachment to substrate and tensions 
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are transferred to these adhesion points (SASTRY and BURIDGE 2000). Taken together, i.e. 
the above discussion and the result obtained by examining the EC formation of FAs and stress 
fibers on HApp and AApp, it can be suggested that these two plasma polymer coatings 
promote initial adsorption of protein derived from biological media with subsequent strong EC 
adhesion and spreading. 
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Figure 6.8: Images obtained by epifluorescence microscopy of the HUVECs stained for actin 
filaments with TRITC-phalloidin (red, right) and nuclei with SYTOX Green 
(green, right); vinculin (primary antibody (! 
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ECM 
Figure 6.9: In focal adhesion points, ECM is linked to actin filaments via integrin receptors 
(adapted from SASTRY and BURIDGE 2000). 
It has been found that many cell types tend to attach and grow on various plasma polymer 
deposited surfaces or on plasma-treated surfaces. Cell adhesion on plasma modified surfaces 
in vitro shows that cell-adhesive proteins can be adsorbed onto these surfaces without 
influential conformational changes (SIOW, et al. 2006). Studies on the cell adhesion ability of 
plasma-coated surfaces have focused on oxygen- and nitrogen- containing surfaces, may be 
due to the success of some commercial products used as tissue culture labware, such as 
plasma-oxidized polystyrene (PS) or nitrogen-containing Primaria tissue culture ware. 
However, it is still unclear whether the presence of oxygen containing groups or the total 
oxygen content on the substrate surface is a key element to promote cell attachment. The same 
confusion exists about nitrogen containing surfaces (SIOW, et al. 2006). However, some 
studies have shown that some typical factors, such as chemical groups e.g. amide (SIOW, et 
al. 2006) and carbonyl (ERTEL, et al. 1991), or even adsorption of the VN, from the serum 
components of the culture medium on oxygen containing surfaces, may promote cell adhesion 
(STEELE, et al. 1993; and 1995). 
142 
In this study, cell attachment observation, in conjunction with XPS analysis, suggests that 
the increase in nitrogen concentration also increased HUVEC cell adhesion. This suggestion is 
supported by observation that HUVEC adhesion is enhanced on HApp-coated ePTFE which 
dramatically increased cell adhesion (Fig. 6.4 and 6.5) when N% increased from 0% for 
uncoated ePTFE to a 6.5% for HApp-coated ePTFE (Table 6.1). This observation can be 
atributed to the presence of NH2 groups, created by HApp or CONH groups that have been 
generated by post plasma oxidation. This is identical to the findings by Keselowsky et al. 
(2004) who investigated the effect of functional groups including NH2 on FN adsorption and 
subsequent integrin mediated cell adhesion and FA formation. They showed that NH2 surface 
groups mediated all of the above mentioned characteristics. The HApp coating is solid and 
dense; therefore the effect of interfacial steric-entropic repulsion should not be considerable. 
In addition, when present in buffered culture medium (pH 7.4), HApp coating should exhibit a 
very low density of positive surface charges (CHATELIER, et al. 1995; and 1997). Hence, 
protein adsorption onto the HApp layer may occur, mainly by the action of dispersion and 
hydrophobic forces. Therefore, it suggests that cell adhesion on HApp coated surface, in our 
culture study, is due to serum proteins adsorbed by dispersion and hydrophobic forces on these 
surfaces, and is probably due to positive surface charges produced by protonation of NH2 
groups in the buffered culture medium (pH 7.4). 
Our observations also showed that in the increase in the oxygen concentration on the 
substrate surface can not be the sole reason to enhance adhesion of HUVECs. Borosilicate 
glass, having an oxygen concentration of 3.9 times greater than AApp-coated borosilicate, 
resulted in less cell adhesion than the AApp-coated borosilicate (Table 6.1). 
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Table 6.1: Chemical structures and elemental composition of surfaces and HUVECs adhesion 
Surface Elemental 
compositions 
Chemical structure 
0 % N % 
PET 25.1 0 O 0 
—(-C—(C^ J)—c—0—CHi-CHj-O-tj 
ePTFE 0 0 
F F F F P P 
— H — 
Borosilicate glass (1) 63.15 0 
PET+HApp (2) 3.1 8.3 NH, 1 
CH3(CH2)3CH2CHCH3 
/V-heptylamine 
ePTFE+HApp (3) 2 6.4 
PET+AApp (4) 19.5 0 
O II 
C H 3 - C - H 
Acetaldehyde 
Borosilicate glass +AApp (5) 16.1 0 
Chemical bonds 
NH2 2,3 
COOH PET 
OH PET 
CONH 2,3 
CO 4, 5, PET 
HUVECs adhesion 
HUVECs adhesion : ePTFE< PET (Fig. 6.4 and 6.5) 
PET< 2 and 4 (Fig. 6.7 and 6.11) 
ePTFE < 3 (Fig. 6.4 and 6.5) 
1< 5 (Fig. 6.2 and 6.3) 
Therefore, it is possible that the type and amount of oxygen containing chemical groups 
manage the cell attachment. However, our observation showed that AApp coatings promoted 
HUVECs attachment and maintenance. These observations are supported by a few pieces of 
evidence reported in 2 recent publications (SIOW, et al. 2006; THISSEN, et al. 2006) in which 
144 
an aldehyde plasma supported the attachment and growth of epithelial cells to a certain extent, 
comparable to tissue culture PS (SIOW, et al. 2006), and that AApp coatings were able to 
adsorb ECM proteins, such as type I collagen (THISSEN, et al. 2006). 
Thus, our findings also suggest that cell adhesion is affected by other compositions of the 
plasma-treated polymers or their surface structures (e.g. roughness), in addition to the 
presence of carbonyl or amide groups created by plasma polymer directly, or by post-plasma 
oxidisation indirectly. 
It has been demonstrated that plasma-deposited polymeric thin films offer alternatives to 
enhance the performance of existing biomaterials and medical devices and for the 
development of new biomaterials (FAVIA, et al. 2003; SANBORN, et al. 2002). For example, 
in order to promote the performance of vascular prostheses, it has been suggested that these 
products can be seeded with the ECs of patients, isolated from their veins. However, the 
mateials used in vascular prostheses applications (e.g. ePTFE) are almost inert (hydrophobic 
surface), resulting in poor cell adhesion. Thus, some surface modifications are needed to 
promote ECs monolayer formation. A potential approach to this aim is to coat surfaces of 
substrates with materials having desired properties to promote EC adhesion and growth on the 
surface (KIRKPATRICK, et al. 1999). For this reason, studies have shown that plasma 
polymerization processes could be employed to modify substrates (e.g. PET) that support 
attachment and growth of cells such as ECs (HADJIZADEH, et al. 2007). There are many 
studies reporting application of various plasma polymerizations for biomaterial surface 
modifications, including PTFE (KIRKPATRICK, et al. 1999). However, to my present 
knowledge, there is a lack of reports investigating EC behavior on HApp and AApp plasma 
polymer coated surfaces. Thus, the findings of this study demonstrate the suitability of RF 
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HApp and AApp in inducing desirable coatings on substrates, so as to improve their ability to 
support the strong adhesion of ECs. 
6.3.2. CMD grafted surfaces (cell resistant material) 
Cell adhesion 
Coating the material surface with polysaccharides is of interest in biomaterials research 
because of their ability to reduce surface fouling by biological molecules (particularly 
proteins) (MCARTHUR, et al. 2000) and cells (HADJIZADEH, et al. 2007). These coatings 
can prevent the adhesion of mammalian cells and also bacteria, to biomaterial surfaces 
(MORRA and CASSINELI 1999). Dextrans and their derivatives have been used for these 
purposes (LOFAS and JOHNSSON 1990; MCARTHUR, et al. 2000). Dextran has excellent 
ability for resisting the protein adsorption, and its multiple reactive sites can be used for the 
covalent grafting of biomolecules along its polymer chain (MASSIA and STARK 2001). 
Polysaccharides are comprised of highly hydrated hydrogel-like structure and mobile 
molecular chains which make them able to reject biological molecules and cells by providing 
steric-entropic forces. Thus, the polysaccharide molecules should be introduced in an 
appropriate microstructure to produce such repulsive forces more effectively (MCLEAN, et al. 
2000a). For the above mentioned reasons, in this present thesis, CMD, a derivative of dextran, 
has been chosen as a low-fouling platform for the bioactive molecule immobilization. CMD 
(Fig. 2.6) is a derivative, carboxymethyl substitution, of dextran which is synthesized by the 
reaction of dextran with bromoacetic acid (LOFAS and JOHNSSON 1990). The effects of 
chemical and structural properties, generated by charge density (MCLEAN, et al. 2000b), 
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molecular weight, carboxylation degree and method of immobilization (MCLEAN, et al. 
2000a), of CMD molecules, have been previously shown to play a role in the protein and cell 
rejection. Moreover, previously reported studies have shown that, CMD coatings, via an 
amine-rich polyelectrolyte interlayer (i.e. PEI), grafted onto the plasma polymer surface (i.e, 
AApp), generated more effective resistance towards protein adsorption and epithelial cell 
adhesion than the CMD coating that is directly immobilized onto the plasma polymer (i.e, 
HApp) (MCLEAN, et al. 2000a). In addition, a thicker CMD layer in aqueous phase solution 
was observed, either when the polysaccharide had a high carboxyl density (i.e. CMD 1:2) 
(GRIESSER, et al. 2002) or when polysaccharide was immobilized, via PEI spacer grafted 
onto the plasma polymer coated surface prior to polysaccharide grafting (HARTLEY, et al. 
2002). Moreover, polysaccharide bearing a high density of carboxyl groups (i.e. CMD 1:2) 
pinned to the HApp-coated surface in many points and created a dense polysaccharide layer 
having loops and tails (MCARTHUR, et al. 2000). 
In this thesis I use CMD coatings for two purposes: a) as a low-fouling coating and b) as a 
platform for biomolecule immobilization, a dense and thick coating with high density of 
carboxyl groups was preferable. Therefore, to achieve this aim, and based on the results 
obtained by others, I have tested CMDs with carboxyl substitution of 1: 2 by using two 
different methods of immobilization, via HApp and AApp + PEI. In addition, CMD of two 
different molecular weights 70 and 500 kDa, in two different CMD solution concentrations of 
1 and 2 mg /ml, have been tested to determine the effect of CMD molecular weight and CMD 
solution concentrations on the surface coverage of the CMD coating. According to the XPS 
analysis the best candidate with a thicker surface coating was CMD having a molecular weight 
of 70 KDa and a CMD solution concentration of 2 mg/ml on AApp interlayer at the first level 
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and on HApp at the second level. Therefore, these two CMDs coatings were considered as 
optimal conditions on which the behavior of the HUVECs has been investigated. 
CMD coatings on borosilicate glass surfaces, via both methods, were strongly cell resistant 
(Fig. 6.2 and 6.3). Two hrs after cell seeding up to 4 days of cell culture, no cell was observed 
neither on the CMD- coated surfaces via HApp nor on the CMD- coated surfaces, via the 
AApp + PEI interlayers. Similarly, CMD-coated fibres, either by means of HApp or the AApp 
+ PEI interlayer, dramatically reduced cell attachment (Fig. 6.4, 6.5, 6.6 and 6.7). Very little 
difference was observed to the cell resistance efficiency of the CMDs grafted by use of two 
different interlayers (i.e, HApp and AApp) (Fig. 6.3, 6.5 and 6.7), and by using CMD with a 
carboxymethyl substitution of 1:2 and a CMD solution concentration of 2 mg/ml on different 
substrates surfaces (borosilicate glass, PET and PTFE fibres). This may be due to some defect 
caused by the manipulation process. Since HApp and PEI are cell adhesive (Fig. 6.6B and E 
respectively), these observations could also be interpreted as a result of incomplete CMD 
coverage and/or is due to the presence of a thin CMD layer on the substrates. As reported 
previously (MCLEAN, et al. 2000a), the CMD grafted onto the HApp and AApp layer may be 
seen as a "carpet pile" structure (see the schematic presentation in Fig. 6.10). The highly water 
soluble chains (loops and tail ends) having charged groups extend into the aqueous phase 
solution, spreading out away from the interface. Such a polysaccharide structure provides 
steric-entropic repulsive forces to reject proteins and cells from the surface. Thus, it can be 
concluded that the cell resistant behaviour observed on CMD-coated substrates could be 
mainly due to such repulsive interfacial forces (i.e. steric-entropic, hydration and 
electrostatic). 
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Figure 6.10: Schematic presentation of CMD chains with a "carpet pile" like structure having 
COO" groups (red). 
In conclusion, CMD immobilized by both methods results in a resistance to the adhesion 
of HUVECs, therefore these two strategies can be applied to providing a non-fouling surface 
which can serve as a platform for bimolecular immobilization to induce selective cell adhesion 
surfaces. 
6.3.3. Biomolecule grafted surfaces (bioactive materials) 
It is believed that the interaction of a cell with neighboring cells and surrounding ECM are 
regulated by cell adhesion receptors present on the cell membrane. Among these receptors, the 
integrin family plays the most important roles (HERSEL, et al. 2003). Different types of 
integrin receptors, composed of a and p subunits, have been shown to be present on the 
surface of the vascular ECs, among which OC5P1 and ocvPs mainly mediate the EC attachment to 
the cell binding motifs (i.e. RGD domains) of ECM proteins (e.g. FN, VN, collagen, and 
fibrinogen) (PAPETTI and HERMAN 2002; HERSEL, et al. 2003). Many studies have shown 
that adhesion of ECs was promoted by RGD immobilization on the biomaterials surfaces 
(GAO, et al. 2003; KOUVROUKOGLOU, et al. 2000; MASSIA and STARK 2001). 
However, covalent grafting of any biomolecule, such as protein and RGD molecules, onto a 
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CMD coating, and its biological effectiveness towards cell behavior, have not been previously 
investigated. 
Biomolecule immobilization via HApp and CMD interlayer 
Cell adhesion 
In order to ensure the performance and reproducibility of the techniques for RGD 
immobilization onto non-fouling CMD layer by using multilayer surface modification, this 
method was performed on various substrates such as flat surfaces and polymer fibres (see 
Chapter 4, section 4.2.2-9). Three types of bioactive molecules, such as RGD peptide, FN and 
gelatin, were investigated towards elucidating HUVEC behavior. 
GRGDS peptide, in 3 different concentrations (0.1, 0.5 and 1 mg/ml), were immobilized 
via HApp and CMD interlayers onto microscope cover slips (glass) which were then seeded 
with HUVECs at a density of 1 x 104 cells/cm2 (see Chapter 4 section 4.3.6) and incubated for 
at least 4 days. All of the surfaces supported cell adhesion except the CMD- and RGD- coated 
at low concentration (0.1 mg/ml) (Fig. 6.11). 
In order to ensure whether the covalent immobilization of the biomolecule, via amide bond 
formation, onto the CMD coated surface have been successfully performed, FN were either 
immobilized on the same substrates, using the same strategy, or adsorbed onto uncoated 
microscope cover slips, considered as a control adhesion surface. Both physisorbed and 
covalently FN-coated surfaces showed very effective cell adhesion and reached confluence in 
4 days (Fig. 6.11). Cell adhesion on those substrates demonstrated successful covalent grafting 
of FN onto the CMD interlayer via amide bond formation. 
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In addition to FN, gelatin was either covalently immobilized by use of the same strategy 
onto FEP film and PET fibre, via HApp and CMD interlayers or adsorbed onto uncoated FEP 
film. After cell seeding, HUVECs adhered to covalent gelatin-coated FEP film and PET fibres 
but not to untreated and gelatin adsorbed FEP films (Fig. 6.12). This is not surprising since 
FEP is hydrophobic and is almost an inert material; therefore it did not support protein or 
gelatin adsorption. This observation demonstrated that biomolecules can be successfully 
immobilized onto a CMD interlayer, via amide bond formation, which can then support cell 
adhesion. Moreover, mobile chains of CMD did not prevent cells from interacting with the 
bioactive molecules and thereby cell adhesion and maintenance on biomolecules such as RGD 
peptide, FN and gelatin. This observation demonstrated that the lack of cell adhesion and 
maintenance on the RGD (0.1 mg/ml) may be due to an insufficient number of RGD 
molecules present on the surface. 
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Figure 6.11: Cell adhesion and confluence (4 days following cell seeding) on glass microscope 
cover slip, the pictures represent one experiment with triplicate samples. 
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Figure 6.12: Cell adhesion on physically and covalently grafted gelatin onto FEP film and 
PET fibre surfaces in 2hrs after cell seeding. The pictures A, B and C represent 
one experiment with triplicate samples. The picture D represents at least 2 
experiments with duplicate samples. 
Formation of stress fibers and FA on RGD grafted surfaces 
As explained earlier, stress fibers and FA formation, which take place during cell 
spreading or migration on substrates containing ECM components, are needed for cell 
functions. For this reason, the study of FAs formation is a useful approach to provide 
information on cell-substrate interactions. Therefore, observation of FAs and stress fibers 
formation by HUVECs seeded onto RGD coated surface can be a proof for both existence of 
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covalently grafted RGD on the non-cell adhesion CMD-coated surfaces and functionality of 
RGD to interact with integrins present on cell surfaces. Few studies have been reported 
investigating EC behaviours in terms of stress fibers and FAs formation on the surface-
coupled adhesive RGD peptide (MASSLA and HUBBELL 1991b). For this aim, HUVECs 
were seeded on surface coated substrates including, HApp + CMD- and HApp + CMD + 
RGD-coated glass substrates to study the effect of these coatings on the formation of stress 
fibers and FAs. In figure 6.13, the red and green staining denotes stress fibers, stained with 
TRITC-phalloidin; and vinculin stained with a primary antibody (Monoclonal Anti-Vinculin 
and secondary antibody (Anti-Mouse IgG), (see Chapter 4, sections 4.3.4 and 4.3.6). Vinculin 
is a membrane-cytoskeletal protein present in the FA points. The sharp vinculin spots and 
intense actin staining observed on RGD-coated substrates when compared to the CMD-coated 
surfaces, on which there was no cell, demonstrate the bioactivity of RGD-coated substrates. 
These results suggest that the RGD peptides are strongly immobilized on the CMD graft layer. 
This strong ligand immobilization is needed to promote strong cell adhesion because 
formation of FAs only occurs if the ligands can withstand cell contractile forces (HERSEL, et 
al. 2003). These results and discussions have been previously published (HADJIZADEH, et al. 
2007). 
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Figure 6.13: Images obtained by epifluorescence microscopy of the HUVECs stained for 
stress fibers (red, right) and vinculin (primary antibody (Monoclonal Anti-
Vinculin) and secondary antibody (Anti-Mouse IgG)) (green, left), Original 
magnification was 600X. The pictures represent 2 experiments with triplicate 
samples. This figure has been previously published (HADJIZADEH, et al. 2007). 
RGD immobilized polymer fibres 
PET Fibres 
Many studies have investigated surface modification of flat substrates with cell-adhesive 
and non cell-adhesive coatings (HERSEL, et al. 2003). However, only a few studies have 
reported on a procedure to functionalize 3D surfaces using biological molecules that can be 
applied in tissue engineering. In the latter condition, this is an important requirement to direct 
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cell responses and tissue development by providing selective surface chemistry in a 3D 
environment. For this reason, I have applied the multilayer surface modification technique 
developed in this study to covalently graft RGD onto polymer fibres to produce bioactive 
polymer fibres. These bioactive fibres can be organised into a 3D network to modulate cell 
patterning. 
In order to produce bioactive polymer fibre, PET fibres were surface coated using a 
multilayer step surface modification, as explained earlier (see Chapter 4 sections 4.2.2-9). 
Then untreated and HApp-, CMD-, GRGDS- and GREDS-coated PET fibres were seeded with 
HUVECs to evaluate cell adhesion and spreading (see also section 4.3.2-4). GRGDS was 
compared to GREDS that was considered as an inactive control coating. The result of the cell 
adhesion and cell spreading tests correlate with the results obtained by chemical analysis. 
Cell adhesion 
Cell adhesion was studied on all samples and the results expressed as relative cell adhesion 
percentages. The numbers of cell nuclei (stained by Hoechst), corresponding to the number of 
adherent cells per fibre length, were counted, four hours after cell seeding. ANOVA (using 
SigmaStat software) was used to compare groups, at P < 0.05. The percentage of relative cell 
adhesion was calculated by taking the ratios of average numbers of attached cells (obtained by 
ANOVA) on untreated PET, HApp-, CMD-, and peptide-grafted fibres to the average number 
of attached cells found on untreated PET fibres (as the control), multiplied by 100. Similarly, 
the relative standard deviations (SD) were calculated by taking the ratio of the SDs of attached 
cells (obtained by ANOVA) on untreated PET, HApp-, CMD-, and peptide-grafted fibres to 
the average number of attached cells found on untreated PET fibres, multiplied by 100. The 
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significant differences were compared with the untreated fibres at p < 0.05. As shown in Fig. 
6.14, cell adhesion was significantly reduced on CMD- and RGE-coated fibres, whereas the 
HApp- and GRGDS-coated (i.e. 0.5 and 1 mg/ml) fibres significantly promoted cell adhesion. 
These results and discussions have been previously published (HADJIZADEH, et al. 2007). 
In order to produce an effective bioactive surface, a spacer layer is often introduced onto 
the substrate surface before biomolecule immobilization, bioactive molecule (HERSEL, et al. 
2003), preferably one with protein resistance properties (e.g. poly (ethylene oxide) (PEO), 
carboxy-methylated-dextrans (CMD). Such surface coatings may be useful in the production 
of materials resistant to non-specific cell adhesion. For this aim, CMD coatings have the 
advantage to act as a platform for covalent immobilization of cell-adhesive peptides or other 
biological signalling proteins. Such constructs enable the fabrication of systems that possess 
specific biological responses since the non-adhesive CMD interlayer would limit other non-
specific, undesired biological responses. 
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Figure 6.14: EC adhesion (4 hours following cell seeding) on clean untreated PET fibres, 
considered as 100% (control) (A) and the PET fibres with the different layers: 
PET + HApp (B), PET + HApp + CMD (C), PET + HApp + CMD + GRGDS(0.1 
mg/ml) (D), PET + HApp + CMD + GRGDS (0.5 mg/ml) (E), PET + HApp + 
CMD + GRGDS (1 mg/ml) (F), and PET + HApp + CMD + GRGES (0.5 mg/ml) 
(G) interlayers. Error bars represent relative standard deviations. 70kDa CMD, 
carboxylation degree of 1:2, and 2 mg/ml CMD solution concentration were used 
in these experiments. N indicates the number of fibres which were selected from 
2 to 3 different experiments. This figure has been previously published 
(HADJIZADEH, et al. 2007). * indicates the values significantly different from 
control (untreated PET fiber) by ANOVA at p <0.05. 
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GRGDS-coated PET fibres (or monofilaments) promoted cell adhesion significantly, when 
compared to CMD-coated fibres at p <0.05. Furthermore, cell adhesion promotion depended 
on the GRGDS solution concentration used during the grafting procedure (Fig. 6.14). Cell 
adhesion on the GRGES (inactive control, Fig. 6.14G) was significantly lower than the 
amounts observed on GRGDS-coated samples. These results suggest that the significant 
increase in EC adhesion on GRGDS-grafted PET fibres were due to the biospecific responses 
between cell membrane integrins and the GRGDS ligands present on the fibre surfaces. Thus, 
cell adhesion was effectively modulated by the covalent incorporation of small cell adhesion-
peptides on the fibre surface rather than via random adsorption of serum-derived cell adhesive 
proteins present in culture medium. The little amount of cell adhesion observed on GRGES-
immobilized surfaces (inactive control) may be due to some electrostatic forces, acting 
between these surfaces and proteins and cells. These results and discussions have been 
previously published (HADJIZADEH, et al. 2007). 
The decreased cell adhesion observed on GRGDS-coated fibres (0.1 mg/ml GRGDS 
solution) could be due to the presence of an insufficient surface density of RGD molecules. 
This correlates with the low surface concentration of nitrogen found in the XPS analyses of 
this RGD coating (i.e. 0.1 mg/ml). Another possibility is that the GRGDS molecules are much 
smaller than the extended chains of the CMD layer; as a result, CMD chains could act as a 
"cover up" for the small GRGDS molecules present in such low density. Therefore, CMD 
loops and chain ends prevent cells to access the RGD molecules, by providing steric-entropic 
repulsion. This view is supported by another study in which reduced cell attachment was 
observed when the spacer moiety was too long (BEER, et al. 1992). In Beer's study, it was 
concluded that reduced cell attachment may be due to increased entropy of the longer flexible 
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spacer chains which prevent strong binding. Finally, a concentration of 0.5 mg/ml GRGDS 
was chosen for further experiments, because a reasonable number of adherent cells were 
observed in this condition. These results and discussions have been previously published 
(HADJIZADEH, et al. 2007). 
Cell spreading 
Cell spreading occurs following cell adhesion on substrate surfaces. In order to examine 
the effect of the fibre surface chemistry and curvature on HUVEC spreading, cells were 
double-stained to identify cell cytoskeleton (i.e. actin filaments) and nuclei, following 4 days 
of cell culture. As expected, EC spreading depends on the surface chemistry of the samples 
(see Fig. 6.15). Figure 6.15 shows the degree of attachment and spreading of HUVECs on 
surface-modified PET fibres at day 4. Although a few cells attached on the CMD-coated (Fig. 
6.14C) and GRGES-coated fibres (Fig. 6.14G) at 4 hrs (cell adhesion assay); cells were absent 
on these surfaces by day 4 (Figs.6.13A and 6.15C, respectively). It is possible that the cells 
attached on these surfaces, in early culture, may detach because of their inability to establish a 
strong adhesion to these surfaces. In contrast, cells reached to confluence and they largely 
spread on GRGDS-coated fibres (Fig. 6.15B). These results suggest that GRGDS-coated 
fibres, with a sufficient RGD surface density, not only provide a desirable surface for EC 
adhesion, but cell spreading, and maintenance through an integrin stimulated cell adhesion 
towards GRGDS ligands present along the fibre surfaces. These results and discussions have 
been previously published (HADJIZADEH, et al. 2007). 
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To ensure if the GRGDS coating is stable under cell culture conditions for a longer period 
of time, HUVECs were seeded on the GRGDS-coated fibres (0.5 mg/ml GRGDS 
concentration) and kept in culture for a long period of time (i.e 10 days). At day 2, cells were 
stained with Dil-acetylated LDL and were daily observed with epifluorescence and confocal 
microscopes. All these observations showed a level of uniform cell distribution (Fig. 6.15D) 
Figure 6.15: Confocal microscopic observations of HUVECs at day 4 on A) PET + HApp + 
CMD (70kDa, carboxylation degree of 1:2, 2 mg/ml), B) PET + HApp + CMD Hh 
GRGDS (0.5 mg/ml), C) PE + HApp + CMD + GRGES (0.5 mg/ml), and D) 
PET 4- HApp 4- CMD + GRGDS (0.5 mg/ml), HUVECs were stained for nuclei 
with SYTOX Green Nucleic Acid Stain and for actin filaments with TRITC-
phalloidin in A, B, C, and with Dil-acetylated LDL in D. Original magnification 
was 200X. The pictures represent at least 2 experiments with duplicate samples. 
This figure has been previously published (HADJIZADEH, et al. 2007). 
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Bioactive ePTFE fibres 
Cell adhesion 
In another study, ePTFE fibres, of 200-pm diameter, were treated in a same manner as the 
PET fibres (with 100-pm diameters) with bioactive molecules on their surfaces (see Chapter 4, 
sections 4.2.2-9). The purpose of this exercise was to perform a comparative study, to prove 
the performance and reproducibility of the technique used for the biomolecule immobilization 
via a multilayer surface modification strategy and thereby modulation of the EC behavior on a 
polymer fibre with different physical and chemical properties (i.e. ePTFE) than those of the 
PET fibre. 
The uncoated ePTFE and HApp-, CMD-, GRGDS- and the GRGES-coated ePTFE fibres 
were tested for HUVEC adhesion, as previously explained in Chapter 4 (see sections 4.3.2-4). 
As expected, no EC adhesion was observed on the CMD-modified ePTFE fibres (Fig. 6.4C) 
whereas the RGD-coated fibres provided the highest cell adhesion (Fig. 6.16A2). Surface 
grafting of GRGES (inactive control) peptides onto the CMD-coated ePTFE fibres prevented 
cell adhesion by comparison with those observed on GRGDS-coated fibres (Fig. 6.16B2). 
Moreover, these results have also been confirmed by the quantitative analysis, shown in figure 
6.5, GRGDS-coated ePTFE fibres significantly promoted cell adhesion, when compared to the 
untreated fiber (control) at p < 0.05. However, cell adhesion was as low on the CMD-modified 
ePTFE fibres as on the control fibres. Conversly, on CMD- and CMD-GRGES-coated fibers, 
cell adhesion was significantly reduced in comparison to those observed with GRGDS and 
HApp (Fig. 6.5) at p < 0.05). These results are in agrement with those obtained for PET fibres 
with the same coatings (Fig. 6.14, 6.16Aland Bl). This suggests that the technique used to 
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graft bioactive molecules is reproducible on polymer monofilaments (fibres), having different 
physical and chemical properties. 
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Figure 6.16: EC adhesion and distribution (4 days following cell seeding) on the PET (left) 
and ePTFE (right) fibres having GRGDS and GRGES pep tides. The pictures in 
the right column have been previously published (HADJIZADEH and 
VERMETTE 2007), Note that the cells seen in background are those which 
migrated from the fibre surface to the surface of the culture plate and were grown 
on that situation. However, the focus has been performed on the fibres to 
specifically observe the cells attached to the fibres. The pictures Al and B1 
represent at least 2 experiments with duplicate samples. The pictures A2 and B2 
represent one experiment with duplicate samples. HUVECs were stained for 
nuclei with the SYTOX Green Nucleic Acid Stain. 
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To sum up, the RGD peptides appear to provide efficient ligand for the HUVECs to adhere 
to on the monofilament surfaces, as schematically presented in figure 6.17. 
Polymer Monofilament Bioactive Polymer Monofilament HUVECs adhesion 
Figure 6.17: Schematic presentation of bioactive fibre fabrication and EC adhesion 
RGD grafting via AApp and CMD 
Cell adhesion 
The aim of this study was to test the effectiveness of RGD, grafted onto CMD platforms 
which were immobilized; via two different interlayers, such as AApp + PEI and HApp . Such 
a comparative study may have an interest since the CMD grafted layers on AApp + PEI were 
different in surface roughness (SEM and AFM analysis) in comparison with the HApp (see 
Chapter 5). Furthermore, XPS high resolution spectra showed that the CMD coating, via Aapp 
+ PEI, was more effective (or thicker) than the CMD coating via HApp. Thus, both PET fibre 
and borosilicate glass surfaces were coated according to the procedures described in Chapter 4 
(sections 4.2.2-9). Aapp + PEI + CMD + RGD-coated fibres, in comparison with AApp + PEI 
+ CMD-coated fibres, showed an EC attachment after some 4 hrs of culture (Fig. 6.18). 
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A) PET + AApp +PEI+CMD 
B ) PET + AApp PEI CMD +RGD (0.5 mg nil) 
Figure 6.18: Cell adhesion on RGD- coated PET fibres via AApp + PEI + CMD, 4 hrs after 
HUVEC seeding. The pictures represent one experiment conducted with 
duplicate samples. HUVECs were stained for nuclei with Hoescht. 
A quantitative analysis of the cell adhesion, following a 4 day culturing period, was 
performed on these coatings (Fig. 6.7). As expected, cell adhesion was significantly reduced 
on the CMD-coated fibres on which the CMD was grafted via the AApp-PEI (Fig. 6.7); when 
compared to the untreated, clean PET fibre (control) at p < 0.05. Unfortunately, data 
concerning the GRGDS-coated samples were not available due to a technical issue with the 
GRGDS peptide, while the data relating to GRGES was not included, due to lack of 
comparison with RGD. These preliminary results suggest that successful performance of the 
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biomolecule immobilization on CMD, via AApp-PEI, was achieved. However, repetition of 
these experiments is deemed necessary. 
6.4. The effect of surface topography on EC behaviour 
6.4.1.3D cell patterning using polymer fibres 
Cell patterning is an interesting concept that can have many applications over a number of 
domains, such as cell biology, cell-based chemical sensors, and tissue engineering. As an 
example, all of engineered tissues for ligaments (BASHUR, et al. 2006) and muscles (BACH, 
et al. 2006; LEVENBERG, et al. 2005) require cell orientation. In recent years, cell orientation 
by means of "contact guidance", has become an attractive research subject. In this 
phenomenon, a topographical feature of the substrate regulated the direction of cell spreading 
and migration (BASHUR, et al. 2006). Decades ago, it was observed that collagen gel aligned 
into parallel fibres bundles during gel contraction, which then guided the cell migration. 
"Contact guidance", can thus be used in tissue engineering to guide migrating cells along 
aligned ECM-fiber bundles for the tissue regeneration (SCHWARZ and BISCHOFS 2005). In 
addition to ECM fibers, a few studies have reported that different cell types can orient 
themselves and move along synthetic polymeric fibres having diameters ranging from 5 to 108 
pm (CURTIS and RIEHLE 2001; KHANG, et al. 1999; MILLER, et al. 2002). 
Furthermore, model studies on micropatterned substrates have shown that parallel 
microgrooves, with feature sizes of less than 100 pm, can orient numerous types of anchorage 
dependent cells. For example, analyses of EC behavior, on micropatterned materials with 
different stripe sizes (i.e. 10, 25, 50 and 100 pm), have been performed in terms of the 
adhesion, migration and orientation factors involved (BARBUCCI, et al. 2002). This study 
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showed that decreasing the stripe dimensions also modified the EC shape to that of a fusiform 
shape which subsequently enhanced the cell movement and orientation (BARBUCCI, et al. 
2002). With the exception of a few studies, including Weiss' study (collagen gel); many 
studies on cell patterning have been performed on two-dimensional systems. However, 
transferring those results to a 3D-system, and then as 3D scaffold, is a great challenge in the 
tissue engineering field (BASHUR, et al. 2006). Moreover, very few studies have considered 
applying biological molecules in a 3D system for tissue engineering, in order to direct or guide 
cell responses and tissue development. In the present study, I have fabricated surface modified 
fibres with adhesive property (i.e. plasma polymers) (Fig. 6.4, and 6.6), non-adhesive property 
(i.e. CMD coating) (Fig. 6.4, and 6.6) and bioactive property (grafted with biological 
molecules (i.e. RGD)) (Fig. 6.15 and 6.16) to induce a directional, 3D cell patterning on these 
fibres, once they are dispersed in a 3D environment. 
The effect of fibre curvature and surface micro and nano topography on HUVEC 
behaviour 
Cell elongation along the fibre axis 
The effect of fibre curvature and fibre surface chemistry on the EC spreading and 
orientation were investigated, after 10 days of EC cultures. HUVECs were stained with 
TRITC-phalloidin for actin filaments. As observed by confocal microscopy, the majority of 
actin filaments were oriented parallel to the fibre axis. Conversely, HUVECs on the flat 
surfaces of a TCPS exhibited randomly distributed actin filaments (Fig. 6.19). Similar actin 
filaments orientation was observed on un-coated and HApp- and RGD-coated PET fibres. 
These observations suggest that cell orientation was not related to the surface chemistry but to 
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the fibre curvature (100 |am) and/or the micro and nano features of fibre surface. These results 
and discussions have been previously published (HADJIZADEH, et al. 2007). 
Figure 6.19: Confocal microscopic images of the EC spreading and orientation of HUVECs 
along a PET fibre axis (A) compared to EC spreading on a tissue culture 
polystyrene plate [B:TCPS] (B). The pictures represent at least 2 experiments 
with duplicate samples. This figure has been previously published 
(HADJIZADEH and VERMETTE 2007). HUVECs were stained for nuclei with 
Hoescht and for actin filaments with TRITC-phalloidin. 
168 
The effect of surface micro and nano features on HUVEC morphology 
The PET fibre surface features and EC morphology are shown in Figure 6.20. Based on 
the AFM image of a PET fibre, with a large scan area (20x20 pm 2), parallel micron-scale 
features, formed by manufacturing techniques, are seen along the fibre (Fig. 6.20A). 
Furthermore, the SEM image of a PET fibre (Fig. 6.20B), at high magnification, shows the 
similar features on the nanometer scale. The randomly distributed "particle like" features 
observed in figure 6.20 B belong to the AApp coating. EC morphology on a PET fibre coated 
with AApp is shown in Figure 6.20 C. As this figure shows; most of the cells are oriented 
along the fibre. 
The effect of the ePTFE fibre (with a 200pm diameter) surface features on HUVEC 
behavior is shown in figure 6.21. An AFM image of an ePTFE fibre in a scan area of lOx 10 
pm 2 is shown in figure 6.21 Al (2D AFM image), and A2 (3D AFM image). These images 
show that, fibre like features with a width of about 2 pm and a height of about 600 nm, are 
present on the surface of this fibre. In addition to the AFM images, SEM images in low 
magnification (Fig. 6.21B1) and high magnification (Fig. 6.21B2) were provided, in order to 
identify both large size surface features (micrometric scale) and very fine features (nanometric 
scale) of ePTFE fibre. The two images (Fig. 6.21B1 and B2) together demonstrate the 
existence of oriented micro and nano features along the fibre with randomly distributed, nano 
scale pores. Finally, EC behavior (i.e. adhesion and spreading) is shown on both untreated 
ePTFE fibre (Fig. 6.21 CI) and HApp-coated ePTFE fibre (Fig. 6.21C2 and C3) which 
demonstrate the effect of fibre surface features in conjunction with fibre surface chemistry on 
the EC adhesion and spreading. Based on the Figures 6.21 CI and C2, only the surface micro 
and nanometer scale features are not able to promote cell adhesion, but cell adhesive surface 
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chemistry is required. Furthermore, though oriented surface features are present on the ePTFE 
fibre surface, cells are not oriented but their morphology resembles that of the cells on a flat 
surface (Fig. 6.21C3). 
Therefore, cell orientation along the PET fibres can be due to the response of HUVECs to 
a typical fibre curvature (i.e. lOOjam). Because ePTFE fibres, having oriented surface features 
are similar to those of PET fibres, but with the larger curvature of « 200 pm, did not show cell 
orientation along the fibre axis (Fig. 6.21C3). This interpretation can be supported by the 
previously reported studies, in which cell orientation along the fibre, are influenced by the 
fibre curvature, and most cell types are oriented in the 5-108 pm range (CURTIS and RIEHLE 
2001; KHANG, et al. 1999). However, more investigations will be needed to better understand 
how the fibre curvature and fibre diameter can affect the cell responses. 
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Figure 6.20: 100pm PET fibre surface and EC behavior: A) AFM image of PET fibre with 
scan area of 20x20 pm2 B) SEM image of PET fibre + AApp, C) HUVECs 
morphology on a PET fibre +AApp. The pictures represent at least 2 experiments 
with duplicate samples. HUVECs were stained for nuclei with SYTOX Green 
Nucleic Acid Stain and for actin filaments with TRITC-phalloidin in C. 
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Figure 6.21: The effect of 200 fjni ePTFE fibre surface features and chemistry on HUVEC 
response: Al and A2) AFM image of ePTFE HI- HApp fibre with scan area of 
10x10 jum2, B1 and B2) SEM image of ePTFE fibre, CI) HUVEC adhesion on 
untreated ePTFE fibre, C2) HUVEC adhesion on HApp-coated ePTFE fibre, C3) 
HUVEC morphology on HApp-coated ePTFE fibre, The pictures Al and A2 
represent at least 2 experiments. The pictures B1 and B2 represent SEM images 
on one sample in different magnifications. The pictures CI and C2 represent at 
least 2 experiments with duplicate samples. The pictures C3 represent one 
experiment in duplicate samples, similar cell morphology was observed on the 
same fibre with RGD coating. HUVECs were stained for nuclei with SYTOX 
Green Nucleic Acid Stain in CI-3 and for actin filaments with TRITC-phalloidin 
in C3. 
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The effect of surface micro and nano features on HUVECs adhesion 
Rosso et al. (2006) have shown that the roughness of a surface generated by plasma 
polymerization increased the fibroblast proliferation, due to the presence of a smooth nano-
structured fluorocarbon coatings deposited on PET films. In addition, it has been reported that 
nano-scale surface features can influence EC functions. For example, nano-structured cast 
poly (lactic-co-glycolic acid) (PLGA) substrates promoted endothelial and smooth muscle cell 
growth (MILLER, et al. 2004). Chung et al. (2003b) showed that even graft layers, such as 
PEG-RGD, increased the surface roughness of biomaterial surfaces (i.e. polyurethane coated 
with PEG-RGD) at nanometric scale and could enhance the adhesion and growth of the 
HUVECs. Moreover, in a very recent study, the size and proliferation rate of fibroblasts 
decreased when cultured on needle-like nanoposts, while blade-like nano-grates enhanced the 
elongation of the same cells (CHOI, et al. 2007). 
Based on those previous studies, I have hypothesized that the increased cell adhesion and 
growth on the AApp, in comparison with that of the HApp (Fig. 6.2), may be attributed to the 
nanometric surface roughness, as previously shown in Chapter 5 (Fig. 5.7 and 5.8). 
Furthermore, non-coated ePTFE fibre, having micrometric and nanometric surface roughness 
values (Figs.6.21Al 6.21A2, 6.21B1 and 6.21B2) exhibited very poor cell adhesion, whereas 
the same fibre coated with HApp promotes cell adhesion (Fig. 6.21C1 and 6.18C2). 
Taken together, it can be concluded that, topographical parameters become effective once 
surface chemistry promotes cell adhesion. Therefore, controlled cell growth in tissue 
engineering can be achieved using polymer fibres having diameters in the micrometer range, 
having those identified chemical and topographical characteristics which can applied to the 
design of new substrates. 
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6.5. Conclusions 
In the present chapter, surface modified substrates, including polymer fibres, which were 
earlier developed and characterized in Chapters 4 and 5 respectively, are validated with 
respect their biological functionality, using HUVEC. The EC behaviours in terms of the cell 
adhesion, spreading, and orientation, were investigated as a function of the fibre surface 
properties. As expected, the cell adhesion was reduced on CMD-coated fibres, whereas 
aldehyde-, amine- and GRGDS-coated fibres all promoted cell adhesion and spreading. Low-
fouling CMD surface coatings, in conjunction with topograpghical characteristics of the 
polymer fibres could be an approach that may allow a specific control of the directional 
cellular interactions at the tissue-biomaterial interface. Moreover, reduced cell adhesion on the 
GRGES-coated fibres (inactive peptide control) suggests that the high EC adhesion on the 
polymer fibres bearing surface-grafted GRGDS were due to the integrin stimulated cell 
adhesion towards the RGD ligands present on the surfaces. Cell adhesion increased as a 
function of GRGDS solution concentration (over a range of 0.1-1 mg/ml). Cells on RGD-
coated substrates formed strong spots of vinculin (typical of Fas) and well-defined stress 
fibers. In addition, in comparison with flat surfaces, fibre curvature (lOOpm) promoted cell 
orientation along the fibre axis, and this event occurred more effectively in the longer-term 
cell culture. In addition, it was also observed that the surface chemistry is dominant in 
modifying the HUVEC cell behavior. Topographical parameters become effective when 
specific surface chemistry promotes cell adhesion. Moreover, the findings of this study point 
to the suitability, of RF n-heptylamine and acetaldehyde plasma polymerization, to induce 
desirable coatings to form on the presented substrates, as well as to improve their ability to 
support strong adhesion of HUVECs. In addition, the cell responses on PET fibres were in 
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agreement with those on ePTFE fibres and flat substrates. Therefore, the multilayer surface 
modification technique is reproducible and performs adequately. 
This multilayer surface modification technique have the following advantages: 1) HApp 
or AApp enhanced cell adhesion by altering physicochemical properties of the substrate 
surface; and allows the inducement of new functional groups (i.e. amine or aldehyde) to 
covalently graft a second desired layer (e.g. CMD), 2) CMD layer provides a non-fouling 
surface towards proteins and cells, and also allows the introduction of COOH functional 
groups, in order to covalently immobilize bioactive molecules (e.g. RGD) and producing 
predictable cell adhesive surfaces. 3) Covalently grafted-RGD on the surface carboxylic 
groups correlates with an integrin stimulated cell adhesion. 
In conclusion, surface-modified polymer fibres bearing cell adhesive and non-adhesive 
coatings can be applied to produce biomaterials (e.g. 3D-scaffold) with multifunctional 
surfaces with the capability of 3D cell patterning. These materials may have an important 
impact in current and future tissue engineering applications and regenerative medicine. 
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Chapter 7 
Results and discussion III: In vitro evaluation of 
surface modified PET fibres towards microvessel 
formation in 3D cell culture system 
7.1. Overview 
Preserving the viability of thick and complex tissue masses, such as muscle, within the 
tissue construct both in vitro and in vivo is a challenging issue in the tissue engineering field. 
Thus, developing an in vitro pre-vascularized tissue construct could be one of the more 
promising solutions. Furthermore, physicochemical properties of the scaffolding material and 
the method of cell seeding can regulate angiogenesis in the in vitro constructs. To this aim, in 
this chapter, the development of an in vitro vascularized 3D tissue construct, using the 
physicochemical properties of multilayer surface modified PET polymer fibres, and three 
different methods of cell seeding by HUVECs, have been studied. The capability of enhancing 
angiogenesis in contact with fibres and the induction and guidance of microvessel formation 
within a 3D scaffold, were investigated. The preparation, characterization and evaluation of 
surface modified polymer fibres, towards HUVECs, have been currently published 
(HADJIZADEH, et al. 2007) and explained further in Chapters 5 and 6 of this thesis. Briefly, 
biological molecules (e.g. RGD peptides and gelatin) have been immobilized onto the surface 
of 100-pm dia. PET monofilaments, treated via HApp and CMD interlayers. Three in vitro cell 
culture systems have been used to investigate the microvessel formation. The first system 
attempted to combine simultaneously HUVECs and fibres in the fibrin gel. In the second 
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system, the HUVECs and fibres, having various coatings, were sandwiched between two 
layers of fibrin gel. In the third arrangement, cell adhesive fibres were precoated with 
HUVECs and then embedded in the fibrin gel. The 3D constructs (culture systems) were 
examined under phase contrast microscopy, epifluorescence microscopy and confocal 
microscopy, periodically, and finally through the tissue sections which were prepared for 
histological observations. Angiogenesis did not occur in the first model whereas in the second 
and third systems, angiogenesis appeared along the fibres axis. The presence of fibroblasts 
over fibrin gel promoted the formation and stabilization of the microvessels. Though cell 
adhesive coatings accelerated tube-like structure formation, may be by enhancing EC 
attachment, no major differences were observed between fibres having different coatings on 
the induction of angiogenesis. Furthermore, the architecture of polymer fibres in conjunction 
with cell attachment to fibrin (as an ECM component) may be largely involved in modeling a 
3D EC pattern which promoted the formation of directional microvessels along the fibres axis. 
With increased incubation times the microvessel number increased and a network was formed 
in which microvessels connected to each other, from one fibre to another. A fibre spacing 
ranging from 200 to 600 pm, was optimal to form a network. This approach uses the 
phenomena of contact guidance to modulate 3D patterning of EC by enhancing HUVECs 
migration, proliferation and orientation and ECM components (covalently grafted onto the 
fibre) to support EC attachment and growth on and along the fibre. These factors enhance the 
induction of directional angiogenesis in vitro. Therefore, these results demonstrate that, by 
using fibre-shape polymeric material which was surface coated with a cell adhesive material 
preferably with an ECM component such as RGD peptide or gelatin, guidance and 
interconnection of microvessel was possible. This approach can be applied in tissue 
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engineering such as in vitro prevascularised tissue construct fabrication and in therapeutic 
angiogenesis. 
7.2. First system: system containing polymer fibres and HUVECs 
both dispersed in fibrin gels 
In this system (see Chapter 4, first system), randomly dispersed fibres (i.e. not on the 
holder) were embedded in a fibrin gel mixed with HUVECs. PET monofilaments coated with 
i) HApp + CMD, ii) HApp + CMD + RGD, and iii) HApp + CMD + gelatin, were tested in 
this system. First fibres and HUVECs were mixed with fibrinogen solution and then thrombin 
was added to form fibrin gel in the plates. Angiogenesis was not observed after 10 days of 
culture. From days 3 to 10, cell adhesion was only observed on gelatin and RGD coated fibres 
(Fig. 7.1). Moreover, no cell adhesion was observed on CMD coated fibres. It should be noted 
that, no fibroblast cell were used in this system. 
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Figure 7.1: First system: surface coated PET fibres and HUVECs randomly embedded in 
fibrin gel. No EC organization to make well-formed tube-like structures were 
observed in control samples (without fibres, Al and A2) or in samples containing 
fibre (B1-D2). The pictures represent one experiment with triplicate samples. 
Fibre diameter: 100pm. The double head arrows indicate the fibres. HUVECs 
were stained with calcein-AM (left column) 
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7.3. Second system: system with HUVECs sandwiched between 
two fibrin gels containing cell-free fibres 
Previous studies with HUVECs sandwiched at high density between two layers of fibrin 
have been shown to induce rapidly microvessels at the fibrin interface (BACH, et al. 1998). 
Based on this culture system, HUVECs and the holder holding fibres were introduced at the 
fibrin interface in order to investigate the physicochemical properties of surface coated fibres 
to enhance and orient the formation of microvessels. Non-coated PET fibres and HApp- and 
RGD-coated PET fibres as well as cell-non-adhesive fibres (i.e. CMD- and RGE-coated 
fibres) induced similar response of microvessel formation by days 2-5 of culture. EC strands 
were observed between the two layers of fibrin gel largely over the interface. Much of these 
strands presented tube-like structures that were directed along the fibres (Fig. 7.2). These 
directional tube-like structures were observed for all tested fibres. In addition they presented 
branches and connections between microvessels resulting in a complex EC network. Figure 
7.2, as an example, shows these observations for uncoated PET and HApp-, CMD- and RGD-
coated PET fibres. 
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Figure 7.2: Observation by epifluorescence microscopy of the 
of culture) in which HUVECs and cell-free 
interface of 2 fibrin gels, In A cells stained 
the fibre were stained for actin filaments, using TRITC-
microvessels around 
phalloidin, and 
position of the nuclei. The 
The pictures represent 3 experiments with triplicate samples. Fibre diameter: 
100pm. 
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Furthermore, it has been previously reported that the presence of fibroblasts facilitated 
angiogenesis in fibrin gel in which ECs were seeded on beads (NEHLS and DRENCKHAHN 
1995). In our system the presence of a monolayer of fibroblasts on the top of the 2nd layer of 
fibrin gel facilitated the endothelial progression (Fig. 7.3). These observations have not been 
reported previously in this system neither with fibres nor with fibroblasts cells (BACH, et al. 
1998). 
Qualitatively, the formation of directional tube-like structures was not observed in controls 
(i.e. in the absence of fibres) (Fig. 7.3 Aland A2). This suggests that, physical shape of fibres 
may induce directional microvessel formation around the fibres in this system. This 
interpretation, particularly in the case of non-cell adhesive fibres (i.e. CMD-coated fibres) is 
supported by accumulation of HUVECs along the fibre at the time of cell seeding (Fig. 7.4). 
This high density of cells may lead to cell aggregation inducing cell strands and tube 
formation along the fibre and network formation between the fibres. This event is based on the 
fact that positioning the holder bearing fibre onto the under-layer fibrin gel; a fine deformation 
may be generated around the fibre by gravity. At the time of cell seeding, HUVECs may be 
rolled over down on the fibres and subsequently gathered at the fibre-gel border (see the 
schematic presentation in Fig. 7.5). In the case of cell adhesive coated fibres, similar events of 
gathering cells were present; in addition cell attachment was further facilitated the 
maintenance of more cells on the fibres and around them by the adhesiveness of the fibre 
surfaces. Therefore polymer fibres, typically those with a cell adhesive coating, enhanced 
directional tub-like structure formation and interconnected networks in the second system. 
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gure 7.3: The effect of fibroblast monolayer on top of the fibrin gel and as well as the 
physical effect of fibre on micro vessel formation in the second system: In Al , 
B1 and CI cells stained with calcein AM did not showed well formed tube-like 
structures in the absence of fibroblasts, after 5 days of culture. Conversely, in the 
presence of fibroblasts, HUVECs stained with Dil-acetylated LDL formed a 
microvessel network as shown in A2, B2 and C2. In Al and A2 in the absence of 
polymer fibres (i.e. controls) no directional EC strands can be observed but in 
Bl , B2, CI and C2 in the presence of polymer fibre the directional cell strands 
are observed. The pictures represent 2 experiments with triplicate samples. Scale 
bar: 100(jm. The double head arrows indicate the fibres and single head arrows 
the cell strands. 
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Figure7.4: HUVEC accumulation along the fibre at the time of cell seeding in second 
system, the double head arrows indicate the fibres and single head arrows the 
HUVECs. 
ECs 
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Figure 7.5: A schematic presentation of the hypothetical position of PET fibres on the surface 
of underlying fibrin gel (1st layer) in the second system and HUVEC distribution 
around fibres at the time of cell seeding 
7.4. Third system: system with cell-precoated fibres embedded in 
fibrin 
Within 2-3 days of cultures, elongated EC strands were formed along the fibres which 
appeared on both side of the fibres as viewed under microscopy focusing at different depths in 
the fibres. Sprouting was also observed from these cell strands (Figure 7.6). After an 8-10 day 
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culture period, fully formed tube-like structures were generated, reaching lengths ranging 
between 0.1 to 1mm (Fig. 7.7). When left in the culture for up to 20 days, the capillary 
network continued to remodel itself, developing a network both along and between the 
neighboring fibres (Fig. 7.8). Phase-contrast microscopy images revealed the presence of 
lumens within tube-like structures (Fig. 7.8A, B, D and El). As additional evidence of lumen 
formation, histological sections of the specimens also showed the presence of lumens having 
multi-cellular architecture (Fig. 7.9). In figure 7.9, specific staining for vWf confirms the 
existence of endothelial lining (brown) and counter-staining by hematoxylin shows the 
nucleus (blue). These observations were in the presence of fibroblast cells. Conversely, in the 
absence of fibroblasts, the HUVECs on fibres remained dispersed in the fibrin and did not 
exhibit any well-formed tube-like structures (Fig. 7.10). 
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Figure 7.6: Third system: In vitro cell strands and sprout formation along the cell-coated 
polymer fibres embedded in fibrin gel. By day 2-3 HUVECs formed cell strands 
and sprouts as observed by phase contrast on PET (A), PET + HApp (B), PET + 
HApp + CMD + RGD peptide (C) and PET + HApp + CMD + gelatin (D). Fibre 
diameter: 100pm. The pictures represent at least 3 experiments with triplicate 
samples. The double head arrows indicate the fibres and arrow heads the 
microvessel-like structures. 
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Figure 7.7: Third system (by day 8-10): Initially formed directional microvessel (indicated by 
arrow head) along the fibre, branching, elongation and lumen formation (narrow 
arrows), as observed by phase contrast (Al) and after Dil-acetylated LDL uptake 
(A2), fibre type: covalently gelatin grafted fibre (i.e. PET fibre + HApp + CMD + 
gelatin). The pictures represent one experiment with triplicate samples. Fibre 
diameter: 100pm. 
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Figure 7.8: Third system: Phase contrast observation demonstrates the progression of 
microvessel reorganization and network formation (day 14-22). Tube-like 
structures have extended in fibrin and connections were established between the 
different microvessels, as observed by phase contrast (A-El) and after Dil-
acetylated LDL uptake (E2). Note, the presence of a lumen within the 
microvessel (A, B, D and El), the fibre types are covalently gelatin grafted fibres 
(i.e. PET fibre HI- HApp + CMD -F gelatin). The pictures represent at least 2 
experiments with triplicate samples. Fibre diameter: 100pm. The double head 
arrows indicate the fibres, the arrow head the initially formed directional 
microvessel and single head arrows the microvessels. 
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Figure 7.9: Histology and immunohistochemistry demonstrating tube-like structure with 
lumen near the polymer fibres in the third system: Sections counterstained with 
hematoxylin (Al and B in blue color) demonstrates cellular region near the fibre. 
Immunohistochemistry with Factor VIII antibody on histological sections 
identified HUVECs from fibroblasts and underlined the HUVECs forming a 
lumen close to the fibre as observed in A2 and C (in brown color) Fibre type: 
gelatin- grafted fibre (i.e. PET fibre + HApp + CMD + gelatin). The pictures 
represent sections from at least 3 different experiments with triplicate samples. 
Fibre diameter: 100pm. 
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Figure 7.10: In the third system HUVECs in the absence of a fibroblast monolayer remained 
close to the fibers without any tube-like structures formation. RGD- coated (A) 
and gelatin-coated (B) fibre, the pictures represent at least 2 experiments with 
triplicate samples. Fibre diameter: lOOpm. The double head arrows indicate the 
fibres and single head arrows the HUVECs. 
The incubation time period seems to be important in the development of microvascular 
network within a fibrin-based construct. The effect of incubation time period was indirectly 
quantified by determining the average vessel number per unit length of fibre, according to the 
procedure explained in Chapter 4 (section 4.4.4 and 4.4.5). Microvessel formation was 
significantly increased after 10-15-day culture period compared to the shortest time periods 
(p <0.05) (Fig. 7.11). The results suggest that by increasing over time of culture period did 
not significantly enhance the number of microvessels. 
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Figure 7.11: The number of microvessels as a function of incubation time periods. Fibre type: 
gelatin-grafted fibres (i.e. PET fibre + HApp + CMD + gelatin). The number of 
vessels has been counted on both sides of the fibres. Short sprouts have also been 
taken into account. N represents the number of fibres used for image analysis 
from at least one experiment. * indicates values significantly different from the 
early culture period (2-5 days) by ANOVA at p <0.05. Error bars represent the 
standard error of the mean (SEM). 
7.4.1. Effect of fibre surface chemistry on angiogenesis stimulation 
Despite ultimate knowledge of the roles of cell-matrix interactions in angiogenesis, the 
successful control of this process by implementation of ECM in artificial scaffolds has still to 
be achieved (POMPE, et al. 2004). The incorporation of specific ECM molecules with 
angiogenic properties in biomaterials may enhance angiogenesis and subsequently tissue 
ingrowth (BATTISTA, et al. 2005; FOURNIER and DOILLON 1992; FOURNIER and 
DOILLON 1996; WU, et al. 2007). ECM molecules can be simply mixed with scaffolding 
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material, immobilized onto the surface of these materials, or composed the scaffold. Such 
designs have been reviewed early in Chapter 3 (section 3.4.1). 
Although, the adhesion of ECs using ECM and derivatives (e.g. RGD peptides) have been 
achieved on biomaterials (e.g. synthetic polymeric materials), induction of angiogenesis by 
this approach has rarely been reported (FOURNIER and DOILLON 1996; KIDD, et al. 2002; 
UNGER, et al. 2005b). In this thesis, the aim was to create a desirable surface for cells 
mimicking a close to natural cell environment thought that by covalently coating polymer 
fibre surfaces, using biomolecules. Moreover, as a result of these, the possibility of developing 
directional microvessel formation within a 3D environment would be provided. By using 
biological molecules (i.e. RGD or gelatin), it was expected to have a more efficient EC 
organisation in the nearby of a fibre which could have been a controllable and predictable 
biological response. Surprisingly, all surface-modified fibres, with cell-adhesive coatings, (i.e. 
PET coated by HApp, RGD and gelatin), showed similar behaviours towards microvessel 
formation. Even these phenomena observed, in lower level, on uncoated PET fibres (Fig. 
7.12). 
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The effect of gelatin-coated fibres on angiogenesis 
Gelatin hydrogels have been used for sustained release of growth factors in tissue 
engineered devices in order to promote tissue regeneration and vascularization (DOI, et al. 
2007; YOUNG, et al. 2005). Gelatin-coated substrates have been used to enhance EC adhesion 
and proliferation (CHOONG, et al. 2006). However, there are very few reports about 
angiogenesis occurring on gelatin coated surfaces (UNGER, et al. 2005b). Our results 
demonstrate that, covalent immobilization of gelatin via a hydrogel like interlayer (i.e. CMD) 
onto PET polymer fibres enhanced HUVEC adhesion, confluence in 2D cell culture system, 
and microvessel formation in 3D fibrin gel system (Fig. 7.7-7.9). Therefore, this approach can 
be applied on polymeric scaffolding material to enhance vacularization of tissue engineering 
constructs. 
The effect of RGD-coated fibres on angiogenesis 
Additional to the formation of sprouting and tube-like structures (Fig. 7.6), RGD-coated 
fibres exhibited "zigzag-shape" structures around the fibre after 2 days of culture (Fig. 7.13). 
These structures may correspond to short-length microvessels and branches rather than 
elongated and separate microvessels as observed on gelatin- and HApp-coated fibres (Figs.7.7 
and 7.12 respectively). In some of the observations, even "zigzag-shape" structures were 
maintained with no branch and short-length microvessel formation for a period of 3-11 days 
(Fig. 7.14). Theses particular forms of microvessels structures as observed on RGD-coated 
fibres are schematically shown in Figure 7.15. 
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Figure 7.14: "Zigzag-shape" microvessels without branch (indicated by arrow heads) along 
RGD-coated fibre, observed at days 2 (A 1) and 9-11 (A2-A3) in the third system, 
the pictures represent at least 2 experiments with triplicate samples. Fibre 
diameter: 100pm. The double- head arrows indicate the fibres. 
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The formation of zigzag-shape microvessel suggests that previously attached cells may 
detach from the fibres in some areas, giving raise to short-length microvessels and branching. 
Whereas the cells remaining attached to the fibres may be activated to sprout and also to form 
subsequent branches. 
The effects of tripeptide RGD on tissue regeneration in vivo and in vitro have been 
extensively reported. For example, RGD-containing peptides have been shown to accelerate 
the healing response and to improve the quality of the regenerated tissue in bone 
(KARDESTUNCER, et al. 2006; RAMMELT, et al. 2006), in cardiovascular (TWEDEN, et 
al. 1995), in diabetic (STEED, et al. 1995; WETHERS, et al. 1994), and in brain tissue repairs 
(CUI, et al. 2006). Nevertheless, there is little evidence of the effect of RGD peptide to trigger 
directly angiogenesis (CUI, et al. 2006) and there are many reports suggesting that soluble 
RGDs peptides inhibited angiogenesis (BUERKLE, et al. 2002; HAUBNER and WESTER 
2004; KIM, et al. 2006; MEEROVITCH, et al. 2003; SHEU, et al. 1997; WESTLIN 2001). 
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Figure 7.15: Typical microvessel forms observed on RGD coated fibres: "zigzag-shape" 
microvessels along the fibres (1), with a branch connecting microvessels of the 
same fibre (2), with branches issued from a microvessel towards fibrin gel (3), 
and with branches that connect two neighboring fibres (4). 
Indeed, linear and cyclic RGD peptides have been used in cancer therapy by which 
a
 v/?3 integrins were targeted (ZHANG, et al. 2007). In fact, the RGD sequence mediates ECs 
attachment to the ECM by specific cell membrane receptors i.e., oc5fil and ocv^ integrins. It 
has been demonstrated that RGD-containing peptides are able to detach ECs from plastic or 
ECM-coated substrate by competing with the binding of RGD-containing ECM compounds to 
integrins. As mentioned earlier, during angiogenesis ECs interact with RGD-containing ECM 
compounds i.e., FN, laminin, collagen, vWf and VN (SHEU, et al. 1997). These interactions 
play prominent roles in EC function i.e., adhesion and migration. Since EC adhesion and 
migration are two important factors in angiogenesis, thus the RGD sequence modulates the 
interactions between sprouting ECs and the ECM molecules during microvessel development 
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(SHEU, et al. 1997). In conclution, soluble RGD inhibits tumor angiogenesis by targeting 
a
 v (5 3 integrins inhibiting adhesion and migration of ECs via ECM molecules (SHEU, et al. 
1997). In contrast, RGD-coated implants accelerated wound healing (STEED, et al. 1995). 
Though there are few studies reporting this effect in vivo, to our knowledge there is no in vitro 
study reporting the effect of RGD on angiogenesis. In thesis, it has been demonstrated that at 
least in a 3D in vitro system that covalently immobilized RGD peptide can induce 
angiogenesis as shown in Figure 7.13-14. 
7.4.2. Physical effect of fibre on angiogenesis induction 
Cellular functions such as cell shape, migration, and orientation can be controlled by the 
phenomenon called contact guidance or "topographic guidance" (LO, et al. 2000; CURTIS 
and RIEHLE 2001). Many studies have reported the guiding of cells by topographical 
features, for example cell orientation along micro-grooves (FLEMMING, et al. 1999) as well 
as fibres (HADJIZADEH, et al. 2007). In addition, some studies have reported that cell (i.e. 
fibroblast) movement can be guided by solely physical interactions at the cell-substrate 
interface (LO, et al. 2000). In fact, fibroblasts followed a rigidity gradient (with Young's 
modulus values varying from 140 to 300 kdyne/cm) when cultured on collagen-coated 
polyacrylamide sheets. Moreover, it has been also reported that fibroblasts exhibited different 
shapes and motility rates when cultured on collagen-coated polyacrylamide with different 
rigidities (LO, et al. 2000). The 3D network formation by ECs is regulated by mechanical 
properties of adhesion matrix. For example, ECs formed dense, thin networks in the flexible 
gel (YAMAMURA, et al. 2007) and the softer and more malleable substrate (i.e. ECM matrix) 
exhibited an increase in the formation of tube-like structures (INGBER and FOLKMAN 1989). In 
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addition, it has been suggested that the in vitro capillary sprouting are regulated by the relative 
magnitudes of forces generated by ECs and matrix rigidity (SIEMINSKI et al. 2004). 
Accordingly, it can be hypothesized that the ECs situated at the interface between the rigid 
fibres and the soft fibrin gel in the culture system responded to two distinct substrate rigidities 
or deformabilities, in this study. Subsequently, activated ECs may be mobilized toward a 
preferred direction or destination along the fibre long axis. Such phenomenon has been 
previously reported, at least, for fibroblasts (SHEETZ, et al. 1998). 
7.4.3. Effect of fibre-fibre distance on angiogenesis 
The distance between two distinct fibres seems also to play role in the development of 
microvascular network within a fibrin-based construct. Although the design of our fibre holder 
is limited to investigate certain distances in a random manner (i.e. between ca.0.1 and 2mm), it 
was possible to figure out some effect of fibre spacing. The quantitative analysis of this effect 
was performed according to the procedure explained in Chapter 4 (section 4.4.4 and 4.4.5). 
Microvessel formation was particularly observed between two fibres distanced of 200-600 
which is higher than those found below 200pm or above 1mm (Fig. 7.16) However, the 
majority of connections were in the vicinity of 200-300 microns (Figure 7.17 B1 and B2). 
Below distances of 200pm juxtaposed microvessels were frequently observed along the 
respective fibres (Figures 7.17 A) and, in some instances, communicated to each other. 
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Figure 7.16: Number of microvessels relative to the range of distances between fibres, this 
quantification has been performed on specimens in cultures for a 14-21 day 
period. Covalently gelatin-grafted fibres (i.e. PET fibre + HApp + CMD + 
gelatin) were considered. The number of vessels has only been counted in face to 
face sides of the fibres. Short length sprouts have also been taken into account. 
Error bars represent standard errors of the mean (SEM), N is the number of fibres 
from 2 separated experiments, #N from one experiment. * indicates the values 
significantly different from the lowest distance (0.2-0.6 mm) by ANOVA at 
p <0.05. 
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Figure 7.17: An example of the effect of fibre-fibre distances on microvessel formation. In A, 
fibres were distanced in space about 100pm. Two microvesssels with lumens that 
follow along the neiboring fibres and even connect to each other, In B1 and B2, 
the distance is below 300pm and vascular connection is observed, particularly 
close to a 200pm distance. In C, the distance is higher than 1mm which results in 
no vascular connection. The double-head arrows show the fibre and single- heads 
the microvessels. The pictures represent one experiment with three different 
fibres coatings, untreated, HApp- and gelatin-coated PET fibers, with triplicate 
samples (having similar results). Scale bar: 100pm 
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7.5. Conclusion 
The two main goals of this study were (i) to investigate the feasibility of producing a pre-
vascularized fibrin-based tissue construct in vitro, and (ii) to influence the guidance of vessels 
in a pre-determined direction using 100pm diameter polymer fibres. Using fibres, the whole 
angiogenic process can take place in vitro ranging from "sprouting" of HUVECs from cell 
pre-coated fibres (mimicking a pre-existing vessel) to tubes and through connections between 
branches as schematically presented in Figure 7.18. These two goals have been largely 
achieved by the use of surface modified polymer fibres on which covalently immobilized 
gelatin and RGD peptides facilitate and modulate the directional vessel formation within the 
3D gel environment. Two 3D culture systems have been developed to investigate microvessel 
formation along the fibres, in optimal condition such as the presence of a fibroblast monolayer 
over fibrin gel. Moreover, the physical effect of fibres in conjunction with the surface 
chemistry of fibres enhanced microvessel formation in vitro, and allowed an interconnected 
microvessel network. Therefore, these specifically modified polymer fibres have interesting 
features towards tissue engineering such as the development of an in vitro prevascularized 
composite construct consisting of a biocompatible matrix (e.g. fibrin) and polymer fibres. 
Furthermore, production of directional vascularization within the construct may be 
subsequently employed to orient new tissue for replacement or substitution. 
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Figure 7.18: Schematic presentation of the microvessel network formed progressively in the 
fibrin-based constructs with fibres in vitro. By 14-22 days, connections between 
microvessels have been established. Presentation adapted from [website ref. 7]. 
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Chapter 8 
Preliminary study: Designing of a large-scale 3D 
composite scaffold involving bioactive polymer 
fibres, porous hollow membrane sheet and fibrin gel 
8.1. Overview 
The overall objective of this study is to design a 3D large-scale scaffold that will create a 
desirable directional condition firstly for blood microvessel formation and secondly to allow 
formation of tissue mass within a bioreactor. This aim can be achieved by designing of a 3D 
composite scaffold involving bioactive polymer fibre, porous hollow membrane sheet 
(PHMSH) and fibrin gel. The fabrication, characterization and evaluation of bioactive polymer 
fibres as well as the in vitro 3D tissue construct models have been explained in previous 
chapters of this thesis. In this chapter, first the design of a 3D scaffold is studied. Then, the 
preliminary results obtained in the design, fabrication and morphology analysis of a PHMSH 
as well as its behavior towards EC and fibroblast adhesion is presented. Finally, the future 
experimentation including characterization of the PHMSH and testing in a bioreactor, to 
complete this study, is briefly explained. 
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8.2.3D scaffold designing 
Based on previously developed the two in vitro 3D angiogenesis model (see Chapter 4 
and 7 of this thesis) in which HUVECs form a directional angiogenic network when they were 
present on the surface modified polymer fibres between 2 layers of fibrin gel or embedded in 
it, we (Davod Mohebbi Kalhori and I) have proposed a sandwich-shape 3D composite scaffold 
for this study. In this scaffold the two above mentioned systems in conjunction with a PHMSH 
will generate a new approach to produce a large scale vascularised tissue mass. The reasons, 
for choosing the components of this proposed scaffold, are presented in Figure 8.1 (i.e. chart). 
One of the issues in tissue engineering is the limitation in size of any tissue grown in vitro, 
even using a bioreactor. This is due to the lack of a capillary network for nutrient supply and 
waste product removal within the construct. To overcome this problem, fabrication of a 
capillary bed to supply engineered tissue as it grows in a bioreactor is essential. However, the 
technical construction of a capillary-like architecture is complex and chalenging. For this 
reason we have proposed to design a PHMSH. 
In our design the bioactive polymer fibres (developed in this thesis), a PHMSH and a 
hydrogel will be combined to create suitable conditions for microvessel formation inside the 
3D scaffold within a bioreactor to investigate microvessel and subsquent tissue formation 
under well-controlled physiological conditions. In this 3D scaffold, gel, as a soft matrix is 
expected to provide a desirable environment for microvessel formation in the extra-capillary 
space of the PHMSH during the bioreactor culture which should allow continuous nutrient 
supply from the perfused circulating medium. Cells are expected to orient onto the bioactive 
polymer fibres in the extra-capillary spaces. Nutrients and oxygen in the circulating medium 
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will diffuse through the PHMSH walls to nourish the cells. This scaffold design is a novel 
concept in tissue engineering. This is because, not only cells will be guided along a defined 
growth directions in a 3D environment, but also these scaffolds will allow nutrient supply and 
waste product removal within a large-scale 3D environment. This design can be unique 
approach for the generation of large-scale living tissues. This sandwich-shape 3D scaffold can 
be in flat or rolled format which their architecture is shown in figure 8.2. 
Why this structure? 
Because: 
Micro-vessel Directional Large scale 
needs 
Soft matrix 
needs needs 
Directional stimulator S y s t e m f o r fluid flow 
and mass transport 
Gel Bioactive polymer fiber Porous hollow membrane 
i 
Effective structure and easy way for fabrication of a composite scaffold? 
A sandwich shaped architecture 
Figure 8.1: The chart represents the components and the purposes of our proposed 3D large-
scale scaffold 
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Figure 8.2: Components of 3D scaffold in longitudinal sectional view (A) and in cross 
8.3. Materials and methods 
Bioactive polymer fibre, one of the components of this composite 3D scaffold, have been 
already fabricated and evaluated towards EC behavior in 2D cell culture system which has 
been published (HADJIZADEH, et al. 2007) and explained in this thesis as well. Moreover 
their effect in 3D cell culture system towards angiogenesis has been investigated (see Chapter 
4 and 7 of this thesis). The PHMSH, the second component of this scaffold has been 
previously produced which is briefly explained below. 
The material to be used should be sterilizable, biocompatible, biodegradable, and able to 
supply nutrients through porous tubing, mechanically strong, flexible and processable into 
desired 3D porous structure. 
Based on desired properties (i.e. biodegradability and permeability, elasticity, mechanical 
strength, processing techniques and commercially availability), the selected polymers were 
sectional view (B) 
8.3.1. PHMSH fabrication 
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Poly (DL-lactide) (PDLLA) and Poly (£ -caprolactone) (PCL) blends, PDLA-co-PCL 
copolymer and PCL. PDLLA is a glassy polymer that is rapidly degraded due to its 
amorphous structure. However, PCL is rubbery. Simple blending between these two polymers 
results in a biodegradable material having a range of physical properties. Preparation of 
blends by solution is advatageous in comparion to the melting of mixed polymers, because 
melting at high temperature can cause degradation of aliphatic polyesters and 
transesterification between them. The considered dimensions and distances of the tubes in 
PHMSH are based on a primarily Computational Fluid Dynamics (CFD) study by the 
software of Fluent (data from Davod Mohebbi kalhori) and on acceptable distance to nourish 
cells (<500fim) as previously reported (EISELT, et al. 1998). Our design therefore considers 
tubes with an internal diameter below 1 mm, a wall thickness < 1 mm, and distances between 
tubes < 1 mm. In addition, this design should be available in several lengths to adapt 
according to their further applications. According to the above mentioned dimensions a mold 
has been designed and fabricated. Pieces and assembly are presented in Figure 8.3. 
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Figure 8.3: Pieces and assembly of mold designed for PHMSH fabrication (polymer solution 
casting). The pictures have been provided using the SolidWork software (drawn 
by Marc G. Couture). 
The phase separation techniques from a polymer solution were considered to shape the 
PHMSH in the homemade mold and around rods. The phase separation techniques have been 
widely employed to fabricate porous architecture such as polymer membranes and scaffold for 
tissue engineering applications (DAY, et al. 2004; KIM, et al. 2004). Phase separation of 
polymer solutions can be induced by several methods such as air-casting of the polymer 
solution, immersion precipitation and thermally induced phase separation. The two first 
methods have been selected for design studied in this thesis. In the dry phase inversion 
210 
method, porous membranes were made by evaporating the solvent from a solution of PDLLA 
and PCL in acetone or methylene chloride. This technique (schematically) is shown in Figure 
8.4. 
rod 
Polymer •+• Solvent 
support -
Schematic depiction of the air drying 
Figure 8.4: Schematic representation of the system used in dry phase inversion method 
The second method used was immersion precipitation. In this method, the polymer 
solution was cast as a thin film on our homemade mold, which was subsequently immersed in 
a non-solvent bath (i.e. water). Phase separation and gelation in solution were responsible for 
the pore generation and for the fixation of the porous morphology. In the preparation of porous 
PDLLA and PCL structures by the immersion precipitation method, 1,4-dioxane, chloroform, 
or acetone can be used as the solvent while water, methanol, or ethanol can be used as the non-
solvent in a ternary casting solution. This technique is shown in Figure 8.5. 
rod 
p + s 
, support 
Figure 8.5: Schematic depiction of the immersion precipitation process: P, polymer; S, 
solvent; NS, nonsolvent 
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8.4. Preliminary results 
Characterization 
The SEM and optical microscopy images of PHMSH resulted in the air-drying method by 
using PCL or PCL + PDLA (4% w/v in chloroform) is shown in Figure 8.6. A flexible sheet 
containing tubes can be produced by this method which can be rolled without any fracture or 
breaking. According to SEM analysis this sheet contains small pore size around 1 jJm. 
Rolled sheet 
SEM Optical microscopy 
Figure 8.6: Microscopic pictures of PHMSH made by PCL and PCL + PDLA resulted from 
air-drying method 
The SEM and optical microscopy images of PHMSH resulted in immersion precipitation 
process by using PCL (4% w/v in chloroform) and using water as non-solvent is shown in 
figure 8.7. This PHMSH has foam-like appearance and it is flexible which can be bended or 
rolled without being damaged. According to SEM analysis, this sheet had a well porous 
structure. This sheet contains hollow fibre- like tubes (Fig. 8.7A) with open pores which can 
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be seen on cross section (Fig. 8.7A) inside the tube (Fig. 8.7B) and on the back side of the 
sheet (Fig. 8.7C). 
Optical microscopy 
Figure 8.7: SEM and optical microscopic pictures of PCL membrane obtained by immersion 
precipitation method 
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Cell culture in static system 
To investigate the cell response towards our PHMSH, HUVECs and fibroblast were 
seeded onto it in static cell culture system. None of the two cells types were attached to the 
sheets, but when the same membrane was coated with HApp the both cell types were 
considerably attached on it (Fig. 8.8). 
Moreover by adapting to our third system of angiogenesis, developed in this thesis (see 
Chapter 7) a co-culture cell seeding by using 50% HUVECs and 50% fibroblast cells (with a 
cell density of 10 6 cells/ml were performed on RGD coated PET fibres, as developed in my 
thesis and previously published (HADJIZADEH, et al. 2007). These fibres were then 
embedded in fibrin gel. In an 11 day culture period a layer of fibroblasts were formed (Fig. 8.9 
gray color) containing microvessel-like structures, formed by HUVECs (Fig. 8.9 red color, 
stained by Dil-acetylated LDL). All these preliminary observations demonstrate that our 
composite scaffold (i.e. comprising PHMSH, polymer fibre and fibrin gel) can be further 
applied to investigate multicellular tissue fabrication in a bioreactor system. 
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Figure 8.8: Endothelial and fibroblast adhesion on PCL PHMSH: Observation by 
epifluorescence microscopy of PCL PHMSH seeded by EC (A 1-4) and fibroblast 
(Bl-4). In A1-4, B1 and B4 cells stained with Sytox Green to highlight the 
position of the nuclei. In A3 cells stained using TRITC-phalloidin, and 
counterstained with Sytox Green. In B2 and B3 cells stained with calcein AM. In 
A4 and B4 cells were injected inside the tubes of PHMSH but in the others cells 
were seeded on the PHMSH. The pictures A1-3 and Bl-2 have been previously 
published (HADJIZADEH and VERMETTE 2007). 
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8.5. Future experimentations 
PHMSH characterization 
Determination of porosity, mechanical properties and degradation will be performed in 
future experiments. 
Cell culture test in bioreactor 
Finally, the 3D scaffold will be tested in bioreactor culture. A chamber has been 
previously designed (data from Davod Mohebbi Kalhori and myself) and made for bioreactor 
cell culture testing of the PHMSH and then the above mentioned 3D composite flat shape 
scaffold. 
Figure 8.10: Chamber for cell and tissue culture in bioreactor (data from Davod Mohebbi 
Kalhori and myself) 
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8.6. Conclusion 
The findings in previous chapters of this thesis were used for designing and fabrication of 
a large scale, sandwich-shape 3D composite scaffold. The preliminary results obtained by 
SEM analysis and cell culture testing demonstrated the successful design, fabrication and 
evaluation of the PHMSH which is the main part of the composite scaffold. In this scaffold, 
our in vitro 3D angiogenesis models in conjunction with the PHMSH will generate a new 
approach to produce a large scale vascularised mass-like tissue. 
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Chapter 9 
Conclusion and perspectives 
9.1. Conclusion 
In order to enhance vascularization in engineered tissue constructs, several approaches are 
currently under investigation. Biomaterials in the form of scaffolds are currently the subject of 
intensive research on this matter. These include; enhancing the capability of scaffolds to 
induce vascularization with the incorporation of ECM compounds and, angiogenic growth 
factors, as well as modifying the architecture and biomechanics of scaffolds. However, in 
order to induce prompt vascularization, needed to supply oxygen for the cells within a scaffold 
on its implantation in the host, a tissue construct or scaffold should be able to be vascularized 
in vitro, prior to implantation. Therefore, in this research project, fibrous scaffolding materials 
have been fabricated and then in vitro angiogenesis models have been developed to guide 
vascularization within a 3D environment. Such developments create a desirable directional 
condition for blood microvessel formation. Therefore, the aim of this study was to investigate the 
possibility of producing surface modified polymeric fibres, with the capability of both 
directional EC patterning and of inducing angiogenesis in a 3D cell culture system. This is the 
goal for developing an in vitro, prevascularized 3D scaffold, made of a fibre network. The 
fibres were surface coated with an ECM component, RGD peptide or gelatin. Then, by the use 
of these fibers, exhibiting the phenomenon of contact guidance to modulate the 3D patterning 
of EC, the directional angiogenesis in vitro was created. These approaches have been achieved 
through following three specific objectives in this study: 
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1) Surface modification and characterization of flat and fibrous materials, with both cell 
resistant and cell adhesive compounds, to produce controlled biological responses. 
2) In vitro evaluation of surface modified substrates towards the EC behavior in a 2D cell 
culture system. 
3) In vitro evaluation of surface modified polymer fibres towards a more complex EC 
behavior (i.e. angiogenesis) in a 3D cell culture system. 
These studies and their results for each step have been summarized in the paragraphs below. 
Surface modification and characterization of materials, more specifically polymeric fibre 
surfaces, with cell adhesive, cell non-adhesive and bioactive compounds 
Surface chemistry; physics and topography can all control the behaviours of different cell 
types on polymeric materials at the cell-biomaterial interface. To achieve controlled and 
predictable biological responses, the surface of polymer fibres were pre-coated with a layer of 
the desired biomolecule, using a multilayer surface coating strategy, that exhibited predictable 
biological responses. This surface modification consists of the following steps and aims: 
1) HApp or AApp was deposited onto the surfaces as a thin polymeric interfacial 
layer having amine or aldehyde groups, respectively, by RFGD deposition. 
These coatings offer two advantages; i) introduction of new functional groups 
(i.e. the amine or aldehyde) for the covalent grafting of a desired second layer 
(e.g. CMD), and ii) altering physicochemical properties of the surface to 
increase the cell adhesion. 
2) CMD has been covalently immobilized onto the amine functional groups, 
present on the substrate surfaces via water-soluble carbodiimide chemistry 
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(EDC/NHS). Prior to the CMD grafting, the acetaldehyde coated surfaces were 
amine functionalised by on-the grafting of PEI layers. Here, the CMD layer 
plays two roles; i) prevent surface fouling towards proteins and cells, and ii) 
introducing -COOH functional groups in order to covalently immobilize bio-
active molecules. 
3) Finally, biological molecules, such as the RGD peptides, have been covalently 
immobilized onto the surface carboxylic acid groups (COOH), present on the 
surfaces, again, by use of water-soluble carbodiimide chemistry (EDC/NHS). 
This coating enables the surface to exhibit an integrin stimulated, cell adhesion. 
The characterization of surface chemistry and topography, using XPS, AFM and SEM 
respectively, shows that the multilayer production steps were effective. XPS analyses revealed 
that HApp and AApp, using the RFGD method, can be deposited on different substrates with 
distinct rigidity and shape. Substrates include: - polymer fibre, porous and non porous 
polymeric films and non polymeric, flat surfaces. Moreover, XPS characterization of PTFE 
and borosilicate, which have specific elemental signals (fluorine and silicon respectively) 
clearly demonstrate the formation of uniform films, thicker than 10 nm, in both HApp and 
AApp surface coatings. 
CMD was successfully grafted covalently onto the surface amine groups, being available 
on the HApp and AApp + PEI coated surfaces, as demonstrated by the XPS analysis. It has 
also been found that CMD, with a molecular weight of 70kDa, and a CMD solution 
concentration of 2 mg/ml, generate more uniform and thicker films, in comparion to that of 
CMD, with the same molecular weight, at a solution concentration of 1 mg/ml, in 
immobilizing, both on the HApp and the on AApp + PEI. The XPS Cls spectrum of CMD 
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indicates that the CMD bound on the AApp-coated surface, via a PEI spacer layer, creates a 
thicker and more effective layer than the same CMD, when directly attached to the HApp 
surface. 
According to the XPS analysis, covalent immobilization of RGD onto the CMD coated 
surface was deemed to be successful, as the N/C atomic ratio increased on the RGD 
immobilized surface, in comparison to the CMD coated surface. In addition, by increasing the 
concentration of the RGD solutions, from 0.1 to 1 mg/ml, the N/C atomic ratio also increased, 
thus demonstrating an increase in the density of the covalently grafted RGD on the surface. 
This technique can be applied to produce surfaces with the capability of integrin-stimulated 
cell adhesion. 
The existence of thin films obtained by plasma deposition, and subsequent surface CMD 
immobilization, as determined by SEM and AFM, produced topographic maps of the analyzed 
surfaces and provided qualitative information on the different coatings. The AApp plasma-
deposited and CMD-coated surfaces were more rough, in comparison to the other surface 
modifications. 
Therefore, in conclusion, these multistep surface fabrication techniques can be applied to 
produce biomaterials with multifunctional surfaces that can have important applications in 
tissue engineering, especially as scaffolding materials for tissue generation. 
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In vitro evaluation of surface modified polymer fibres towards EC behavior in a 2D cell 
culture system. 
Control over cell behavior such as the adhesion, spreading, proliferation and orientation, by 
modifying the surface properties of biomaterial (e.g. scaffold), plays an important role in the 
formation of living tissues. The presence of micro-curvature and bio-signals on a surface allows 
the control of cell-substrate interaction to create patterns of oriented cells. 
The biological properties of surface modified polymer fibres (PET and ePTFE) were 
validated towards the behaviour of HUVECs in a 2D in vitro system. For this purpose, 
HUVECs were used to investigate cell responses (i.e. adhesion, spreading, and orientation) as 
a function of the fibre surface properties. As expected, the cell adhesion was reduced on 
CMD-coated fibres, whereas aldehyde-, amine-, gelatin- and GRGDS-coated fibres promoted 
cell adhesion and spreading. Conversely, cell adhesion on the GRGES-coated fibres (in-active 
peptide control) was significantly lower than that observed on GRGDS-coated fibres. These 
observations suggest that the EC adhesion promotion on RGD-coated polymer fibres can be 
attributed to the biospecific responses of cell surface integrins towards RGD ligands present 
on the surfaces. On these fibres, cell adhesion increased by increasing the GRGDS solution 
concentration from 0.1 to 1.0 mg/ml. The formation of well-defined stress fibers and strong 
vinculin spots (typical of FAs) on RGD-coated substrates, demonstrated a strong cell adhesion 
on this coating. In addition, the cells showed a more oriented morphology along the fibre axis 
in comparison to flat surface substrates, and this became increasingly evident in long-term cell 
cultures. In addition, it was observed that in comparison to the surface features (i.e. roughness) 
surface chemistry was the dominant parameter in inducing HUVEC adhesion and spreading. 
More importantly, this study points out the suitability of RF heptylamine and acetaldehyde 
plasma polymerization, in inducing desirable coatings on substrates, with the subsequent 
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ability to support the attachment and spreading of HUVECs. In order to ensure the 
performance and reproducibility of this multilayer surface modification technique, and to 
further characterize the cell response to the coatings generated by this technique, flat 
substrates were surface coated and cell culture tested, in the same manner as PET and PTFE 
polymer fibres. All results obtained were in agreement with each other, thus demonstrating 
reproducibility of these multilayer steps, surface modifications. 
In vitro evaluation of the surface modified polymer fibres towards complex EC behavior 
(i.e. angiogenesis) in a 3D cell culture system 
The two main goals of this study were; (i) to investigate the possibility of producing pre-
vascularized in vitro 3D tissue constructs, and (ii) to influence the guidance of vessels in a pre-
determined direction, using 100pm diameter polymer fibres, being distanced one from the 
other. Using fibres, an angiogenic process can take place in vitro, ranging from tube formation 
by HUVECs to the connections made between branches. These behaviors have been achieved 
in particular by the use of surface modified polymer fibres on which gelatin and RGD peptides 
were covalently immobilized, via HApp and CMD interlayers, to encourage and modulate 
directional vessel formation within the 3D environment of the construct. Among the three 
different in vitro fibrin-based systems, used to investigate angiogenesis along the fibres, only 
two systems worked well. In addition, the presence of fibroblasts over fibrin gel promoted the 
formation of the microvessels. The physical effect of fibres, in conjunction with the surface 
chemistry of the fibres, influenced in vitro microvessel formation, as observed in both 
systems. The prolongation of the culture period allowed the formation of a network in which 
microvessels, connected to each other, from one fibre to another, following efficient fibre 
224 
spacing, ranging from 200 to 600 pm. Therefore, these specifically modified polymer fibres, 
have interesting features towards tissue engineering. These include (i) the development of an 
in vitro prevascularized system composed of a biocompatible matrix (e.g. fibrin) and polymer 
fibres, and (ii) the production of a directionally vascularized tissue construct, which can 
subsequently be employed to produce directional orientation of tissues. 
In conclusion, I have developed a new approach that can be applied in therapeutic 
angiogenesis and prevascularised tissue engineered construct fabrication. In addition, this 
strategy can also be a suitable in vitro system to evaluate the angiogenic ability of ECM 
components, (investigated for RGD and gelatin in this thesis). Moreover, each of the 
multilayer surface modification steps (i.e. plasma polymerization, non fouling material coating 
and biomolecule immobilization), can be applied for various purposes in tissue engineering. 
Furthermore, the research findings, as mentioned in the three above sections, were used to 
design and fabricate a large scale, sandwich-shape, 3D composite scaffold. This scaffold 
design has been based on our two in vitro 3D angiogenesis models, in which HUVECs form a 
directional angiogenic network, when they are present on the surface modified polymer fibres 
between 2 layers of fibrin gel or when HUVECs are pre-coated onto the fibres bearing cell-
adhesive coating and embedded in the fibrin gel. The preliminary study shows that, in this 
scaffold, the two above mentioned systems in conjunction with a PHMSH will generate a new 
approach to produce a large scale, vascularised mass-like tissue. 
It should be noted that, in this study, the idea of using polymer fibre (100-pm diameter), 
for both EC patterning and inducing angiogenesis, is quite original. Moreover, polymer fibre 
surface modifications, using multilayer surface coatings, including cell adhesive plasma 
polymers (i.e. HApp and AApp), non cell adhesive material (i.e. CMD), and bioactive 
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molecules (i.e. RGD), have not previously been reported by others. In addition, the 
physicochemical characterization of these fibre surface coatings, as well as their influence on 
EC behaviours (i.e. cell adhesion, spreading and patterning) in 2D cell culture system and 
toward the angiogenesis in the two above mentioned 3D cell culture systems (i.e. using 
hydrogel), have not been reported elsewhere. The 3D large scale scaffold design, the PHMSH 
design and fabrication and the bioreactor chamber design and construction, all are truly new 
approaches achieved in this study (by the contribution of Davod mohebbi kalhori). 
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9.2. Perspective study 
RGD-grafted polymer fibres in induction and guidance of angiogenesis in vitro and in 
vivo: The effect of peptide surface density 
In this study, RGD peptides will be immobilized on surface functionalized polymer fibres 
in the same way as explained earlier in this thesis, in using various RGD solution 
concentrations in order to produce distinct, RGD surface densities. The different densities of 
the RGD present on the surface will be determined by the use of tagged molecules (e.g. 
fluorinated tag molecules) and XPS analysis. The RGD-coated fibres will then be tested in a 
3D cell culture system (by performing the models developed in this thesis, i.e. the second and 
third systems, as explained earlier) and also in in vivo models. The latter will have to be 
developed further. 
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Chapter 10 
Appendix 
10.1. Analytical techniques used for surface characterization 
The base of the techniques employed for the characterization of surface modified 
materials, in this thesis, is briefly explained in the following paragraphs. 
10.1.1. X-Ray Photoelectron Spectroscopy (XPS) 
XPS operates based on photoemission of core-level electrons in an atom. Energetic X-rays 
with energy (hv) strike an atom and liberate core-level electrons, with adequate kinetic energy 
(Ek) to escape from the material surface. Figure 10.1 schematically shows the photoemission 
process within an atom. These electrons will pass through the vacuum chamber to the energy 
spectrum analyzer, for which the EK will be measured. The binding energy (EB) is determined 
according to the energy balance, as presented in figure 10.2, and the data are typically 
collected as survey spectra spanning the EB range of about 10 to 1000 electron volts (eV). 
Then high-resolution spectra can be collected in a region of interest to look at carefully for the 
fine structure of typical core-level peaks (e.g. carbon Is, oxygen Is, etc.). Typical Cls and 
Ols EB values for the chemical groups present in polymers can be found in typical tables in 
the references (RATNER and CASTER 1997). 
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Figure 10.1: (a) A surface striked by a high energy photon source will emit electrons. If the 
light source is in the X-ray energy range, this is the XPS experiment, (b) The X-
ray photon transfers its energy to a core-level electron and generates a 
photoelectron (reproduced from RATNER and CASTER 1997). 
hv = EB + EKIN 
Figure 10.2: Energy balance for the process described by (Einstein in 1905). Where EB is the 
binding energy of the electron in the atom (a function of the atom type and its 
environment), hv is the energy of the X-ray source, and Ekin represents the kinetic 
energy of the ejected electron from the atom which is measured in the XPS 
spectrometer (RATNER and CASTER 1997). 
10.1.2. Scanning Electron Microscopy (SEM) 
SEM uses electrons to create an image. In SEM analysis the sample (coated with a very 
thin electrically conductive layer (e.g. gold or platinum) by a sputter coater) is placed inside 
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the microscope's vacuum column. Once the electron beam strikes the sample, the electrons and 
X-rays are ejected from the sample, as shown in Figure. 10.3 [website ref.8]. 
Incident Beam 
Sample 
Figure 10.3: Ejection of secondary electrons, backscattered electrons, Auger electrons and X-
rays from the sample when electron beam hits the sample in SEM analysis 
[reproduced from website ref. 8]. 
Among them secondary electrons are used for surface morphological analysis which are 
collected by a detector and transformed into a signal that is sent to a screen to appear as a 3D 
image [website ref.8]. Secondary electrons refer to those electrons of the test specimen that are 
pushed out of the atom by electron beam, and exit the surface of the sample [Website ref.9]. 
Field Emission Gun Scanning Electron Microscope (FEGSEM) 
Cold cathode field emission microscopy is a new generation of SEM for which the resolution 
and beam density (brightness) is higher than that of a conventional SEM. Moreover, the tip 
life is longer than Thermal Tungsten wire SEMs (conventional SEM) [website ref. 10]. 
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10.1.3. Atomic force microscopy (AFM) 
Surface texture measurements 
The full characterization of the surface texture becomes easy and precise by direct 
visualization of a surface. AFM has been developed for this purpose, especially in those cases 
that the surface feature sizes are of nanometric scale [Website ref. 11]. Topographical imaging 
of a surface with atomic-level resolution on rigid materials can be performed by AFM. In 
surface analysis by AFM, laser light, is reflected from a microfabricated cantilever, of typical 
spring constant (0.1-1 Nm"1). The deflection of the cantilever is recorded by a photodetector. 
The cantilever has a tip that comes very close to the surface and scans the surface in both the x 
and y directions. A feedback system keeps a constant force on the sample by means of a fixed 
laser beam on the photodiode. At the same time, piezoelectric translators adjust the z-axis of 
the sample to complete the processes (LEGGETT 1997). 
Figure 10.4: Schematic representation of the operation of the AFM (reproduced from 
LEGGETT 1997). 
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10.2. Mechanisms of reactions in carbodiimide coupling using 
EDC/NHS 
The formation of amide bonds between carboxylic acids (COOH) and amines (NH2) can 
be catalyzed by carbodiimide, forming an O-urea derivative. This derivative is prone to the 
nucleophillic attacks by nucleophilies (basic, electron-rich reagents that tend to attack the 
nucleus of carbon) resuling in forming amide bonds. 1-Ethyl - 3-(3- dimethylaminopropyl)-
carbodiimide (EDAC) is a water-soluble derivative of carbodiimide, widely used for this 
purpose [Website ref. 12]. 
EDC 1'Efhyi~3-{3-direet!-:y'ammQpropyl) Cafbodhmide Hydrochloride MW 191.7 
N- hydroxysuccinimide (NHS) has been used to accelerate the carbodiimide coupling in 
the presence of EDC. In this reaction, the carboxylic group and NHS condense and produce an 
active ester (as an intermediate), which subsequently produces the final amide bond by 
reacting with the amine group. Figure 10.6 shows the mechanism of the carbodiimide coupling 
reaction provided by EDC and promoted by NHS (HERMANSON 1996). 
° N 0 
OH 
N- Hydroxysuccinimide (NHS) 
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Figure 10.5: The mechanism of the carbodiimide coupling reaction provided by EDC and 
promoted by NHS (reproduced from HERMANSON 1996). 
10.3. Materials 
10.3.1. CMD characterization 
The degree of carboxylation was assessed using 1H NMR. The NMR spectra of the two 
CMDs, 70 kDa and 500 kDa MW, are shown in Figure 10.7. The experimentally determined 
ratios were ca. 1 carboxyl groups per 2 sugar units. 
Nuclear magnetic resonance (NMR) 
High-resolution NMR spectroscopy is able to quantitatively identify nuclei and their 
environments in a polymer molecule. Proton NMR (1HNMR) is commonly used for the 
characterization of polymers. The proton ('Hydrogen nucleus) is the most sensitive (apart 
from tritium) nucleus and is known to produce strong signals [Website ref. 13]. 
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Figure 10.6: The 'H NMR spectra of two synthesized CMDs, 70 kDa and 500 kDa MW which 
were used in this study. 
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Fibre holder design 
o o o o o o o o o o o 
Figure 10.7: Dimensions of the circular fibre holder, provided by SolidWork software (drawn 
by Marc G. Couture) 
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